Health Insurance (General Medical Services Table) Regulations 2021

Schedule 1—General medical services table

5.1.1 Restriction on items in this Part—services connected with provision of pain pump for post‑surgical pain management

An item in Group T1, T2, T3, T4, T6, T7, T8, T9 or T10 does not apply to a service described in the item if the service is provided at the same time as, or in connection with, the provision of a pain pump for post‑surgical pain management.

Division 5.2—Group T1: Miscellaneous therapeutic procedures

5.2.1 Meaning of comprehensive hyperbaric medicine facility

In items 13015, 13020, 13025 and 13030:

comprehensive hyperbaric medicine facility means a separate hospital area that, on a 24‑hour basis:

(a) is equipped and staffed so that it is capable of providing to a patient:

(i) hyperbaric oxygen therapy at a treatment pressure of at least 2.8 atmospheric pressure absolute (180 kilopascal gauge pressure); and

(ii) mechanical ventilation and invasive cardiovascular monitoring within a monoplace or multiplace chamber for the duration of the hyperbaric treatment; and

(b) is under the direction of at least one medical practitioner who is rostered, and immediately available, to the facility during the facility’s ordinary working hours if the practitioner:

(i) is a specialist with training in diving and hyperbaric medicine; or

(ii) holds a Diploma of Diving and Hyperbaric Medicine of the South Pacific Underwater Medicine Society; and

(i) at least one medical practitioner with training in diving and hyperbaric medicine who is present in the facility and immediately available at all times when patients are being treated at the facility; and

(ii) at least one registered nurse with specific training in hyperbaric patient care to the published standards of the Hyperbaric Technicians and Nurses Association, who is present during hyperbaric oxygen therapy; and

(d) has admission and discharge policies in operation.

5.2.2 Meaning of embryology laboratory services

In items 13200 and 13201:

embryology laboratory services includes:

(a) egg recovery from aspirated follicular fluid; and

(b) semen preparation; and

(d) monitoring of fertilisation and embryo development; and

(e) preparation of gametes or embryos for transfer or freezing.

5.2.3 Meaning of treatment cycle

In clause 5.2.4 and items 13200 to 13209, 13215 and 13218:

treatment cycle, for a patient, means a series of treatments for the patient that:

(a) begins:

(i) if treatment with superovulatory drugs is given—on the day on which that treatment begins; or

(ii) if treatment with superovulatory drugs is not given—on the first day of a menstrual cycle of the patient; and

(b) ends:

(i) if a service described in item 13212, 13215 or 13221 is provided in connection with the series of treatments—on the day after the day on which the last of those services is provided; or

(ii) in any other case—not more than 30 days after the day mentioned in subparagraph (a)(i) or (ii).

5.2.4 Items provided as part of treatment cycle relating to assisted reproductive services not to apply

(1) This clause applies if:

(a) a service to which an item (the first item) in Subgroup 3 of Group T1 applies is provided to a patient during a treatment cycle; and

(b) a service described in an item (the second item) (other than an item in Subgroup 3 of Group T1 or item 73384, 73385, 73386 or 73387 of the pathology services table) is provided to the patient during the same treatment cycle; and

(2) The second item does not apply to the service described in that item.

5.2.5 Restriction on item 13104—timing

Item 13104 does not apply to a patient more than 12 times in a 12 month period.

5.2.6 Restriction on items relating to assisted reproductive services—certain pregnancy‑related circumstances

Items 13200 to 13221 do not apply to a service provided in relation to a patient’s pregnancy, or intended pregnancy, that is, at the time of the service, the subject of an agreement, or arrangement, under which the patient makes provision for transfer to another person of the guardianship of, or custodial rights to, a child born as a result of the pregnancy.

5.2.6A Restriction on items 14217 and 14220—maintenance therapy

A service under item 14217 or 14220 cannot be provided to a patient as maintenance therapy for the prevention of further relapse of the patient’s depression.

5.2.7 Restrictions on items 14227 to 14237—patients

Items 14227 to 14237 apply to a service in relation to a patient only if:

(a) the patient has:

(i) chronic spasticity of cerebral origin; or

(ii) chronic spasticity caused by multiple sclerosis, spinal cord injury or spinal cord disease; and

(b) oral antispastic agents have failed or have caused the patient to experience unacceptable side effects; and

5.2.8 Restrictions on item 14245—practitioner and timing

(1) Item 14245 applies only to a service provided by a medical practitioner who is registered by the Chief Executive Medicare to participate in the arrangements made, under paragraph 100(1)(b) of the National Health Act 1953, for providing an adequate pharmaceutical service for persons requiring treatment with an immunomodulating agent.

(2) Item 14245 applies once per day.

5.2.9 Restriction on item 13899—other services performed on the same day

Item 13899 does not apply to professional attendance by a specialist on a day for preparation of goals of care for a patient if, on that day, the specialist performs a service for the patient that is described in item 13870 or 13873.

5.2.10 Items in Group T1

This clause sets out items in Group T1.

Note: The fees in Group T1 are indexed in accordance with clause 1.3.1.

Group T1—Miscellaneous therapeutic procedures
Column 1 Item		Column 2 Description	Column 3 Fee ($)
Subgroup 1—Hyperbaric oxygen therapy
13015		Hyperbaric oxygen therapy, for treatment of localised non‑neurological soft tissue radiation injuries excluding radiation‑induced soft tissue lymphoedema of the arm after treatment for breast cancer, performed in a comprehensive hyperbaric medicine facility under the supervision of a medical practitioner qualified in hyperbaric medicine, for a period in the hyperbaric chamber of at least 1 hour 30 minutes and not more than 3 hours, including any associated attendance	265.10
13020		Hyperbaric oxygen therapy, for treatment of decompression illness, gas gangrene, air or gas embolism, diabetic wounds (including diabetic gangrene and diabetic foot ulcers) or necrotising soft tissue infections (including necrotising fasciitis or Fournier’s gangrene), or for the prevention and treatment of osteoradionecrosis, performed in a comprehensive hyperbaric medicine facility, under the supervision of a medical practitioner qualified in hyperbaric medicine, for a period in the hyperbaric chamber of at least 1 hour 30 minutes and not more than 3 hours, including any associated attendance	269.35
13025		Hyperbaric oxygen therapy, for treatment of decompression illness, air or gas embolism, performed in a comprehensive hyperbaric medicine facility, under the supervision of a medical practitioner qualified in hyperbaric medicine, for a period in the hyperbaric chamber greater than 3 hours, including any associated attendance—per hour (or part of an hour)	120.35
13030		Hyperbaric oxygen therapy performed in a comprehensive hyperbaric medicine facility, if the medical practitioner is pressurised in the hyperbaric chamber for the purpose of providing continuous life‑saving emergency treatment, including any associated attendance—per hour (or part of an hour)	170.05
Subgroup 2—Dialysis
13100		Supervision in hospital by a medical specialist of—haemodialysis, haemofiltration, haemoperfusion or peritoneal dialysis, including all professional attendances, if the total attendance time on the patient by the supervising medical specialist exceeds 45 minutes in one day	142.20
13103		Supervision in hospital by a medical specialist of—haemodialysis, haemofiltration, haemoperfusion or peritoneal dialysis, including all professional attendances, if the total attendance time on the patient by the supervising medical specialist does not exceed 45 minutes in one day	74.10
13104		Planning and management of home dialysis (haemodialysis or peritoneal dialysis) for a patient with end‑stage renal disease and supervision of the patient on self‑administered dialysis, if the attendance is by a consultant physician in the practice of the consultant physician’s specialty of renal medicine	153.90
13105		Haemodialysis for a patient with end‑stage renal disease if: (a) the service is provided by a registered nurse, an Aboriginal health worker or an Aboriginal and Torres Strait Islander health practitioner on behalf of a medical practitioner; and (b) the service is supervised by the medical practitioner (either in person or remotely); and (c) the patient’s care is managed by a nephrologist; and (d) the patient is treated or reviewed by the nephrologist every 3 to 6 months (either in person or remotely); and (e) the patient is not an admitted patient of a hospital; and (f) the service is provided in a Modified Monash 7 area	615.95
13106		Declotting of an arteriovenous shunt	126.30
13109		Indwelling peritoneal catheter (Tenckhoff or similar) for dialysis—insertion and fixation of (Anaes.)	236.95
13110		Indwelling peritoneal catheter (Tenckhoff or similar) for dialysis—removal of (including catheter cuffs) (Anaes.)	237.75
Subgroup 3—Assisted reproductive services
13200		Assisted reproductive technologies superovulated treatment cycle proceeding to oocyte retrieval, involving the use of drugs to induce superovulation and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination, transfer of frozen embryos or donated embryos or ova or a service to which item 13201, 13202, 13203 or 13218 applies, being services rendered during one treatment cycle—initial cycle in a single calendar year	3,236.75
13201		Assisted reproductive technologies superovulated treatment cycle proceeding to oocyte retrieval, involving the use of drugs to induce superovulation and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination, transfer of frozen embryos or donated embryos or ova or a service to which item 13200, 13202, 13203 or 13218 applies, being services rendered during one treatment cycle—each cycle after the first in a single calendar year	3,027.65
13202		Assisted reproductive technologies superovulated treatment cycle that is cancelled before oocyte retrieval, involving the use of drugs to induce superovulation and including quantitative estimation of hormones and ultrasound examinations, but excluding artificial insemination, transfer of frozen embryos or donated embryos or ova or a service to which item 13200, 13201, 13203 or 13218 applies, being services rendered during one treatment cycle	484.40
13203		Ovulation monitoring services for artificial insemination or gonadotrophin, stimulated ovulation induction, including quantitative estimation of hormones and ultrasound examinations, being services rendered during one treatment cycle but excluding a service to which item 13200, 13201, 13202, 13212, 13215 or 13218 applies	506.45
13207		Biopsy of an embryo, from a patient who is eligible for a service described in item 73384 under clause 2.7.3A of the pathology services table, for the purpose of providing a sample for pre‑implantation genetic testing—applicable to one or more tests performed in one assisted reproductive treatment cycle	115.00
13209		Planning and management of a referred patient by a specialist for the purpose of treatment by assisted reproductive technologies or for artificial insemination—applicable once during a treatment cycle	88.15
13212		Oocyte retrieval for the purpose of assisted reproductive technologies—only if rendered in connection with a service to which item 13200 or 13201 applies (Anaes.)	368.80
13215		Transfer of embryos or both ova and sperm to the uterus or fallopian tubes, excluding artificial insemination—only if rendered in connection with a service to which item 13200, 13201 or 13218 applies, being services rendered in one treatment cycle (Anaes.)	115.65
13218		Preparation of frozen or donated embryos or donated oocytes for transfer to the uterus or fallopian tubes, by any means and including quantitative estimation of hormones and all treatment counselling but excluding artificial insemination services rendered in one treatment cycle and excluding a service to which item 13200, 13201, 13202, 13203 or 13212 applies (Anaes.)	825.70
13221		Preparation of semen for the purpose of artificial insemination—only if rendered in connection with a service to which item 13203 applies	52.80
13241		Open surgical testicular sperm retrieval, unilateral, using operating microscope, including the exploration of scrotal contents, with biopsy, for the purposes of intracytoplasmic sperm injection, for male factor infertility, not being a service associated with a service to which item 13218 or 37604 applies (H) (Anaes.)	884.45
13251		Intracytoplasmic sperm injection for the purpose of assisted reproductive technologies, for male factor infertility, excluding a service to which item 13203 or 13218 applies	434.90
13260		Processing and initial cryopreservation (not including storage) of semen for fertility preservation treatment before or after completion of gonadotoxic treatment for malignant or non‑malignant conditions, in a post‑pubertal male in Tanner stages II–V, up to 60 years old, who is referred by a specialist or consultant physician—applicable to not more than 2 semen collection cycles	431.80
13290		Semen, collection of, from a patient with spinal injuries or medically induced impotence, for the purposes of analysis, storage or assisted reproduction, by a medical practitioner using a vibrator or electro‑ejaculation device including catheterisation and drainage of bladder if required	212.50
Subgroup 4—Paediatric and neonatal
13300		Umbilical or scalp vein catheterisation in a neonate with or without infusion or cannulation of a vein	59.25
13303		Umbilical artery catheterisation with or without infusion	87.85
13306		Blood transfusion with venesection and complete replacement of blood, including collection from donor	347.65
13309		Blood transfusion with venesection and complete replacement of blood, using blood already collected	296.40
13312		Blood for pathology test, collection of, by femoral or external jugular vein puncture in infants	29.60
13318		Central vein catheterisation by open exposure, in a patient under 12 years of age (Anaes.)	236.65
13319		Central vein catheterisation in a neonate via peripheral vein (Anaes.)	236.65
Subgroup 5—Cardiovascular
13400		Restoration of cardiac rhythm by electrical stimulation (cardioversion), other than in the course of cardiac surgery (H) (Anaes.)	100.75
Subgroup 6—Gastroenterology
13506		Gastro‑oesophageal balloon intubation for control of bleeding from gastric oesophageal varices	191.95
Subgroup 8—Haematology
13700		Harvesting of homologous (including allogeneic) or autologous bone marrow for the purpose of transplantation (Anaes.)	346.80
13703		Transfusion of blood including collection from donor, when used for intra‑operative normovolaemic haemodilution, other than a service associated with a service to which item 22052 applies	124.30
13706		Transfusion of blood or bone marrow already collected	86.70
13750		Therapeutic haemapheresis for the removal of plasma or cellular (or both) elements of blood, utilising continuous or intermittent flow techniques, including morphological tests for cell counts and viability studies, if performed; continuous monitoring of vital signs, fluid balance, blood volume and other parameters with continuous registered nurse attendance under the supervision of a consultant physician, other than a service associated with a service to which item 13755 applies—each day	142.20
13755		Donor haemapheresis for the collection of blood products for transfusion, utilising continuous or intermittent flow techniques, including morphological tests for cell counts and viability studies; continuous monitoring of vital signs, fluid balance, blood volume and other parameters; with continuous registered nurse attendance under the supervision of a consultant physician—other than a service associated with a service to which item 13750 applies—each day	142.20
13757		Therapeutic venesection for the management of haemochromatosis, polycythemia vera or porphyria cutanea tarda	75.90
13760		In vitro processing with cryopreservation of bone marrow or peripheral blood, for autologous stem cell transplantation for a patient receiving high‑dose chemotherapy for management of: (a) aggressive malignancy; or (b) malignancy that has proven refractory to prior treatment	793.50
Subgroup 9—Procedures associated with intensive care and cardiopulmonary support
13815		Central vein catheterisation, including under ultrasound guidance where clinically appropriate, by percutaneous or open exposure, other than a service to which item 13318 applies (Anaes.)	118.25
13818		Right heart balloon catheter, insertion of, including pulmonary wedge pressure and cardiac output measurement (Anaes.)	118.30
13830		Intracranial pressure, monitoring of, by intraventricular or subdural catheter, subarachnoid bolt or similar, by a specialist or consultant physician—each day	78.40
13832		Peripheral cannulation, including under ultrasound guidance where clinically appropriate, for veno‑arterial cardiopulmonary extracorporeal life support	917.50
13834		Veno–arterial cardiopulmonary extracorporeal life support, management of—the first day	513.65
13835		Veno–arterial cardiopulmonary extracorporeal life support, management of—each day after the first	119.50
13837		Veno‑venous pulmonary extracorporeal life support, management of—the first day	513.65
13838		Veno‑venous pulmonary extracorporeal life support, management of—each day after the first	119.50
13839		Arterial puncture and collection of blood for diagnostic purposes	23.95
13840		Peripheral cannulation, including under ultrasound guidance where clinically appropriate, for veno‑venous pulmonary extracorporeal life support	614.70
13842		Intra‑arterial cannulation, including under ultrasound guidance where clinically appropriate, for the purpose of intra‑arterial pressure monitoring or arterial blood sampling (or both)	97.35
13848		Counterpulsation by intra‑aortic balloon‑management, including associated consultations and monitoring of parameters by means of full haemodynamic assessment and management on several occasions on a day—each day	162.45
13851		Ventricular assist device, management of, for a patient admitted to an intensive care unit for implantation of the device or for complications arising from implantation or management of the device—first day	513.65
13854		Ventricular assist device, management of, for a patient admitted to an intensive care unit, including management of complications arising from implantation or management of the device—each day after the first day	119.50
13857		Airway access and initiation of mechanical ventilation (other than initiation of ventilation in the context of an anaesthetic for surgery), outside of an intensive care unit, for the purpose of subsequent ventilatory support in an intensive care unit	152.35
Subgroup 10—Management and procedures undertaken in an intensive care unit
13870		Management of a patient in an intensive care unit by a specialist or consultant physician who is immediately available and exclusively rostered to intensive care, including initial and subsequent attendances, electrocardiographic monitoring, arterial sampling, bladder catheterisation and blood sampling—management on the first day (H)	376.75
13873		Management of a patient in an intensive care unit by a specialist or consultant physician who is immediately available and exclusively rostered to intensive care, including all attendances, electrocardiographic monitoring, arterial sampling, bladder catheterisation and blood sampling—management on each day after the first day (H)	279.50
13876		Central venous pressure, pulmonary arterial pressure, systemic arterial pressure or cardiac intracavity pressure—once per day for each type of pressure for a patient: (a) when managed for the patient by a specialist or consultant physician who: (i) is immediately available to care for the patient; and (ii) is exclusively rostered to intensive care; and (b) when the patient is continuously monitored by indwelling catheter in an intensive care unit (H)	80.00
13881		Airway access and initiation of mechanical ventilation in an intensive care unit by a specialist or consultant physician to enable subsequent ventilatory support—not in association with any anaesthetic service (H)	152.35
13882		Ventilatory support in an intensive care unit, management of a patient: (a) by: (i) invasive means; or (ii) non‑invasive means, if the only alternative to non‑invasive ventilatory support is invasive ventilatory support; and (b) by a specialist or consultant physician who is immediately available and exclusively rostered to intensive care; each day (H)	119.90
13885		Continuous arterio venous or veno venous haemofiltration, management by a specialist or consultant physician who is immediately available and exclusively rostered to intensive care—on the first day (H)	159.90
13888		Continuous arterio venous or veno venous haemofiltration, management by a specialist or consultant physician who is immediately available and exclusively rostered to intensive care—on each day after the first day (H)	80.00
Subgroup 10A—Preparation of goals of care by intensive care specialist outside intensive care unit
13899		Professional attendance outside an intensive care unit for at least 60 minutes spent in preparation of goals of care for a gravely ill patient lacking current goals of care, by a specialist in the specialty of intensive care who takes overall responsibility for the preparation of the goals of care for the patient	278.75
Subgroup 11—Chemotherapeutic procedures
13950		Parenteral administration of one or more antineoplastic agents, including agents used in cytotoxic chemotherapy or monoclonal antibody therapy but not agents used in anti‑resorptive bone therapy or hormonal therapy, by or on behalf of a specialist or consultant physician—attendance for one or more episodes of administration	112.40
Subgroup 12—Dermatology
14050		UVA or UVB phototherapy administered in a whole body cabinet or hand and foot cabinet including associated consultations other than the initial consultation, if treatment is initiated and supervised by a specialist in the specialty of dermatology Applicable not more than 150 times in a 12 month period	54.90
14100		Laser photocoagulation using laser radiation in the treatment of vascular abnormalities of the head or neck, including any associated consultation, if: (a) the abnormality is visible from 3 metres; and (b) photographic evidence demonstrating the need for this service is documented in the patient notes; to a maximum of 4 sessions (including any sessions to which this item or any of items 14106 to 14118 apply) in any 12 month period (Anaes.)	158.65
14106		Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café‑au‑lait macules and naevi of Ota, other than melanocytic naevi (common moles), if the abnormality is visible from 3 metres, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which this item or any of items 14100 to 14118 apply) in any 12 month period—area of treatment less than 150 cm2 (Anaes.)	166.65
14115		Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café‑au‑lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which this item or any of items 14100 to 14118 apply) in any 12 month period—area of treatment 150 cm2 to 300 cm2 (Anaes.)	266.90
14118		Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café‑au‑lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which this item or any of items 14100 to 14115 apply) in any 12 month period—area of treatment more than 300 cm2 (Anaes.)	338.90
14124		Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café‑au‑lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, if: (a) a seventh or subsequent session (including any sessions to which this item or any of items 14100 to 14118 apply) is indicated in a 12 month period commencing on the day of the first session; and (b) photographic evidence demonstrating the need for this service is documented in the patient notes (Anaes.)	158.65
Subgroup 13—Miscellaneous therapeutic procedures
14201		Poly‑L‑lactic acid, one or more injections of, for the initial session only, for the treatment of severe facial lipoatrophy caused by antiretroviral therapy, if prescribed in accordance with section 85 of the National Health Act 1953—once per patient	246.45
14202		Poly‑L‑lactic acid, one or more injections of (subsequent sessions), for the continuation of treatment of severe facial lipoatrophy caused by antiretroviral therapy, if prescribed in accordance with section 85 of the National Health Act 1953	124.75
14203		Hormone or living tissue implantation, by direct implantation involving incision and suture (Anaes.)	53.20
14206		Hormone or living tissue implantation—by cannula	37.05
14212		Intussusception, management of fluid or gas reduction for (Anaes.)	192.75
14216		Professional attendance on a patient by a psychiatrist, who has undertaken training in Repetitive Transcranial Magnetic Stimulation (rTMS), for treatment mapping for rTMS, if the patient: (a) has not previously received any prior transcranial magnetic stimulation therapy in a public or private setting; and (b) is at least 18 years old; and (c) is diagnosed with a major depressive episode; and (d) has failed to receive satisfactory improvement for the major depressive episode despite the adequate trialling of at least 2 different classes of antidepressant medications, unless contraindicated, and all of the following apply: (i) the patient’s adherence to antidepressant treatment has been formally assessed; (ii) the trialling of each antidepressant medication has been at the recommended therapeutic dose for a minimum of 3 weeks; (iii) where clinically appropriate, the treatment has been titrated to the maximum tolerated therapeutic dose; and (e) has undertaken psychological therapy, if clinically appropriate	186.40
14217		Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of up to 35 services provided by, or on behalf of, a psychiatrist who has undertaken training in rTMS, if the patient has previously received a service under item 14216—each service up to 35 services	160.00
14218		Implanted infusion pump, refilling of reservoir with a therapeutic agent or agents for infusion to the subarachnoid space or accessing the side port to assess catheter patency, with or without pump reprogramming, for the management of chronic pain, including cancer pain	101.90
14219		Professional attendance on a patient by a psychiatrist, who has undertaken training in Repetitive Transcranial Magnetic Stimulation (rTMS), for treatment mapping for rTMS, if the patient: (a) is at least 18 years old; and (b) is diagnosed with a major depressive episode; and (c) has failed to receive satisfactory improvement for the major depressive episode despite the adequate trialling of at least 2 different classes of antidepressant medications, unless contraindicated, and all of the following apply: (i) the patient’s adherence to antidepressant treatment has been formally assessed; (ii) the trialling of each antidepressant medication has been at the recommended therapeutic dose for a minimum of 3 weeks; (iii) where clinically appropriate, the treatment has been titrated to the maximum tolerated therapeutic dose; and (d) has undertaken psychological therapy, if clinically appropriate; and (e) has previously received an initial service under item 14217 and the patient: (i) has relapsed after a remission following the initial service; and (ii) has had a satisfactory clinical response to the service under item 14217 (which has been assessed by a validated major depressive disorder tool at least 4 months after receiving that service)	186.40
14220		Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of up to 15 services provided by, or on behalf of, a psychiatrist who has undertaken training in rTMS, if the patient has previously received: (a) a service under item 14217 (which was not provided in the previous 4 months); and (b) a service under item 14219 Each service up to 15 services	160.00
14221		Long—term implanted device for delivery of therapeutic agents, accessing of, other than a service associated with a service to which item 13950 applies	54.65
14224		Electroconvulsive therapy, with or without the use of stimulus dosing techniques, including any electroencephalographic monitoring and associated consultation (H) (Anaes.)	169.25
14227		Implanted infusion pump, refilling of reservoir with baclofen for infusion to the subarachnoid or epidural space, with or without reprogramming a programmable pump, for the management of severe chronic spasticity	101.90
	14234	Infusion pump or components of an infusion pump, removal or replacement of, and connection to intrathecal or epidural catheter, and loading of reservoir with baclofen, with or without programming of the pump, for the management of severe chronic spasticity (H) (Anaes.)	376.55
	14237	Infusion pump or components of an infusion pump, subcutaneous implantation of, and intrathecal or epidural spinal catheter insertion, and connection of pump to catheter, and loading of reservoir with baclofen, with or without programming of the pump, for the management of severe chronic spasticity (H) (Anaes.)	686.65
14245		Immunomodulating agent, administration of, by intravenous infusion lasting at least 2 hours	101.90
Subgroup 14—Management and procedures undertaken in emergency department
14255		Resuscitation of a patient provided for at least 30 minutes but less than 1 hour, by a specialist in the practice of the specialist’s specialty of emergency medicine at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019 (Anaes.)	154.40
14256		Resuscitation of a patient provided for at least 1 hour but less than 2 hours, by a specialist in the practice of the specialist’s specialty of emergency medicine at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019 (Anaes.)	296.90
14257		Resuscitation of a patient provided for at least 2 hours, by a specialist in the practice of the specialist’s specialty of emergency medicine at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019 (Anaes.)	591.25
14258		Resuscitation of a patient provided for at least 30 minutes but less than 1 hour, by a medical practitioner (except a specialist in the practice of the specialist’s specialty of emergency medicine) at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036 (Anaes.)	115.85
14259		Resuscitation of a patient provided for at least 1 hour but less than 2 hours, by a medical practitioner (except a specialist in the practice of the specialist’s specialty of emergency medicine) at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036 (Anaes.)	222.70
14260		Resuscitation of a patient provided for at least 2 hours, by a medical practitioner (except a specialist in the practice of the specialist’s specialty of emergency medicine) at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036 (Anaes.)	443.45
14263		Minor procedure on a patient by a specialist in the practice of the specialist’s specialty of emergency medicine at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019 (Anaes.)	54.35
14264		Procedure (except a minor procedure) on a patient by a specialist in the practice of the specialist’s specialty of emergency medicine at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019 (Anaes.)	122.35
14265		Minor procedure on a patient by a medical practitioner (except a specialist in the practice of the specialist’s specialty of emergency medicine) at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036 (Anaes.)	40.75
14266		Procedure (except a minor procedure) on a patient by a medical practitioner (except a specialist in the practice of the specialist’s specialty of emergency medicine) at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036 (Anaes.)	91.75
14270		Management, without aftercare, of all fractures and dislocations suffered by a patient that: (a) is provided by a specialist in the practice of the specialist’s specialty of emergency medicine in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019; and (b) occurs at a recognised emergency department of a private hospital (Anaes.)	137.15
14272		Management, without aftercare, of all fractures and dislocations suffered by a patient that: (a) is provided by a medical practitioner (except a specialist in the practice of the specialist’s specialty of emergency medicine) in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (b) occurs at a recognised emergency department of a private hospital (Anaes.)	102.90
14277		Application of chemical or physical restraint of a patient by a specialist in the practice of the specialist’s specialty of emergency medicine at a recognised emergency department of a private hospital	154.40
14278		Application of chemical or physical restraint of a patient by a medical practitioner (except a specialist in the practice of the specialist’s specialty of emergency medicine) at a recognised emergency department of a private hospital	115.85
14280		Anaesthesia (whether general anaesthesia or not) of a patient that: (a) is managed by a specialist in the practice of the specialist’s specialty of emergency medicine at a recognised emergency department of a private hospital; and (b) occurs in conjunction with an attendance on the patient that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017, 5019, 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (c) is not anaesthesia provided by a specialist anaesthetist to which an item in Group T7 or T10 applies	154.40
14283		Anaesthesia (whether general anaesthesia or not) of a patient that: (a) is managed by a medical practitioner (except a specialist in the practice of the specialist’s specialty of emergency medicine) at a recognised emergency department of a private hospital; and (b) occurs in conjunction with an attendance on the patient that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017, 5019, 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (c) is not anaesthesia provided by a specialist anaesthetist to which an item in Group T7 or T10 applies	115.85
14285		Emergent intubation, airway management or both of a patient that: (a) is managed by a specialist in the practice of the specialist’s specialty of emergency medicine at a recognised emergency department of a private hospital; and (b) occurs in conjunction with an attendance on the patient that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017, 5019, 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (c) is not anaesthesia provided by a specialist anaesthetist to which an item in Group T7 or T10 applies	154.40
14288		Emergent intubation, airway management or both of a patient that: (a) is managed by a medical practitioner (except a specialist in the practice of the specialist’s specialty of emergency medicine) at a recognised emergency department of a private hospital; and (b) occurs in conjunction with an attendance on the patient that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017, 5019, 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (c) is not anaesthesia provided by a specialist anaesthetist to which an item in Group T7 or T10 applies	115.85

Division 5.3—Group T2: Radiation oncology

5.3.1 Meaning of amount under clause 5.3.1

In item 15954:

amount under clause 5.3.1 means the sum of:

(a) the fee for item 15952; and

(b) $22.00 for each anatomical site separately treated in excess of one.

5.3.2 Meaning of radiation oncologist

In this Schedule:

radiation oncologist means a specialist practising in the specialist’s specialty of radiation oncology.

5.3.3 Items in Group T2

This clause sets out items in Group T2.

Note: The fees in Group T2 are indexed in accordance with clause 1.3.1.

Group T2—Radiation oncology
Column 1 Item	Column 2 Description	Column 3 Fee ($)
Subgroup 1—Targeted intraoperative radiation therapy
15900	Breast, malignant tumour, targeted intraoperative radiation therapy, using an Intrabeam® or Xoft® Axxent® device, delivered at the time of breast‑conserving surgery (partial mastectomy or lumpectomy) for a patient who: (a) is 45 years of age or over; and (b) has a T1 or small T2 (less than or equal to 3 cm in diameter) primary tumour; and (c) has a histologic grade 1 or 2 tumour; and (d) has an oestrogen‑receptor positive tumour; and (e) has a node negative malignancy; and (f) is suitable for wide local excision of a primary invasive ductal carcinoma that was diagnosed as unifocal on conventional examination and imaging; and (g) has no contra‑indications to breast irradiation Applicable once per breast per lifetime (H)	284.75
Subgroup 2—Megavoltage
15902	Megavoltage planning—level 1.1 Simple complexity single‑field radiation therapy simulation and dosimetry for treatment planning, without imaging for field setting, if: (a) all of the following apply in relation to the simulation: (i) the simulation is to one site; (ii) localisation is based on clinical mark‑up and image‑based simulation is not required; (iii) patient set‑up and immobilisation techniques are suitable for two‑dimensional radiation therapy treatment, with wide margins and allowance for movement; and (b) all of the following apply in relation to the dosimetry: (i) the planning process is required to deliver a prescribed dose to a point, either at depth or on the surface of the patient; (ii) based on review and assessment by a radiation oncologist, the planning process does not require the differential of dose between target, organs at risk and normal tissue dose; (iii) delineation of structures is not possible or required, and field borders will delineate the treatment volume; (iv) doses are calculated in reference to a point, either at depth or on the surface of the patient, from tables, charts or data from a treatment planning system Applicable once per course of treatment	725.45
15904	Megavoltage planning—level 1.2 Simple complexity radiation therapy simulation and dosimetry for treatment planning, with imaging for field setting, if: (a) all of the following apply in relation to the simulation: (i) treatment set‑up and technique specifications are in preparation for two‑dimensional radiation therapy dose planning; (ii) patient set‑up and immobilisation techniques are suitable for two‑dimensional radiation therapy treatment where interfraction reproducibility is required; (iii) imaging datasets are acquired for the relevant region of interest to be planned; and (b) all of the following apply in relation to the dosimetry: (i) the two‑dimensional planning process is required to calculate dose to a volume, however a dose‑volume histogram is not required to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the two‑dimensional planning process is not required to maximise the differential between target dose and normal tissue dose; (iii) the target (which may include gross, clinical and planning targets as a composite structure or field border outline), as defined in the prescription, is rendered as a two‑dimensional structure as field borders or a volume; (iv) organs at risk are delineated if required, and assessment of dose to these structures is derived from dose point calculations, rather than full calculation and inclusion in a dose‑volume histogram; (v) dose calculations are calculated using a specialised algorithm, with prescription and plan details approved and recorded with the plan Applicable once per course of treatment	1,062.85
15906	Megavoltage planning—level 2.1 Three‑dimensional radiation therapy simulation and dosimetry for treatment planning, without motion management, if: (a) all of the following apply in relation to the simulation: (i) treatment set‑up and technique specifications are in preparation for three‑dimensional planning without consideration of motion management; (ii) patient set‑up and immobilisation techniques are reproducible for treatment; (iii) a high‑quality dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and (b) all of the following apply in relation to the dosimetry: (i) the three‑dimensional planning process is required to calculate dose to three‑dimensional volume structures and requires a dose‑volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the three‑dimensional planning process (which must include multi‑leaf collimator‑based shaping to achieve target dose conformity and organs at risk avoidance or dose management or reduction) is required to optimise the differential between target dose and normal tissue dose; (iii) the planning target volume is rendered as a three‑dimensional structure on planning outputs (three‑dimensional plan review, three‑planar sections review or dose‑volume histogram); (iv) organs at risk are delineated, and assessment of dose to these structures is derived from calculation and inclusion in a dose‑volume histogram Applicable once per course of treatment	1,638.70
15908	Megavoltage planning—level 2.2 Three‑dimensional radiation therapy simulation and dosimetry for treatment planning with motion management, if: (a) all of the following apply in relation to the simulation: (i) treatment set‑up and technique specifications are in preparation for complex three‑dimensional planning with consideration of motion management; (ii) patient set‑up and immobilisation techniques are reproducible for treatment; (iii) a high‑quality three‑dimensional or four‑dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and (b) all of the following apply in relation to the dosimetry: (i) the three‑dimensional planning process is required to calculate dose to three‑dimensional volume structures (which must include structures moving with physiologic processes) and requires a dose‑volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the three‑dimensional planning process (which must include multi‑leaf collimator‑based shaping to achieve target dose conformity and organs at risk avoidance or dose management or reduction) is required to optimise the differential between target dose and normal tissue dose; (iii) the planning target volume is rendered as a three‑dimensional structure on planning outputs (three‑dimensional plan review, three‑planar sections review or dose‑volume histogram); (iv) organs at risk are delineated, and assessment of dose to these structures is derived from full calculation and inclusion in a dose‑volume histogram Applicable once per course of treatment	2,649.25
15910	Megavoltage planning—level 3.1 Standard intensity modulated radiation therapy (IMRT) simulation and dosimetry for treatment planning, if: (a) all of the following apply in relation to the simulation: (i) treatment set‑up and technique specifications are in preparation for single‑dose level IMRT planning without motion management; (ii) patient set‑up and immobilisation techniques are suitable for image volume data acquisition and reproducible IMRT treatment; (iii) a high‑quality three‑dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and (b) all of the following apply in relation to the dosimetry: (i) the IMRT planning process is required to calculate dose to a single‑dose level volume structure and requires a dose‑volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the IMRT planning process optimises the differential between target dose, organs at risk and normal tissue dose; (iii) all relevant gross tumour volumes, clinical target volumes, planning target volumes and organs at risk are rendered as volumes and nominated with planning dose objectives; (iv) organs at risk are nominated as planning dose constraints; (v) dose calculations and dose‑volume histograms are generated in an inverse planned process using a specialised algorithm, with prescription and plan details approved and recorded with the plan; (vi) a three‑dimensional image volume dataset is used for the relevant region to be planned and treated with image verification Applicable once per course of treatment	4,142.70
15912	Megavoltage re‑planning—level 3.1 Additional dosimetry plan for re‑planning of standard intensity modulated radiation therapy (IMRT) treatment, if: (a) an initial treatment plan described in item 15910 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment	2,071.35
15914	Megavoltage planning—level 3.2 Complex intensity modulated radiation therapy (IMRT) simulation and dosimetry for treatment planning, if (a) all of the following apply in relation to the simulation: (i) treatment set‑up and technique specifications are in preparation for multiple‑dose level IMRT planning or single‑dose level IMRT planning requiring motion management; (ii) patient set‑up and immobilisation techniques are suitable for image volume data acquisition and reproducible IMRT treatment; (iii) a high‑quality three‑dimensional or four‑dimensional volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and (b) all of the following apply in relation to the dosimetry: (i) the IMRT planning process is required to calculate dose to multiple‑dose level volume structures or single‑dose level volume structures (including structures moving with physiologic processes or requiring precise positioning with respect to beam edges) and requires a dose‑volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the IMRT planning process optimises the differential between target dose, organs at risk and normal tissue dose; (iii) all relevant gross tumour targets, clinical target volumes, planning target volumes, internal target volumes and organs at risk are rendered and nominated with planning dose objectives; (iv) organs at risk are nominated as planning dose constraints; (v) dose calculations and dose‑volume histograms are generated in an inverse planned process using a specialised algorithm, with prescription and plan details approved and recorded with the plan; (vi) a three‑dimensional or four‑dimensional image volume dataset is used for the relevant region to be planned and treated, with image verification for a multiple‑dose level IMRT planning or single‑dose level IMRT planning requiring motion management Applicable once per course of treatment	5,953.95
15916	Megavoltage re‑planning—level 3.2 Additional dosimetry plan for re‑planning of complex intensity modulated radiation therapy (IMRT) treatment, if: (a) an initial treatment plan described in item 15914 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment	2,976.95
15918	Megavoltage planning—level 4 Intracranial stereotactic radiation therapy (SRT) simulation and dosimetry for treatment planning, if: (a) all of the following apply in relation to the simulation: (i) treatment set‑up and technique specifications are in preparation for multiple non‑coplanar, rotational or fixed beam stereotactic delivery; (ii) precise personalised patient set‑up and immobilisation techniques are suitable for reliable imaging acquisition and reproducible SRT small‑field and ablative treatments; (iii) a high‑quality three‑dimensional image volume dataset is acquired in treatment position for the intracranial lesions to be planned and treated and verified; and (b) all of the following apply in relation to the dosimetry: (i) the planning process is required to calculate dose to single or multiple target structures and requires a dose‑volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the planning process maximises the differential between target dose, organs at risk and normal tissue dose; (iii) all relevant gross tumour volumes, clinical target volumes, planning target volumes and organs at risk are rendered and nominated with planning dose objectives; (iv) organs at risk are nominated as planning dose constraints; (v) dose calculations and dose‑volume histograms are generated using a validated stereotactic‑type algorithm, with prescription and plan details approved and recorded with the plan Applicable once per course of treatment	6,676.00
15920	Megavoltage planning—level 4 Stereotactic body radiation therapy (SBRT) simulation and dosimetry for treatment planning, if: (a) all of the following apply in relation to the simulation: (i) treatment set‑up and technique specifications are in preparation for inverse planning with multiple non‑coplanar, rotational or fixed beam stereotactic delivery or intensity modulated radiation therapy (IMRT) stereotactic delivery; (ii) personalised patient set‑up and immobilisation techniques are suitable for reliable imaging acquisition and reproducible, including techniques to minimise motion of organs at risk and targets; (iii) small‑field and ablative treatment is used; (iv) a high‑quality three‑dimensional or four‑dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned, treated and verified (through daily planar or volumetric image guidance strategies); and (b) all of the following apply in relation to the dosimetry: (i) the planning process is required to calculate dose to single or multiple target structures and requires a dose‑volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the planning process maximises the differential between target dose, organs at risk and normal tissue dose; (iii) all relevant gross tumour volumes, clinical target volumes, planning target volumes and organs at risk are rendered and nominated with planning dose objectives; (iv) organs at risk are nominated as planning dose constraints; (v) dose calculations and dose‑volume histograms are generated using a validated stereotactic‑type algorithm, with prescription and plan details approved and recorded with the plan Applicable once per course of treatment	6,676.00
15922	Megavoltage re‑planning—level 4 Additional dosimetry plan for re‑planning of intracranial stereotactic radiation therapy (SRT) or stereotactic body radiation therapy (SBRT) treatment, if: (a) an initial treatment plan described in item 15918 or 15920 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment	3,338.05
15924	Megavoltage planning—level 5 Specialised radiation therapy simulation and dosimetry for treatment planning, if both of the following apply in relation to the simulation: (a) treatment set‑up and technique specifications are in preparation for a specialised case with general anaesthetic or sedation supervised by an anaesthetist; (b) a high‑quality three‑dimensional or four‑dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification Applicable once per course of treatment (Anaes.)	7,046.30
15926	Megavoltage planning—level 5 Specialised radiation therapy simulation and dosimetry for treatment planning, if: (a) all of the following apply in relation to the simulation: (i) treatment set‑up and technique specifications are in preparation for a specialised application such as total skin electron therapy (TSE) or total body irradiation (TBI); (ii) reproducible personalised patient set‑up and immobilisation techniques are suitable to implement three‑dimensional radiation therapy, intensity modulated radiation therapy (IMRT) (including multiple non‑coplanar, rotational or fixed beam treatment delivery) or a specialised total body treatment delivery method; (iii) a specialised dataset of anatomical dimensions is acquired in the treatment position for TSE or TBI; and (b) all of the following apply in relation to the dosimetry: (i) total TSE, TBI, IMRT or multiple non‑coplanar, rotational or fixed beam treatment is used; (ii) the final dosimetry plan is validated by a radiation therapist and a medical physicist, using quality assurance processes; (iii) the final dosimetry plan is approved, prior to treatment delivery, by a radiation oncologist Applicable once per course of treatment	7,046.30
15928	Megavoltage re‑planning—level 5 Additional dosimetry plan for re‑planning of specialised radiation therapy if: (a) an initial treatment plan described in 15924 or 15926 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment (Anaes.)	3,523.15
15930	Megavoltage treatment—level 1.1 Radiation therapy for simple, single‑field treatment (including electron beam treatments), if: (a) the treatment does not use imaging for field setting; and (b) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (c) the treatment is delivered with a one‑dimensional plan; and (d) a two‑dimensional single‑field treatment delivery mode is utilised Applicable once per plan per day	91.25
15932	Megavoltage treatment—level 1.2 Radiation therapy and image verification for simple treatment, with imaging for field setting, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image‑guided radiation therapy (IGRT) imaging is used to implement a two‑dimensional plan, and (c) two‑dimensional treatment is delivered; and (d) image verification decisions and actions are documented in the patient’s record Applicable once per plan per day	113.65
15934	Megavoltage treatment—level 2.1 Radiation therapy and image verification for three‑dimensional treatment, without motion management, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image‑guided radiation therapy (IGRT) imaging is used to implement a standard three‑dimensional plan; and (c) three‑dimensional treatment is delivered; and (d) image verification decisions and actions are documented in the patient’s record Applicable once per plan per day	255.95
15936	Megavoltage treatment—level 2.2 Radiation therapy and image verification for three‑dimensional treatment, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image‑guided radiation therapy (IGRT) imaging is used to implement a complex three‑dimensional plan; and (c) complex three‑dimensional treatment is delivered with management of motion; and (d) image decisions and actions are documented in the patient’s record Applicable once per plan per day	278.40
15938	Megavoltage treatment—level 3.1 Standard single‑dose level intensity modulated radiation therapy (IMRT) treatment and image verification, without motion management, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image‑guided radiation therapy (IGRT) imaging is used to implement a standard IMRT plan described in item 15910 Applicable once per plan per day	278.40
15940	Megavoltage treatment—level 3.2 Complex multiple‑dose level intensity modulated radiation therapy (IMRT) treatment, or single‑dose level IMRT treatment requiring motion management, and image verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image‑guided radiation therapy (IGRT) imaging is used (with motion management functionality if required) to implement a complex IMRT plan described in item 15914; and (c) radiation field positioning requires accurate dose delivery to the target; and (d) image decisions and actions are documented in the patient’s record Applicable once per plan per day	306.25
15942	Megavoltage treatment—level 4 Intracranial stereotactic radiation therapy treatment and image verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image‑guided radiation therapy (IGRT) or minimally invasive stereotactic frame localisation is used to implement an intracranial stereotactic treatment plan described in item 15918; and (c) radiation field positioning requires accurate dose delivery to the target; and (d) image decisions and actions are documented in the patient’s record Applicable once per day	789.35
15944	Megavoltage treatment—level 4 Stereotactic body radiation therapy (SBRT) treatment and image verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image‑guided radiation therapy (IGRT) is used (with motion management functionality if required) to implement a stereotactic body radiation therapy plan described in item 15920; and (c) radiation field positioning requires accurate dose delivery to the target; and (d) image decisions and actions are documented in the patient’s record Applicable once per day	789.35
15946	Megavoltage treatment—level 5 Specialised radiation therapy treatment and verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) a specialised technique is used with general anaesthetic or sedation supervised by an anaesthetist Applicable once per plan per day	907.75
15948	Megavoltage treatment—level 5 Specialised radiation therapy treatment and verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) a specialised technique, such as total skin electron therapy (TSE) or total body irradiation (TBI), is used to implement a treatment plan described in item 15926; and (c) image‑guided radiation therapy (IGRT) is used (with motion management functionality, if required) to implement: (i) three‑dimensional radiation therapy; or (ii) intensity modulated radiation therapy (IMRT) (including multiple non‑coplanar, rotational or fixed beam treatment); or (iii) total skin electrons (TSE) where there is individualised treatment Applicable once per day	907.75
Subgroup 3—Kilovoltage
15950	Kilovoltage planning Simple complexity single‑field radiation therapy simulation and dosimetry for treatment planning without imaging for field setting, if: (a) both of the following apply in relation to the simulation: (i) localisation is based on clinical mark‑up and image‑based simulation is not required; (ii) patient set‑up and immobilisation techniques are suitable for two‑dimensional radiation therapy treatment, with wide margins and allowance for movement; and (b) all of the following apply in relation to the dosimetry: (i) the planning process is required to deliver a prescribed dose to a point, either at depth or on the surface of the patient; (ii) based on review and assessment by a radiation oncologist, the planning process does not require the differential of dose between target, organs at risk and normal tissue dose; (iii) delineation of structures is not possible or required, and field borders will delineate the treatment volume; (iv) doses are calculated in reference to a point, either at depth or on the surface of the patient, from tables, charts or data from a treatment planning system Applicable once per course of treatment	203.70
15952	Delivery of kilovoltage radiation therapy (50 kV to 500 kV range) to one anatomical site (excluding orbital structures where there is placement of an internal eye shield), other than a service to which item 15954 applies	54.85
15954	Delivery of kilovoltage radiation therapy (50 kV to 500 kV range) to 2 or more anatomical sites (excluding orbital structures where there is placement of an internal eye shield)	Amount under clause 5.3.1
15956	Delivery of kilovoltage radiation therapy (50 kV to 500 kV range) to orbital structures where there is placement of an internal eye shield	67.45
Subgroup 4—Brachytherapy
15958	Simple placement or insertion of any of the following kinds of brachytherapy device, without image guidance: (a) intracavitary vaginal cylinder, vaginal ovoids, vaginal ring or vaginal mould; (b) surface mould or applicator, with catheters fixed to or embedded into mould or applicator, on external surface of body; including the removal of applicators, catheters or needles	106.40
15960	Complex construction and manufacture of a personalised brachytherapy applicator or mould, derived from three‑dimensional image volume datasets, to treat intracavitary, intraoral or intranasal site, including the removal of applicators, catheters or needles	146.80
15962	Complex insertion of any of the following kinds of brachytherapy device, with image guidance and if a radiation oncologist is in attendance at the initiation of the service: (a) intrauterine tubes with or without ovoids, ring or cylinder; (b) endocavity applicators; (c) intraluminal catheters for treatment of bronchus, trachea, oesophagus, nasopharynx, bile duct; (d) endovascular catheters for treatment of vessels; including the removal of applicators, catheters or needles (Anaes.)	319.15
15964	Complex insertion and removal of hybrid intracavitary and interstitial brachytherapy applicators, or intracavitary and multi‑catheter applicators, with image guidance and if a radiation oncologist is in attendance at the initiation of the service (Anaes.)	425.60
15966	Complex insertion of any of the following kinds of interstitial brachytherapy implants not requiring surgical exposure, with image guidance, and if a radiation oncologist is in attendance during the service: (a) catheters or needles for temporary implants; (b) radioactive sources for permanent implants; (c) breast applicators, single channel and multi‑channel strut devices; including the removal of applicators, catheters or needles (Anaes.)	531.95
15968	Complex insertion of any of the following interstitial brachytherapy implants requiring surgical exposure (other than a service to which item 15900 applies), if a radiation oncologist is in attendance at the initiation of the service: (a) catheters, needles or applicators to a region requiring surgical exposure; (b) radioactive sources for permanent implants; (c) surface moulds during intraoperative brachytherapy; (d) plastic catheters or stainless steel needles, requiring surgical exposure; including implantation and removal of applicators, catheters or needles (Anaes.)	833.80
15970	Simple level dosimetry for brachytherapy plans prescribed to surface or depth from catheter and library plans, if: (a) the planning process is required to deliver a prescribed dose to a three‑dimensional volume, and relative to a single line or multiple channel delivery applicator; and (b) the planning process does not require the differential of dose between the target, organs at risk and normal tissue dose; and (c) delineation of structures is not required; and (d) dose calculations are performed in reference to the surface or a point at depth (two‑dimensional plan) from tables, charts or data from a treatment planning system library plan Applicable once per course of treatment	138.35
15972	Simple level dosimetry re‑planning of an initial brachytherapy plan described in item 15970 if treatment adjustments to that initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment	69.20
15974	Intermediate level dosimetry calculated on a volumetric dataset for intracavitary or intraluminal or endocavity applicators, for brachytherapy plans that have three‑dimensional image datasets acquired as part of simulation, if: (a) the planning process is required to deliver the prescribed dose to a three‑dimensional volume, and relative to multiple line for channel delivery applicators (excluding interstitial catheters and needles and multi‑catheter devices); and (b) based on review and assessment by a radiation oncologist, the planning process requires the differential of dose between target, organs at risk and normal tissue dose using avoidance strategies (which include placement of sources and/or dwell‑times or tissue packing); and (c) delineation of structures is required as part of the planning process to produce a dose‑volume histogram integral to the avoidance strategies; and (d) dose calculations are performed on a personalised basis, which must include three‑dimensional dose calculation to target and organ‑at‑risk volumes; and (e) dose calculations and the dose‑volume histogram are approved and recorded with the plan Applicable once per course of treatment	927.75
15976	Intermediate level dosimetry re‑planning of an initial brachytherapy plan described in item 15974 if treatment adjustments to that initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment	463.90
15978	Complex level dosimetry for brachytherapy plans that contain multiple needles, catheters or radiation sources, calculated on the three‑dimensional volumetric dataset, if: (a) the planning process is required to deliver a prescribed dose to a target volume relative to multiple channel delivery applicators, needles or catheters or radiation sources; and (b) based on review and assessment by a radiation oncologist, the planning process requires the differential of doses between the target, organs at risk and normal tissue dose using avoidance strategies (which include the placement of sources and/or dwell times or tissue packing; and (c) delineation of structures is required as part of the planning process, in order to produce a dose‑volume histogram to review and assess the plan; and (d) dose calculations are performed on a personalised basis, which must include three‑dimensional dose calculation to target and organ at risk volumes; and (e) dose calculations and the dose‑volume histogram are approved and recorded with the plan Applicable once per course of treatment	1,078.10
15980	Complex level dosimetry re‑planning of an initial brachytherapy plan described in item 15978 if treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment	539.10
15982	Brachytherapy treatment, if: (a) the service is performed by radiation therapists and medical physicists; and (b) a radiation oncologist is in attendance during the service; and (c) the treatment is to implement a brachytherapy treatment plan described in any of items 15970, 15972, 15974, 15976, 15978 and 15980	404.25
15984	Verification of position of brachytherapy applicators, needles, catheters or radioactive sources, if: (a) a two‑dimensional or three‑dimensional volumetric image set, or a validated in‑vivo dosimetry measurement, is required to facilitate an adjustment to the applicators, needles, catheters or dosimetry plan; and (b) decisions using the acquired images are based on action algorithms and enacted immediately prior to, or during, treatment, where treatment is preceded by manipulation or adjustment of delivery applicator or adjustment of the dosimetry plan; and (c) the service is associated with a service to which any of the following items apply: (i) items 15958 to 15968; (ii) item 15982	148.95

Division 5.4—Group T3: Therapeutic nuclear medicine

5.4.1 Items in Group T3

This clause sets out items in Group T3.

Note: The fees in Group T3 are indexed in accordance with clause 1.3.1.

Group T3—Therapeutic nuclear medicine
Column 1 Item	Column 2 Description	Column 3 Fee ($)
16003	Intra‑cavitary administration of a therapeutic dose of Yttrium 90 (not including preliminary paracentesis and other than a service to which item 35404, 35406 or 35408 applies or a service associated with selective internal radiation therapy) (Anaes.)	1,554.25
16006	Administration of a therapeutic dose of Iodine 131 for thyroid cancer by single dose technique	1,047.70
16009	Administration of a therapeutic dose of Iodine 131 for thyrotoxicosis by single dose technique	507.55
16012	Intravenous administration of a therapeutic dose of Phosphorous 32	2,915.10
16015	Administration of Strontium 89 for the relief of bone pain due to skeletal metastases (as indicated by a positive bone scan), if systemic antineoplastic therapy is unavailable or has failed to control the patient’s disease and either: (a) the disease is poorly controlled by conventional radiotherapy; or (b) conventional radiotherapy is inappropriate, due to the wide distribution of sites of bone pain	4,251.20
16018	Administration of 153 Sm‑lexidronam for the relief of bone pain due to skeletal metastases (as indicated by a positive bone scan), if systemic antineoplastic therapy is unavailable or has failed to control the patient’s disease, and: (a) the disease is poorly controlled by conventional radiotherapy; or (b) conventional radiotherapy is inappropriate, due to the wide distribution of sites of bone pain	4,814.70

Division 5.5—Group T4: Obstetrics

5.5.1 Definitions for item 16400

In item 16400:

nurse means a person:

(a) who is registered under a law of a State or Territory as a registered nurse or enrolled nurse; and

(b) who is employed by, or whose services are otherwise retained by, a medical practitioner or a practice operated by a medical practitioner.

5.5.2 Meaning of practice midwife in items 16400 and 16408

In items 16400 and 16408:

practice midwife means a midwife who is employed by, or whose services are otherwise retained by, a medical practitioner or a practice operated by a medical practitioner.

5.5.3 Restrictions on item 16400—provider and timing

(1) Item 16400 applies to an antenatal service provided to a patient by a practice midwife, nurse or Aboriginal and Torres Strait Islander health practitioner only if:

(a) the practice midwife, nurse or Aboriginal and Torres Strait Islander health practitioner has the appropriate training and skills to perform an antenatal service; and

(b) the medical practitioner under whose supervision the antenatal service is provided retains responsibility for clinical outcomes and for the health and safety of the patient; and

(c) the practice midwife, nurse or Aboriginal and Torres Strait Islander health practitioner complies with relevant legislative or regulatory requirements regarding the provision of the antenatal service in the State or Territory where the service is provided.

(2) Item 16400 does not apply in conjunction with another antenatal attendance item for the same patient, on the same day by the same practitioner.

(3) Item 16400 does not apply in conjunction with item 10990, 10991, 10992, 75855, 75856, 75857 or 75858.

(4) For any particular patient, item 16400 applies not more than 10 times in a 9 month period.

5.5.4 Items in Group T4

This clause sets out items in Group T4.

Note: The fees in Group T4 are indexed in accordance with clause 1.3.1.

Group T4—Obstetrics
Column 1 Item	Column 2 Description	Column 3 Fee ($)
16400	Antenatal service provided by a practice midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, applicable 10 times for a pregnancy, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and (c) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner; and (d) the service is not provided for an admitted patient of a hospital or approved day facility	28.35
16401	Professional attendance at consulting rooms or a hospital by a specialist in the practice of the specialist’s specialty of obstetrics after referral of the patient to the specialist—initial attendance in a single course of treatment	89.00
16404	Professional attendance at consulting rooms or a hospital by a specialist in the practice of the specialist’s specialty of obstetrics after referral of the patient to the specialist—an attendance after the initial attendance in a single course of treatment	44.75
16406	Antenatal professional attendance by an obstetrician or general practitioner, as part of a single course of treatment when the patient is referred by a participating midwife Applicable once for a pregnancy	139.40
16407	Postnatal professional attendance (other than a service to which any other item applies) if the attendance: (a) is by an obstetrician or general practitioner; and (b) is in hospital or at consulting rooms; and (c) is between 4 and 8 weeks after the birth; and (d) lasts at least 20 minutes; and (e) includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (f) is for a pregnancy in relation to which a service to which item 82140 applies is not provided Applicable once for a pregnancy	74.60
16408	Postnatal attendance (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if the attendance: (a) is by: (i) a practice midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 applies is not provided Applicable once for a pregnancy	55.55
16500	Antenatal attendance	49.05
16501	External cephalic version for breech presentation, after 36 weeks, if no contraindication exists, in a unit with facilities for caesarean section, including pre and post version CTG, with or without tocolysis, other than a service to which items 55718 to 55728 and 55768 to 55774 apply—chargeable whether or not the version is successful and limited to a maximum of 2 ECVs per pregnancy	146.25
16502	Polyhydramnios, unstable lie, multiple pregnancy, pregnancy complicated by diabetes or anaemia, threatened premature labour treated by bed rest only or oral medication, requiring admission to hospital—a professional attendance that is not a routine antenatal attendance, applicable once per day	49.05
16505	Threatened abortion, threatened miscarriage or hyperemesis gravidarum, requiring admission to hospital, treatment of—an attendance that is not a routine antenatal attendance	49.05
16508	Pregnancy complicated by acute intercurrent infection, fetal growth restriction, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital—professional attendance (other than a service to which item 16533 applies) that is not a routine antenatal attendance, applicable once per day	49.05
16509	Pre‑eclampsia, eclampsia or antepartum haemorrhage, treatment of—professional attendance (other than a service to which item 16534 applies) that is not a routine antenatal attendance	49.05
16511	Cervix, purse string ligation of (Anaes.)	228.85
16512	Cervix, removal of purse string ligature of (Anaes.)	66.05
16514	Antenatal cardiotocography in the management of high risk pregnancy (not during the course of the confinement)	38.15
16515	Management of vaginal birth as an independent procedure, if the patient’s care has been transferred by another medical practitioner for management of the birth and the attending medical practitioner has not provided antenatal care to the patient, including all attendances related to the birth (Anaes.)	656.40
16518	Management of labour, incomplete, if the patient’s care has been transferred to another medical practitioner for completion of the birth (Anaes.)	468.90
16519	Management of labour and birth by any means (including Caesarean section) including post‑partum care for 5 days (Anaes.)	722.10
16520	Caesarean section and post‑operative care for 7 days, if the patient’s care has been transferred by another medical practitioner for management of the confinement and the attending medical practitioner has not provided any of the antenatal care (Anaes.)	656.40
16522	Management of labour and birth, or birth alone, (including caesarean section), on or after 23 weeks gestation, if in the course of antenatal supervision or intrapartum management one or more of the following conditions is present, including postnatal care for 7 days: (a) fetal loss; (b) multiple pregnancy; (c) antepartum haemorrhage that is: (i) of greater than 200 ml; or (ii) associated with disseminated intravascular coagulation; (d) placenta praevia on ultrasound in the third trimester with the placenta within 2 cm of the internal cervical os; (e) baby with a birth weight less than or equal to 2,500 g; (f) trial of vaginal birth in a patient with uterine scar if there has been a planned vaginal birth after caesarean section; (g) trial of vaginal breech birth if there has been a planned vaginal breech birth; (h) prolonged labour greater than 12 hours with partogram evidence of abnormal cervimetric progress as evidenced by cervical dilatation at less than 1 cm/hr in the active phase of labour (after 3 cm cervical dilatation and effacement until full dilatation of the cervix); (i) acute fetal compromise evidenced by: (i) scalp pH less than 7.15; or (ii) scalp lactate greater than 4.0; (j) acute fetal compromise evidenced by at least one of the following significant cardiotocograph abnormalities: (i) prolonged bradycardia (less than 100 bpm for more than 2 minutes); (ii) absent baseline variability (less than 3 bpm); (iii) sinusoidal pattern; (iv) complicated variable decelerations with reduced (3 to 5 bpm) or absent baseline variability; (v) late decelerations; (k) pregnancy induced hypertension of at least 140/90 mm Hg associated with: (i) at least 2+ proteinuria on urinalysis; or (ii) protein‑creatinine ratio greater than 30 mg/mmol; or (iii) platelet count less than 150 x 109/L; or (iv) uric acid greater than 0.36 mmol/L; (l) gestational diabetes mellitus requiring at least daily blood glucose monitoring; (m) mental health disorder (whether arising prior to pregnancy, during pregnancy or postpartum) that is demonstrated by: (i) the patient requiring hospitalisation; or (ii) the patient receiving ongoing care by a psychologist or psychiatrist to treat the symptoms of a mental health disorder; or (iii) the patient having a GP mental health treatment plan; or (iv) the patient having a management plan prepared in accordance with item 291; (n) disclosure or evidence of domestic violence; (o) any of the following conditions either diagnosed pre‑pregnancy or evident at the first antenatal visit before 20 weeks gestation: (i) pre‑existing hypertension requiring antihypertensive medication prior to pregnancy; (ii) cardiac disease (co‑managed with a specialist physician and with echocardiographic evidence of myocardial dysfunction); (iii) previous renal or liver transplant; (iv) renal dialysis; (v) chronic liver disease with documented oesophageal varices; (vi) renal insufficiency in early pregnancy (serum creatinine greater than 110 mmol/L); (vii) neurological disorder that confines the patient to a wheelchair throughout pregnancy; (viii) maternal height of less than 148 cm; (ix) a body mass index greater than or equal to 40; (x) pre‑existing diabetes mellitus on medication prior to pregnancy; (xi) thyrotoxicosis requiring medication; (xii) previous thrombosis or thromboembolism requiring anticoagulant therapy through pregnancy and the early puerperium; (xiii) thrombocytopenia with platelet count of less than 100,000 prior to 20 weeks gestation; (xiv) HIV, hepatitis B or hepatitis C carrier status positive; (xv) red cell or platelet iso‑immunisation; (xvi) cancer with metastatic disease; (xvii) illicit drug misuse during pregnancy (H) (Anaes.)	1,695.35
16527	Management of vaginal birth, if the patient’s care has been transferred by a participating midwife for management of the birth, including all attendances related to the birth (Anaes.) Applicable once for a pregnancy	656.40
16528	Caesarean section and post‑operative care for 7 days, if the patient’s care has been transferred by a participating midwife for management of the birth (Anaes.) Applicable once for a pregnancy	656.40
16530	Management of pregnancy loss, from 14 weeks to 15 weeks and 6 days gestation, other than a service to which item 16531, 35640 or 35643 applies (Anaes.)	399.90
16531	Management of pregnancy loss, from 16 weeks to 22 weeks and 6 days gestation, other than a service to which item 16530, 35640 or 35643 applies (Anaes.) (H)	799.85
16533	Pregnancy complicated by acute intercurrent infection, fetal growth restriction, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital—each professional attendance lasting at least 40 minutes that is not a routine antenatal attendance, applicable 3 times for a pregnancy (H)	109.85
16534	Pre‑eclampsia, eclampsia or antepartum haemorrhage, treatment of—each professional attendance lasting at least 40 minutes that is not a routine antenatal attendance, applicable 3 times for a pregnancy (H)	109.85
16564	Evacuation of retained products of conception (placenta, membranes or mole) as a complication of confinement, with or without curettage of the uterus, as an independent procedure (Anaes.)	226.80
16567	Management of postpartum haemorrhage by special measures such as packing of uterus, as an independent procedure (Anaes.)	331.70
16570	Acute inversion of the uterus, vaginal correction of, as an independent procedure (Anaes.)	432.90
16571	Cervix, repair of extensive laceration or lacerations (Anaes.)	331.70
16573	Third degree tear, involving anal sphincter muscles and rectal mucosa, repair of, as an independent procedure (Anaes.)	270.30
16590	Planning and management, by a practitioner, of a pregnancy if: (a) the practitioner intends to take primary responsibility for management of the pregnancy and any complications, and to be available for the birth; and (b) the patient intends to be privately admitted for the birth; and (c) the pregnancy has progressed beyond 28 weeks gestation; and (d) the practitioner has maternity privileges at a hospital or birth centre; and (e) the service includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (f) a service to which item 16591 applies is not provided in relation to the same pregnancy Applicable once for a pregnancy	387.85
16591	Planning and management, by a practitioner, of a pregnancy if: (a) the pregnancy has progressed beyond 28 weeks gestation; and (b) the service includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (c) a service to which item 16590 applies is not provided in relation to the same pregnancy Applicable once for a pregnancy	148.40
16600	Amniocentesis, diagnostic	66.05
16603	Chorionic villus sampling, by any route	126.80
16606	Fetal blood sampling, using interventional techniques from umbilical cord or fetus, including fetal neuromuscular blockade and amniocentesis (Anaes.)	253.10
16609	Fetal intravascular blood transfusion, using blood already collected, including neuromuscular blockade, amniocentesis and fetal blood sampling (Anaes.)	516.10
16612	Fetal intraperitoneal blood transfusion, using blood already collected, including neuromuscular blockade, amniocentesis and fetal blood sampling—not performed in conjunction with a service described in item 16609 (Anaes.)	406.05
16615	Fetal intraperitoneal blood transfusion, using blood already collected, including neuromuscular blockade, amniocentesis and fetal blood sampling—performed in conjunction with a service described in item 16609 (Anaes.)	216.30
16618	Amniocentesis, therapeutic, when indicated because of polyhydramnios with at least 500 ml being aspirated	216.30
16621	Amnioinfusion, for diagnostic or therapeutic purposes in the presence of severe oligohydramnios	216.30
16624	Fetal fluid filled cavity, drainage of	311.25
16627	Feto‑amniotic shunt, insertion of, into fetal fluid filled cavity, including neuromuscular blockade and amniocentesis	633.65

Division 5.6—Group T6: Examination by anaesthetist

5.6.1 Items in Group T6

This clause sets out items in Group T6.

Note: The fees in Group T6 are indexed in accordance with clause 1.3.1.

Group T6—Examination by anaesthetist
Column 1 Item	Column 2 Description	Column 3 Fee ($)
17610	Professional attendance by a medical practitioner in the practice of anaesthesia for a brief consultation involving a targeted history and limited examination, including the cardio‑respiratory system, lasting not more than 15 minutes (other than a service associated with a service to which any of items 2801 to 3000 apply)	45.40
17615	Professional attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems, involving a selective history and an extensive examination of multiple systems and the formulation of a written patient management plan documented in the patient notes, and lasting more than 15 minutes, but not more than 30 minutes, (other than a service associated with a service to which any of items 2801 to 3000 apply)	90.35
17620	Professional attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems involving a detailed history and comprehensive examination of multiple systems, and the formulation of a written patient management plan documented in the patient notes, and lasting more than 30 minutes, but not more than 45 minutes, (other than a service associated with a service to which any of items 2801 to 3000 apply)	125.15
17625	Professional attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems involving an exhaustive history and comprehensive examination of multiple systems, the formulation of a written patient management plan following discussion with relevant health care professionals and/or the patient, involving medical planning of high complexity documented in the patient notes, and lasting more than 45 minutes (other than a service associated with a service to which any of items 2801 to 3000 apply)	159.35
17640	Professional attendance by a specialist anaesthetist in the practice of anaesthesia, if the patient is referred to the specialist anaesthetist—a brief consultation involving a short history, a limited examination, and lasting not more than 15 minutes (other than a service associated with a service to which any of items 2801 to 3000 apply)	45.40
17645	Professional attendance by a specialist anaesthetist in the practice of anaesthesia, if the patient is referred to the specialist anaesthetist—a consultation involving a selective history and examination of multiple systems, the formulation of a written patient management plan, and lasting more than 15 minutes, but not more than 30 minutes, (other than a service associated with a service to which any of items 2801 to 3000 apply)	90.35
17650	Professional attendance by a specialist anaesthetist in the practice of anaesthesia, if the patient is referred to the specialist anaesthetist—a consultation involving a detailed history and comprehensive examination of multiple systems, and the formulation of a written patient management plan, and lasting more than 30 minutes, but not more than 45 minutes, (other than a service associated with a service to which any of items 2801 to 3000 apply)	125.15
17655	Professional attendance by a specialist anaesthetist in the practice of anaesthesia, if the patient is referred to the specialist anaesthetist—a consultation involving an exhaustive history and comprehensive examination of multiple systems, and the formulation of a written patient management plan following discussion with relevant health care professionals or the patient, involving medical planning of high complexity, and lasting more than 45 minutes (other than a service associated with a service to which any of items 2801 to 3000 apply)	159.35
17680	Professional attendance by a medical practitioner in the practice of anaesthesia—a consultation immediately before the institution of a major regional blockade in a patient in labour, if no previous anaesthesia consultation has occurred (other than a service associated with a service to which any of items 2801 to 3000 apply)	90.35
17690	A medical service in association with an item in the range 17615 to 17625 if: (a) the service is provided to a patient before an admitted patient episode of care involving anaesthesia; and (b) the service is not provided to an admitted patient of a hospital or day‑hospital facility; and (c) the service is not provided on the day of admission to hospital for the subsequent episode of care involving anaesthesia services; and (d) the service lasts more than 15 minutes; (other than a service associated with a service to which any of items 2801 to 3000 apply)	41.75

Division 5.7—Group T7: Regional or field nerve blocks

5.7.1 Meaning of amount under clause 5.7.1

(1) In item 18219:

amount under clause 5.7.1 means the sum of:

(a) the fee for item 18216; and

(b) $21.65 for each additional period of 15 minutes, and part of a period of 15 minutes, of continuous attendance beyond the first hour of attendance.

(2) In item 18227:

amount under clause 5.7.1 means the sum of:

(a) the fee for item 18226; and

(b) $32.60 for each additional period of 15 minutes, and part of a period of 15 minutes, of continuous attendance beyond the first hour of attendance.

5.7.2 Items in Group T7

This clause sets out items in Group T7.

Note: The fees in Group T7 are indexed in accordance with clause 1.3.1.

Group T7—Regional or field nerve blocks
Column 1 Item	Column 2 Description	Column 3 Fee ($)
18213	Intravenous regional anaesthesia of limb by retrograde perfusion of local anaesthetic agent	92.20
18216	Intrathecal, combined spinal‑epidural or epidural infusion of a therapeutic substance, initial injection or commencement of, including up to 1 hour of continuous attendance by the medical practitioner (Anaes.)	197.60
18219	Intrathecal, combined spinal‑epidural or epidural infusion of a therapeutic substance, initial injection or commencement of, if continuous attendance by the medical practitioner extends beyond the first hour (Anaes.)	Amount under clause 5.7.1
18222	Continuous infusion, or injection by catheter, of a therapeutic substance (not contrast agent) to maintain regional anaesthesia or analgesia, subsequent injection or revision of, if the period of continuous medical practitioner attendance is 15 minutes or less	39.15
18225	Continuous infusion, or injection by catheter, of a therapeutic substance (not contrast agent) to maintain regional anaesthesia or analgesia, subsequent injection or revision of, if the period of continuous medical practitioner attendance is more than 15 minutes	52.05
18226	Intrathecal, combined spinal‑epidural or epidural infusion of a therapeutic substance, initial injection or commencement of, including up to 1 hour of continuous attendance by the medical practitioner—for a patient in labour, if the service is provided between 8 pm to 8 am on any weekday, or on a Saturday, Sunday or public holiday	296.35
18227	Intrathecal, combined spinal‑epidural or epidural infusion of a therapeutic substance, initial injection or commencement of, if continuous attendance by a medical practitioner extends beyond the first hour—for a patient in labour, if the service is provided between 8 pm to 8 am on any weekday, or on a Saturday, Sunday or public holiday	Amount under clause 5.7.1
18228	Interpleural block, initial injection or commencement of infusion of a therapeutic substance, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach	65.05
18230	Intrathecal or epidural injection of neurolytic substance (not contrast agent) by any route, including transforaminal route (Anaes.)	248.10
18232	Intrathecal or epidural injection (including translaminar and transforaminal approaches) of therapeutic substance or substances (anaesthetic, steroid or chemotherapeutic agents): (a) other than a service to which another item in this Group applies; and (b) not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach (Anaes.)	197.60
18233	Epidural injection of blood for blood patch (Anaes.)	197.60
18234	Trigeminal nerve, primary branch (ophthalmic, maxillary or mandibular branches, excluding infraorbital nerve), injection of an anaesthetic agent or steroid, but not in association with a service to which an item in Group T8 applies, unless a targeted percutaneous technique is used (Anaes.)	129.90
18236	Trigeminal nerve, peripheral branch (including infraorbital nerve), injection of an anaesthetic agent, but not in association with a service to which an item in Group T8 applies, unless a targeted percutaneous technique is used (Anaes.)	65.05
18238	Facial nerve, injection of an anaesthetic agent, other than a service associated with a service to which item 18240 applies, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach	39.15
18240	Retrobulbar or peribulbar injection of an anaesthetic agent	97.40
18242	Greater occipital nerve, injection of an anaesthetic agent (Anaes.)	39.15
18244	Vagus nerve, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach	104.90
18248	Phrenic nerve, injection of an anaesthetic agent	92.20
18250	Spinal accessory nerve, injection of an anaesthetic agent	65.05
18252	Cervical plexus, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach	104.90
18254	Brachial plexus, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach	104.90
18256	Suprascapular nerve, injection of an anaesthetic agent	65.05
18258	Intercostal nerve (single), injection of an anaesthetic agent	65.05
18260	Intercostal nerves (multiple), injection of an anaesthetic agent	92.20
18262	Ilio‑inguinal, iliohypogastric or genitofemoral nerves, one or more of, injections of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach (Anaes.)	65.05
18264	Pudendal nerve or dorsal nerve (or both), injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach	104.90
18266	Ulnar, radial or median nerve, main trunk of, one or more of, injections of an anaesthetic agent, not being associated with a brachial plexus block, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach	65.05
18268	Obturator nerve, injection of an anaesthetic agent	92.20
18270	Femoral nerve, injection of an anaesthetic agent	92.20
18272	Saphenous, sural, popliteal or posterior tibial nerve, main trunk of, one or more of, injections of an anaesthetic agent	65.05
18276	Paravertebral nerves, injection of an anaesthetic agent, (multiple levels)	129.90
18278	Sciatic nerve, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach	92.20
18280	Sphenopalatine ganglion, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach (Anaes.)	129.90
18282	Carotid sinus, injection of an anaesthetic agent, as an independent percutaneous procedure	104.90
18284	Cervical or thoracic sympathetic chain, injection of an anaesthetic agent (Anaes.)	153.60
18286	Lumbar or pelvic sympathetic chain, injection of an anaesthetic agent (Anaes.)	153.60
18288	Coeliac plexus or splanchnic nerves, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach (Anaes.)	153.60
18290	Cranial nerve other than trigeminal, destruction by a neurolytic agent under image guidance, other than a service associated with the injection of botulinum toxin (Anaes.)	259.85
18292	Nerve branch, destruction by a neurolytic agent under image guidance, other than a service to which another item in this Group applies or a service associated with the injection of botulinum toxin except a service to which item 18354 applies (Anaes.)	129.90
18294	Coeliac plexus or splanchnic nerves, destruction by a neurolytic agent under image guidance (Anaes.)	183.15
18296	Lumbar or pelvic sympathetic chain, destruction by a neurolytic agent under image guidance (Anaes.)	156.65
18297	Assistance at the administration of an epidural blood patch (a service to which item 18233 applies) by another medical practitioner	61.75
18298	Cervical or thoracic sympathetic chain, destruction by a neurolytic agent (Anaes.)	183.15

Division 5.8—Group T11: Botulinum toxin

5.8.1 Group T11 services do not include supply of botulinum toxin

A service described in any of items 18350 to 18379 does not include the supply of the botulinum toxin to which the service relates.

5.8.2 Restrictions on items in Group T11

(1) Items 18350 to 18354, 18362 and 18369 to 18379 do not apply to an injection of botulinum toxin if the botulinum toxin is not supplied under the pharmaceutical benefits scheme.

(2) A service described in item 18360 is applicable to the first 4 treatments, not exceeding 2 for each limb, on any one day.

(3) Items 18360, 18366 and 18368 apply only to a service provided by a specialist or consultant physician in the practice of the specialist’s or consultant physician’s speciality.

5.8.3 Items in Group T11

This clause sets out items in Group T11.

Note: The fees in Group T11 are indexed in accordance with clause 1.3.1.

Group T11—Botulinum toxin
Column 1 Item	Column 2 Description	Column 3 Fee ($)
18350	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of hemifacial spasm in a patient who is at least 12 years of age, including all such injections on any one day	129.90
18351	Clostridium Botulinum Type A Toxin‑Haemagglutinin Complex (Dysport), injection of, for the treatment of hemifacial spasm in a patient who is at least 18 years of age, including all such injections on any one day	129.90
18353	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin‑Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of cervical dystonia (spasmodic torticollis), including all such injections on any one day	259.85
18354	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin‑Haemagglutinin Complex (Dysport), injection of, for the treatment of dynamic equinus foot deformity (including equinovarus and equinovulgus) due to spasticity in an ambulant cerebral palsy patient, if: (a) the patient is at least 2 years of age; and (b) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each lower limb), including all injections per set (Anaes.)	129.90
18360	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin Haemagglutinin Complex (Dysport), injection of, for the treatment of moderate to severe focal spasticity if: (a) the patient is at least 18 years of age; and (b) the spasticity is associated with a previously diagnosed neurological disorder; and (c) the treatment is provided as: (i) second line therapy when standard treatment for the condition has failed; or (ii) an adjunct to physical therapy; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each limb), including all injections per set	129.90
18362	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of severe primary axillary hyperhidrosis, including all such injections on any one day, if: (a) the patient is at least 12 years of age; and (b) the patient has been intolerant of, or has not responded to, topical aluminium chloride hexahydrate; and (c) the patient has not had treatment with botulinum toxin within the immediately preceding 4 months; and (d) if the patient has had treatment with botulinum toxin within the previous 12 months—the patient had treatment on no more than 2 separate occasions (Anaes.)	256.70
18366	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of strabismus, including all such injections on any one day and associated electromyography (Anaes.)	162.75
18368	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of spasmodic dysphonia, including all such injections on any one day	277.85
18369	Clostridium Botulinum Type A Toxin‑Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of unilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day (Anaes.)	46.85
18370	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for unilateral blepharospasm in a patient who is at least 12 years of age, including all such injections on any one day (Anaes.)	46.85
18372	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of bilateral blepharospasm, in a patient who is at least 12 years of age, including all such injections on any one day (Anaes.)	129.90
18374	Clostridium Botulinum Type A Toxin‑Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of bilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day (Anaes.)	129.90
18375	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesial injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if: (a) the urinary incontinence is due to neurogenic detrusor overactivity as demonstrated by urodynamic study of a patient with: (i) multiple sclerosis; or (ii) spinal cord injury; or (iii) for a patient who is at least 18 years of age—spina bifida; and (b) the patient has urinary incontinence that is inadequately controlled by anti‑cholinergic therapy, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment; and (c) the patient is willing and able to self‑catheterise; and (d) the treatment is not provided on the same occasion as a service described in item 104, 105, 110, 116, 119, 11900 or 11919 Applicable only once unless the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment (H) (Anaes.)	239.20
18377	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of chronic migraine, including all injections in one day, if: (a) the patient is at least 18 years of age; and (b) the patient has experienced an inadequate response, intolerance or contraindication to at least 3 prophylactic migraine medications before commencement of treatment with botulinum toxin, as manifested by an average of 15 or more headache days per month, with at least 8 days of migraine, over a period of at least 6 months, before commencement of treatment with botulinum toxin Applicable not more than twice unless the patient achieves and maintains at least a 50% reduction in the number of headache days per month from baseline after 2 cycles of treatment (each of 12 weeks)	129.90
18379	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesial injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if: (a) the urinary incontinence is due to idiopathic overactive bladder in a patient; and (b) the patient is at least 18 years of age; and (c) the patient has urinary incontinence that is inadequately controlled by at least 2 alternative anti‑cholinergic agents, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment with botulinum toxin; and (d) the patient is willing and able to self‑catheterise; and (e) treatment is not provided on the same occasion as a service described in item 104, 105, 110, 116, 119, 11900 or 11919 Applicable only once unless the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment (H) (Anaes.)	239.20

Division 5.9—Group T10: Anaesthesia performed in connection with certain services (Relative Value Guide)

5.9.1A Meaning of base unit

In an item in Group T10:

base unit means an amount of $22.55.

5.9.1 Meaning of amount under clause 5.9.1

(1) In item 25025:

amount under clause 5.9.1 means 50% of the sum of:

(a) the fee mentioned in any of items 20100 to 21997 or 22900 for the initiation of the management of anaesthesia in association with which the anaesthesia is performed; and

(b) the fee mentioned in the item in the range 23010 to 24136 that applies to the anaesthesia; and

(d) if a service described in any of items 22002 to 22051 is performed in association with the anaesthesia—the fee mentioned in the item.

(2) In item 25030:

amount under clause 5.9.1 means 50% of the sum of:

(a) the fee mentioned in the item in the range 25200 to 25205 that applies to the assistance; and

(b) the fee mentioned in the item in the range 23010 to 24136 that applies to the assistance; and

(d) if a service described in any of items 22002 to 22051 is performed in association with the assistance—the fee mentioned in the item.

(3) In item 25050:

amount under clause 5.9.1 means 50% of the sum of:

(a) the fee mentioned in item 22060; and

(b) the fee mentioned in the item in the range 23010 to 24136 that applies to the perfusion; and

(d) if a service described in any of items 22002 to 22051 or 22065 to 22075 is performed in association with the perfusion—the fee mentioned in the item.

5.9.2 Meaning of amount under clause 5.9.2

In items 25200 and 25205:

amount under clause 5.9.2 means the sum of:

(a) $112.85; and

(b) the fee mentioned in the item in the range 23010 to 24136 that applies to the assistance; and

(d) if a service described in an item in the range 22002 to 22051 applies to the assistance—the fee mentioned in the item.

5.9.3 Meaning of service time

In Subgroups 21, 24, 25 and 26 of Group T10:

service time means:

(a) for the management of anaesthesia on a patient by an anaesthetist—the period that:

(i) starts when the anaesthetist commences exclusive and continuous care of the patient for anaesthesia; and

(ii) ends when the anaesthetist places the patient safely under the supervision of other personnel; and

(b) for perfusion performed on a patient under anaesthesia—the period that:

(i) starts when the anaesthetic commences; and

(ii) ends with the closure of the chest of the patient; and

(c) for assistance given by an assistant anaesthetist in the management of anaesthesia performed on a patient—the period when the assistant anaesthetist is actively attending on the patient.

5.9.4 Restrictions on items in Group T10

Items applying only to services connected with services described using “(Anaes.)”

(1) Items 20100 to 21990 (other than item 21965), 22060, 23010 to 24136, 25200 and 25205 apply to a service only if the service is provided in connection with a service that:

(a) is a professional service within the meaning of subsection 3(1) of the Act; and

(b) is mentioned in an item that includes, in its description, “(Anaes.)”.

Items 22900 and 22905 applying only to services connected with dental services

(2) Items 22900 and 22905 apply to a service only if the service is provided in connection with a dental service (other than a dental service that is a prescribed medical service under paragraph (b) of the definition of professional service in subsection 3(1) of the Act).

Services associated with certain diagnostic imaging services

(3) An item in Group T10 does not apply to a service described in the item if the service is claimed in association with a service to which item 55026 or 55054 of the diagnostic imaging services table applies.

Restriction on item 22054

(4) Item 22054 does not apply to a service if the service is performed on diagnostic imaging equipment that exceeds the applicable life age of the equipment within the meaning of the diagnostic imaging services table.

5.9.5 Application of Subgroup 21 of Group T10

(1) Items 23010 to 24136 apply to perfusion.

(2) Items 23010 to 24136 apply to assistance only as a component of item 25200 or 25205 and for the purpose of calculating the amount of fee for that item.

(3) Items 23010 to 24136 apply to a service provided to a patient under anaesthesia, but only if the anaesthesia start and end times are recorded in writing.

5.9.6 Meaning of anaesthesia, assistance and perfusion in Subgroups 21 to 25 of Group T10

In Subgroups 21 to 25 of Group T10:

anaesthesia means the management of anaesthesia performed in association with a service to which any of items 20100 to 21997, 22900 and 22905 applies.

assistance means assistance:

(a) in the management of anaesthesia; and

(b) to which item 25200 or 25205 applies.

perfusion means perfusion to which item 22060 applies.

5.9.7 Application of Subgroups 22 and 23 of Group T10

(1) Items 25000 to 25020 apply to anaesthesia in addition to any other item that applies to anaesthesia.

(2) Items 25000 to 25020 apply to perfusion in addition to any other item that applies to perfusion.

(3) Items 25000 to 25020 apply:

(a) to assistance only as a component of item 25200 or 25205; and

(b) for calculating the amount of fee for the item.

5.9.8 Application of Subgroups 24 and 25 of Group T10

Items 25025 to 25050 apply to anaesthesia, assistance or perfusion in addition to any other item that applies to the service.

5.9.9 Items in Group T10

This clause sets out items in Group T10.

Group T10—Anaesthesia performed in connection with certain services (Relative Value Guide)
Column 1 Item	Column 2 Description	Column 3 Fee ($)
Subgroup 1—Head
20100	Initiation of the management of anaesthesia for procedures on the skin, subcutaneous tissue, muscles, salivary glands or superficial vessels of the head, including biopsy, other than a service to which another item in this Subgroup applies	5 base units
20102	Initiation of the management of anaesthesia for plastic repair of cleft lip	6 base units
20104	Initiation of the management of anaesthesia for electroconvulsive therapy	4 base units
20120	Initiation of the management of anaesthesia for procedures on external, middle or inner ear, including biopsy, other than a service to which another item in this Subgroup applies	5 base units
20124	Initiation of the management of anaesthesia for otoscopy	4 base units
20140	Initiation of the management of anaesthesia for procedures on eye, other than a service to which another item in this Subgroup applies	5 base units
20142	Initiation of the management of anaesthesia for lens surgery	5 base units
20143	Initiation of the management of anaesthesia for retinal surgery	6 base units
20144	Initiation of the management of anaesthesia for corneal transplant	7 base units
20145	Initiation of the management of anaesthesia for vitrectomy	7 base units
20146	Initiation of the management of anaesthesia for biopsy of conjunctiva	5 base units
20147	Initiation of the management of anaesthesia for squint repair	6 base units
20148	Initiation of the management of anaesthesia for ophthalmoscopy	4 base units
20160	Initiation of the management of anaesthesia for intranasal procedures on nose or accessory sinuses, other than a service to which another item in this Subgroup applies	6 base units
20162	Initiation of the management of anaesthesia for intranasal surgery for malignancy or for intranasal ablation	7 base units
20164	Initiation of the management of anaesthesia for biopsy of soft tissue of the nose and accessory sinuses	4 base units
20170	Initiation of the management of anaesthesia for intraoral procedures, including biopsy, other than a service to which another item in this Subgroup applies	6 base units
20172	Initiation of the management of anaesthesia for repair of cleft palate	7 base units
20174	Initiation of the management of anaesthesia for excision of retropharyngeal tumour	9 base units
20176	Initiation of the management of anaesthesia for radical intraoral surgery	10 base units
20190	Initiation of the management of anaesthesia for procedures on facial bones, other than a service to which another item in this Subgroup applies	5 base units
20192	Initiation of the management of anaesthesia for extensive surgery on facial bones (including prognathism and extensive facial bone reconstruction)	10 base units
20210	Initiation of the management of anaesthesia for intracranial procedures, other than a service to which another item in this Subgroup applies	15 base units
20212	Initiation of the management of anaesthesia for subdural taps	5 base units
20214	Initiation of the management of anaesthesia for burr holes of the cranium	9 base units
20216	Initiation of the management of anaesthesia for intracranial vascular procedures, including those for aneurysms or arterio‑venous abnormalities	20 base units
20220	Initiation of the management of anaesthesia for spinal fluid shunt procedures	10 base units
20222	Initiation of the management of anaesthesia for ablation of an intracranial nerve	6 base units
20225	Initiation of the management of anaesthesia for all cranial bone procedures	12 base units
20230	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the head or face	12 base units
Subgroup 2—Neck
20300	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the neck, other than a service to which another item in this Subgroup applies	5 base units
20305	Initiation of the management of anaesthesia for incision and drainage of large haematoma, large abscess, cellulitis or similar lesion or epiglottitis, causing life threatening airway obstruction	15 base units
20320	Initiation of the management of anaesthesia for procedures on oesophagus, thyroid, larynx, trachea, lymphatic system, muscles, nerves or other deep tissues of the neck, other than a service to which another item in this Subgroup applies	6 base units
20321	Initiation of the management of anaesthesia for laryngectomy, hemi laryngectomy, laryngopharyngectomy or pharyngectomy	10 base units
20330	Initiation of the management of anaesthesia for laser surgery to the airway (excluding nose and mouth)	8 base units
20350	Initiation of the management of anaesthesia for procedures on major vessels of neck, other than a service to which another item in this Subgroup applies	10 base units
20352	Initiation of the management of anaesthesia for simple ligation of major vessels of neck	5 base units
20355	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the neck	12 base units
Subgroup 3—Thorax
20400	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the anterior part of the chest, other than a service to which another item in this Subgroup applies	3 base units
20401	Initiation of the management of anaesthesia for procedures on the breast, other than a service to which another item in this Subgroup applies	4 base units
20402	Initiation of the management of anaesthesia for reconstructive procedures on breast, including implant reconstruction and exchange	5 base units
20403	Initiation of the management of anaesthesia for axillary dissection or sentinel node biopsy	5 base units
20404	Initiation of the management of anaesthesia for mastectomy	6 base units
20405	Initiation of the management of anaesthesia for reconstructive procedures on the breast using myocutaneous flaps	8 base units
20406	Initiation of the management of anaesthesia for radical or modified radical procedures on breast with internal mammary node dissection	13 base units
20410	Initiation of the management of anaesthesia for electrical conversion of arrhythmias	4 base units
20420	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the posterior part of the chest, other than a service to which another item in this Subgroup applies	5 base units
20440	Initiation of the management of anaesthesia for percutaneous bone marrow biopsy of the sternum	4 base units
20450	Initiation of the management of anaesthesia for procedures on clavicle, scapula or sternum, other than a service to which another item in this Subgroup applies	5 base units
20452	Initiation of the management of anaesthesia for radical surgery on clavicle, scapula or sternum	6 base units
20470	Initiation of the management of anaesthesia for partial rib resection, other than a service to which another item in this Subgroup applies	6 base units
20472	Initiation of the management of anaesthesia for thoracoplasty	10 base units
20474	Initiation of the management of anaesthesia for radical procedures on chest wall	13 base units
20475	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the anterior or posterior thorax	10 base units
Subgroup 4—Intrathoracic
20500	Initiation of the management of anaesthesia for open procedures on the oesophagus	15 base units
20520	Initiation of the management of anaesthesia for all closed chest procedures (including rigid oesophagoscopy or bronchoscopy), other than a service to which another item in this Subgroup applies	6 base units
20522	Initiation of the management of anaesthesia for needle biopsy of pleura	4 base units
20524	Initiation of the management of anaesthesia for pneumocentesis	4 base units
20526	Initiation of the management of anaesthesia for thoracoscopy	10 base units
20528	Initiation of the management of anaesthesia for mediastinoscopy	8 base units
20540	Initiation of the management of anaesthesia for thoracotomy procedures involving lungs, pleura, diaphragm, or mediastinum, other than a service to which another item in this Subgroup applies	13 base units
20542	Initiation of the management of anaesthesia for pulmonary decortication	15 base units
20546	Initiation of the management of anaesthesia for pulmonary resection with thoracoplasty	15 base units
20548	Initiation of the management of anaesthesia for intrathoracic repair of trauma to trachea and bronchi	15 base units
20560	Initiation of the management of anaesthesia for: (a) open procedures on the heart, pericardium or great vessels of the chest; or (b) percutaneous insertion of a valvular prosthesis	20 base units
Subgroup 5—Spine and spinal cord
20600	Initiation of the management of anaesthesia for procedures on cervical spine or spinal cord, or both, other than a service to which another item in this Subgroup applies	10 base units
20604	Initiation of the management of anaesthesia for posterior cervical laminectomy with the patient in the sitting position	13 base units
20620	Initiation of the management of anaesthesia for procedures on thoracic spine or spinal cord, or both, other than a service to which another item in this Subgroup applies	10 base units
20622	Initiation of the management of anaesthesia for thoracolumbar sympathectomy	13 base units
20630	Initiation of the management of anaesthesia for procedures in lumbar region, other than a service to which another item in this Subgroup applies	8 base units
20632	Initiation of the management of anaesthesia for lumbar sympathectomy	7 base units
20634	Initiation of the management of anaesthesia for chemonucleolysis	10 base units
20670	Initiation of the management of anaesthesia for extensive spine or spinal cord procedures, or both	13 base units
20680	Initiation of the management of anaesthesia for manipulation of spine when performed in the operating theatre of a hospital	3 base units
20690	Initiation of the management of anaesthesia for percutaneous spinal procedures, other than a service to which another item in this Subgroup applies	5 base units
Subgroup 6—Upper abdomen
20700	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the upper anterior abdominal wall, other than a service to which another item in this Subgroup applies	3 base units
20702	Initiation of the management of anaesthesia for percutaneous liver biopsy	4 base units
20703	Initiation of the management of anaesthesia for procedures on the nerves, muscles, tendons and fascia of the upper abdominal wall, other than a service to which another item in this Subgroup applies	4 base units
20704	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the anterior or posterior upper abdomen	10 base units
20706	Initiation of the management of anaesthesia for laparoscopic procedures in the upper abdomen, including laparoscopic cholecystectomy, other than a service to which another item in this Subgroup applies	7 base units
20730	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the upper posterior abdominal wall, other than a service to which another item in this Subgroup applies	5 base units
20740	Initiation of the management of anaesthesia for upper gastrointestinal endoscopic procedures	5 base units
20745	Initiation of the management of anaesthesia for any of the following: (a) upper gastrointestinal endoscopic procedures in association with acute gastrointestinal haemorrhage; (b) endoscopic retrograde cholangiopancreatography; (c) upper gastrointestinal endoscopic ultrasound; (d) percutaneous endoscopic gastrostomy; (e) upper gastrointestinal endoscopic mucosal resection of tumour	7 base units
20750	Initiation of the management of anaesthesia for hernia repairs to the upper abdominal wall, other than a service to which another item in this Subgroup applies	5 base units
20752	Initiation of the management of anaesthesia for repair of incisional hernia or wound dehiscence, or both	6 base units
20754	Initiation of the management of anaesthesia for procedures on an omphalocele	7 base units
20756	Initiation of the management of anaesthesia for transabdominal repair of diaphragmatic hernia	9 base units
20770	Initiation of the management of anaesthesia for procedures on major upper abdominal blood vessels	15 base units
20790	Initiation of the management of anaesthesia for procedures within the peritoneal cavity in the upper abdomen, including any of the following: (a) open cholecystectomy; (b) gastrectomy; (c) laparoscopic assisted nephrectomy; (d) bowel shunts	8 base units
20791	Initiation of the management of anaesthesia for bariatric surgery in a patient with clinically severe obesity	10 base units
20792	Initiation of the management of anaesthesia for partial hepatectomy (excluding liver biopsy)	13 base units
20793	Initiation of the management of anaesthesia for extended or trisegmental hepatectomy	15 base units
20794	Initiation of the management of anaesthesia for pancreatectomy, partial or total	12 base units
20798	Initiation of the management of anaesthesia for neuro endocrine tumour removal in the upper abdomen	10 base units
20799	Initiation of the management of anaesthesia for percutaneous procedures on an intra‑abdominal organ in the upper abdomen	6 base units
Subgroup 7—Lower abdomen
20800	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the lower anterior abdominal walls, other than a service to which another item in this Subgroup applies	3 base units
20802	Initiation of the management of anaesthesia for lipectomy of the lower abdomen	5 base units
20803	Initiation of the management of anaesthesia for procedures on the nerves, muscles, tendons and fascia of the lower abdominal wall, other than a service to which another item in this Subgroup applies	4 base units
20804	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the anterior or posterior lower abdomen	10 base units
20806	Initiation of the management of anaesthesia for laparoscopic procedures in the lower abdomen	7 base units
20810	Initiation of the management of anaesthesia for lower intestinal endoscopic procedures	4 base units
20815	Initiation of the management of anaesthesia for extracorporeal shock wave lithotripsy to urinary tract	6 base units
20820	Initiation of the management of anaesthesia for procedures on the skin, its derivatives or subcutaneous tissue of the lower posterior abdominal wall	5 base units
20830	Initiation of the management of anaesthesia for hernia repairs in lower abdomen, other than a service to which another item in this Subgroup applies	4 base units
20832	Initiation of the management of anaesthesia for repair of incisional herniae or wound dehiscence, or both, of the lower abdomen	6 base units
20840	Initiation of the management of anaesthesia for all open procedures within the peritoneal cavity in the lower abdomen, including appendicectomy, other than a service to which another item in this Subgroup applies	6 base units
20841	Initiation of the management of anaesthesia for bowel resection, including laparoscopic bowel resection, other than a service to which another item in this Subgroup applies	8 base units
20842	Initiation of the management of anaesthesia for amniocentesis	4 base units
20844	Initiation of the management of anaesthesia for abdominoperineal resection, including pull through procedures, ultra low anterior resection and formation of bowel reservoir	10 base units
20845	Initiation of the management of anaesthesia for radical prostatectomy	10 base units
20846	Initiation of the management of anaesthesia for radical hysterectomy	10 base units
20847	Initiation of the management of anaesthesia for ovarian malignancy	10 base units
20848	Initiation of the management of anaesthesia for pelvic exenteration	10 base units
20850	Initiation of the management of anaesthesia for caesarean section	12 base units
20855	Initiation of the management of anaesthesia for caesarean hysterectomy or hysterectomy within 24 hours of birth	15 base units
20860	Initiation of the management of anaesthesia for extraperitoneal procedures in lower abdomen, including those on the urinary tract, other than a service to which another item in this Subgroup applies	6 base units
20862	Initiation of the management of anaesthesia for renal procedures, including upper one‑third of ureter	7 base units
20863	Initiation of the management of anaesthesia for nephrectomy	10 base units
20864	Initiation of the management of anaesthesia for total cystectomy	10 base units
20866	Initiation of the management of anaesthesia for adrenalectomy	10 base units
20867	Initiation of the management of anaesthesia for neuro endocrine tumour removal in the lower abdomen	10 base units
20868	Initiation of the management of anaesthesia for renal transplantation (donor or recipient)	10 base units
20880	Initiation of the management of anaesthesia for procedures on major lower abdominal vessels, other than a service to which another item in this Subgroup applies	15 base units
20882	Initiation of the management of anaesthesia for inferior vena cava ligation	10 base units
20884	Initiation of the management of anaesthesia for percutaneous umbrella insertion	5 base units
20886	Initiation of the management of anaesthesia for percutaneous procedures on an intra‑abdominal organ in the lower abdomen	6 base units
Subgroup 8—Perineum
20900	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the perineum, other than a service to which another item in this Subgroup applies	3 base units
20902	Initiation of the management of anaesthesia for anorectal procedures (including surgical haemorrhoidectomy, but not banding of haemorrhoids)	4 base units
20904	Initiation of the management of anaesthesia for radical perineal procedures, including radical perineal prostatectomy or radical vulvectomy	7 base units
20905	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the perineum	10 base units
20906	Initiation of the management of anaesthesia for vulvectomy	4 base units
20910	Initiation of the management of anaesthesia for transurethral procedures (including urethrocyctoscopy), other than a service to which another item in this Subgroup applies	4 base units
20911	Initiation of the management of anaesthesia for endoscopic ureteroscopic surgery including laser procedures	5 base units
20912	Initiation of the management of anaesthesia for transurethral resection of bladder tumour or tumours	5 base units
20914	Initiation of the management of anaesthesia for transurethral resection of prostate	7 base units
20916	Initiation of the management of anaesthesia for bleeding post‑transurethral resection	7 base units
20920	Initiation of the management of anaesthesia for procedures on external genitalia, other than a service to which another item in this Subgroup applies	4 base units
20924	Initiation of the management of anaesthesia for procedures on undescended testis, unilateral or bilateral	4 base units
20926	Initiation of the management of anaesthesia for radical orchidectomy, inguinal approach	4 base units
20928	Initiation of the management of anaesthesia for radical orchidectomy, abdominal approach	6 base units
20930	Initiation of the management of anaesthesia for orchiopexy, unilateral or bilateral	4 base units
20932	Initiation of the management of anaesthesia for complete amputation of penis	4 base units
20934	Initiation of the management of anaesthesia for complete amputation of penis with bilateral inguinal lymphadenectomy	6 base units
20936	Initiation of the management of anaesthesia for complete amputation of penis with bilateral inguinal and iliac lymphadenectomy	8 base units
20938	Initiation of the management of anaesthesia for insertion of penile prosthesis	4 base units
20940	Initiation of the management of anaesthesia for per vagina and vaginal procedures (including biopsy of vagina, cervix or endometrium), other than a service to which another item in this Subgroup applies	4 base units
20942	Initiation of the management of anaesthesia for vaginal procedures (including repair operations and urinary incontinence procedures)	5 base units
20943	Initiation of the management of anaesthesia for transvaginal assisted reproductive services	4 base units
20944	Initiation of the management of anaesthesia for vaginal hysterectomy	6 base units
20946	Initiation of the management of anaesthesia for vaginal birth	8 base units
20948	Initiation of the management of anaesthesia for purse string ligation of cervix, or removal of purse string ligature, or removal of purse string ligature	4 base units
20950	Initiation of the management of anaesthesia for culdoscopy	5 base units
20952	Initiation of the management of anaesthesia for hysteroscopy	4 base units
20954	Initiation of the management of anaesthesia for correction of inverted uterus	10 base units
20956	Initiation of the management of anaesthesia for evacuation of retained products of conception, as a complication of confinement	4 base units
20958	Initiation of the management of anaesthesia for manual removal of retained placenta or for repair of vaginal or perineal tear following birth	5 base units
20960	Initiation of the management of anaesthesia for vaginal procedures in the management of post‑partum haemorrhage, if the blood loss is greater than 500 ml	7 base units
Subgroup 9—Pelvis (except hip)
21100	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the anterior pelvic region (anterior to iliac crest), except external genitalia	3 base units
21110	Initiation of the management of anaesthesia for procedures on the skin, its derivatives or subcutaneous tissue of the pelvic region (posterior to iliac crest), except perineum	5 base units
21112	Initiation of the management of anaesthesia for percutaneous bone marrow biopsy of the anterior iliac crest	4 base units
21114	Initiation of the management of anaesthesia for percutaneous bone marrow biopsy of the posterior iliac crest	5 base units
21116	Initiation of the management of anaesthesia for percutaneous bone marrow harvesting from the pelvis	6 base units
21120	Initiation of the management of anaesthesia for procedures on the bony pelvis	6 base units
21130	Initiation of the management of anaesthesia for body cast application or revision, when performed in the operating theatre of a hospital	3 base units
21140	Initiation of the management of anaesthesia for interpelviabdominal (hindquarter) amputation	15 base units
21150	Initiation of the management of anaesthesia for radical procedures for tumour of the pelvis, except hindquarter amputation	10 base units
21155	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the anterior or posterior pelvis	10 base units
21160	Initiation of the management of anaesthesia for closed procedures involving symphysis pubis or sacroiliac joint, when performed in the operating theatre of a hospital	4 base units
21170	Initiation of the management of anaesthesia for open procedures involving symphysis pubis or sacroiliac joint	8 base units
Subgroup 10—Upper leg (except knee)
21195	Initiation of the management of anaesthesia for procedures on the skins or subcutaneous tissue of the upper leg	3 base units
21199	Initiation of the management of anaesthesia for procedures on nerves, muscles, tendons, fascia or bursae of the upper leg	4 base units
21200	Initiation of the management of anaesthesia for closed procedures involving hip joint, when performed in the operating theatre of a hospital	4 base units
21202	Initiation of the management of anaesthesia for arthroscopic procedures of the hip joint	4 base units
21210	Initiation of the management of anaesthesia for open procedures involving hip joint, other than a service to which another item in this Subgroup applies	6 base units
21212	Initiation of the management of anaesthesia for hip disarticulation	10 base units
21214	Initiation of the management of anaesthesia for primary total hip replacement	10 base units
21215	Initiation of management of anaesthesia for revision total hip replacement	15 base units
21216	Initiation of the management of anaesthesia for bilateral total hip replacement	14 base units
21220	Initiation of the management of anaesthesia for closed procedures involving upper two‑thirds of femur, when performed in the operating theatre of a hospital	4 base units
21230	Initiation of the management of anaesthesia for open procedures involving upper two‑thirds of femur, other than a service to which another item in this Subgroup applies	6 base units
21232	Initiation of the management of anaesthesia for above knee amputation	5 base units
21234	Initiation of the management of anaesthesia for radical resection of the upper two‑thirds of femur	8 base units
21260	Initiation of the management of anaesthesia for procedures involving veins of upper leg, including exploration	4 base units
21270	Initiation of the management of anaesthesia for procedures involving arteries of upper leg, including bypass graft, other than a service to which another item in this Subgroup applies	8 base units
21272	Initiation of the management of anaesthesia for femoral artery ligation	4 base units
21274	Initiation of the management of anaesthesia for femoral artery embolectomy	6 base units
21275	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the upper leg	10 base units
21280	Initiation of the management of anaesthesia for microsurgical reimplantation of upper leg	15 base units
Subgroup 11—Knee and popliteal area
21300	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the knee or popliteal area, or both	3 base units
21321	Initiation of the management of anaesthesia for procedures on nerves, muscles, tendons, fascia or bursae of knee or popliteal area, or both	4 base units
21340	Initiation of the management of anaesthesia for closed procedures on lower one‑third of femur, when performed in the operating theatre of a hospital	4 base units
21360	Initiation of the management of anaesthesia for open procedures on lower one‑third of femur	5 base units
21380	Initiation of the management of anaesthesia for closed procedures on knee joint when performed in the operating theatre of a hospital	3 base units
21382	Initiation of the management of anaesthesia for arthroscopic procedures of knee joint	4 base units
21390	Initiation of the management of anaesthesia for closed procedures on upper ends of tibia, fibula or patella, or any of them, when performed in the operating theatre of a hospital	3 base units
21392	Initiation of the management of anaesthesia for open procedures on upper ends of tibia, fibula or patella, or any of them	4 base units
21400	Initiation of the management of anaesthesia for open procedures on knee joint, other than a service to which another item in this Subgroup applies	4 base units
21402	Initiation of the management of anaesthesia for knee replacement	7 base units
21403	Initiation of the management of anaesthesia for bilateral knee replacement	10 base units
21404	Initiation of the management of anaesthesia for disarticulation of knee	5 base units
21420	Initiation of the management of anaesthesia for cast application, removal or repair, involving knee joint, undertaken in a hospital	3 base units
21430	Initiation of the management of anaesthesia for procedures on veins of knee or popliteal area, other than a service to which another item in this Subgroup applies	4 base units
21432	Initiation of the management of anaesthesia for repair of arteriovenous fistula of knee or popliteal area	5 base units
21440	Initiation of the management of anaesthesia for procedures on arteries of knee or popliteal area, other than a service to which another item in this Subgroup applies	8 base units
21445	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the knee or popliteal area	10 base units
Subgroup 12—Lower leg (below knee)
21460	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of lower leg, ankle or foot	3 base units
21461	Initiation of the management of anaesthesia for procedures on nerves, muscles, tendons or fascia of lower leg, ankle or foot, other than a service to which another item in this Subgroup applies	4 base units
21462	Initiation of the management of anaesthesia for all closed procedures on lower leg, ankle or foot	3 base units
21464	Initiation of the management of anaesthesia for arthroscopic procedure of ankle joint	4 base units
21472	Initiation of the management of anaesthesia for repair of Achilles tendon	5 base units
21474	Initiation of the management of anaesthesia for gastrocnemius recession	5 base units
21480	Initiation of the management of anaesthesia for open procedures on bones of lower leg, ankle or foot, including amputation, other than a service to which another item in this Subgroup applies	4 base units
21482	Initiation of the management of anaesthesia for radical resection of bone involving lower leg, ankle or foot	5 base units
21484	Initiation of the management of anaesthesia for osteotomy or osteoplasty of tibia or fibula	5 base units
21486	Initiation of the management of anaesthesia for total ankle replacement	7 base units
21490	Initiation of the management of anaesthesia for lower leg cast application, removal or repair, undertaken in a hospital	3 base units
21500	Initiation of the management of anaesthesia for procedures on arteries of lower leg, including bypass graft, other than a service to which another item in this Subgroup applies	8 base units
21502	Initiation of the management of anaesthesia for embolectomy of the lower leg	6 base units
21520	Initiation of the management of anaesthesia for procedures on veins of lower leg, other than a service to which another item in this Subgroup applies	4 base units
21522	Initiation of the management of anaesthesia for venous thrombectomy of the lower leg	5 base units
21530	Initiation of the management of anaesthesia for microsurgical reimplantation of lower leg, ankle or foot	15 base units
21532	Initiation of the management of anaesthesia for microsurgical reimplantation of toe	8 base units
21535	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the lower leg	10 base units
Subgroup 13—Shoulder and axilla
21600	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the shoulder or axilla	3 base units
21610	Initiation of the management of anaesthesia for procedures on nerves, muscles, tendons, fascia or bursae of shoulder or axilla, including axillary dissection	5 base units
21620	Initiation of the management of anaesthesia for closed procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint or shoulder joint, when performed in the operating theatre of a hospital	4 base units
21622	Initiation of the management of anaesthesia for arthroscopic procedures of shoulder joint	5 base units
21630	Initiation of the management of anaesthesia for open procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint or shoulder joint, other than a service to which another item in this Subgroup applies	5 base units
21632	Initiation of the management of anaesthesia for radical resection involving humeral head and neck, sternoclavicular joint, acromioclavicular joint or shoulder joint	6 base units
21634	Initiation of the management of anaesthesia for shoulder disarticulation	9 base units
21636	Initiation of the management of anaesthesia for interthoracoscapular (forequarter) amputation	15 base units
21638	Initiation of the management of anaesthesia for total shoulder replacement	10 base units
21650	Initiation of the management of anaesthesia for procedures on arteries of shoulder or axilla, other than a service to which another item in this Subgroup applies	8 base units
21652	Initiation of the management of anaesthesia for procedures for axillary‑brachial aneurysm	10 base units
21654	Initiation of the management of anaesthesia for bypass graft of arteries of shoulder or axilla	8 base units
21656	Initiation of the management of anaesthesia for axillary‑femoral bypass graft	10 base units
21670	Initiation of the management of anaesthesia for procedures on veins of shoulder or axilla	4 base units
21680	Initiation of the management of anaesthesia for shoulder cast application, removal or repair, other than a service to which another item in this Subgroup applies, when undertaken in a hospital	3 base units
21682	Initiation of the management of anaesthesia for shoulder spica application, when undertaken in a hospital	4 base units
21685	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the shoulder or axilla	10 base units
Subgroup 14—Upper arm and elbow
21700	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the upper arm or elbow	3 base units
21710	Initiation of the management of anaesthesia for procedures on nerves, muscles, tendons, fascia or bursae of upper arm or elbow, other than a service to which another item in this Subgroup applies	4 base units
21712	Initiation of the management of anaesthesia for open tenotomy of the upper arm or elbow	5 base units
21714	Initiation of the management of anaesthesia for tenoplasty of the upper arm or elbow	5 base units
21716	Initiation of the management of anaesthesia for tenodesis for rupture of long tendon of biceps	5 base units
21730	Initiation of the management of anaesthesia for closed procedures on the upper arm or elbow, when performed in the operating theatre of a hospital	3 base units
21732	Initiation of the management of anaesthesia for arthroscopic procedures of elbow joint	4 base units
21740	Initiation of the management of anaesthesia for open procedures on the upper arm or elbow, other than a service to which another item in this Subgroup applies	5 base units
21756	Initiation of the management of anaesthesia for radical procedures on the upper arm or elbow	6 base units
21760	Initiation of the management of anaesthesia for total elbow replacement	7 base units
21770	Initiation of the management of anaesthesia for procedures on arteries of upper arm, other than a service to which another item in this Subgroup applies	8 base units
21772	Initiation of the management of anaesthesia for embolectomy of arteries of the upper arm	6 base units
21780	Initiation of the management of anaesthesia for procedures on veins of upper arm, other than a service to which another item in this Subgroup applies	4 base units
21785	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the upper arm or elbow	10 base units
21790	Initiation of the management of anaesthesia for microsurgical reimplantation of upper arm	15 base units
Subgroup 15—Forearm wrist and hand
21800	Initiation of the management of anaesthesia for procedures on the skin or subcutaneous tissue of the forearm, wrist or hand	3 base units
21810	Initiation of the management of anaesthesia for procedures on the nerves, muscles, tendons, fascia, or bursae of the forearm, wrist or hand	4 base units
21820	Initiation of the management of anaesthesia for closed procedures on the radius, ulna, wrist, or hand bones, when performed in the operating theatre of a hospital	3 base units
21830	Initiation of the management of anaesthesia for open procedures on the radius, ulna, wrist, or hand bones, other than a service to which another item in this Subgroup applies	4 base units
21832	Initiation of the management of anaesthesia for total wrist replacement	7 base units
21834	Initiation of the management of anaesthesia for arthroscopic procedures of the wrist joint	4 base units
21840	Initiation of the management of anaesthesia for procedures on the arteries of forearm, wrist or hand, other than a service to which another item in this Subgroup applies	8 base units
21842	Initiation of the management of anaesthesia for embolectomy of artery of forearm, wrist or hand	6 base units
21850	Initiation of the management of anaesthesia for procedures on the veins of forearm, wrist or hand, other than a service to which another item in this Subgroup applies	4 base units
21860	Initiation of the management of anaesthesia for forearm, wrist, or hand cast application, removal or repair, when undertaken in a hospital	3 base units
21865	Initiation of the management of anaesthesia for microvascular free tissue flap surgery involving the forearm, wrist or hand	10 base units
21870	Initiation of the management of anaesthesia for microsurgical reimplantation of forearm, wrist or hand	15 base units
21872	Initiation of the management of anaesthesia for microsurgical reimplantation of a finger	8 base units
Subgroup 16—Anaesthesia for burns
21878	Initiation of the management of anaesthesia for excision or debridement of burns, with or without skin grafting, if the area of burn involves not more than 3% of total body surface	3 base units
21879	Initiation of the management of anaesthesia for excision or debridement of burns, with or without skin grafting, if the area of burn involves more than 3% but less than 10% of total body surface	5 base units
21880	Initiation of the management of anaesthesia for excision or debridement of burns, with or without skin grafting, if the area of burn involves 10% or more but less than 20% of total body surface	7 base units
21881	Initiation of the management of anaesthesia for excision or debridement of burns, with or without skin grafting, if the area of burn involves 20% or more but less than 30% of total body surface	9 base units
21882	Initiation of the management of anaesthesia for excision or debridement of burns, with or without skin grafting, if the area of burn involves 30% or more but less than 40% of total body surface	11 base units
21883	Initiation of the management of anaesthesia for excision or debridement of burns, with or without skin grafting, if the area of burn involves 40% or more but less than 50% of total body surface	13 base units
21884	Initiation of the management of anaesthesia for excision or debridement of burns, with or without skin grafting, if the area of burn involves 50% or more but less than 60% of total body surface	15 base units
21885	Initiation of the management of anaesthesia for excision or debridement of burns, with or without skin grafting, if the area of burn involves 60% or more but less than 70% of total body surface	17 base units
21886	Initiation of the management of anaesthesia for excision or debridement of burns, with or without skin grafting, if the area of burn involves 70% or more but less than 80% of total body surface	19 base units
21887	Initiation of the management of anaesthesia for excision or debridement of burns, with or without skin grafting, if the area of burn involves 80% or more of total body surface	21 base units
Subgroup 17—Anaesthesia for radiological or other diagnostic or therapeutic procedures
21900	Initiation of the management of anaesthesia for injection procedure for hysterosalpingography	3 base units
21906	Initiation of the management of anaesthesia for injection procedure for myelography—lumbar or thoracic	5 base units
21908	Initiation of the management of anaesthesia for injection procedure for myelography—cervical	6 base units
21910	Initiation of the management of anaesthesia for injection procedure for myelography—posterior fossa	9 base units
21912	Initiation of the management of anaesthesia for injection procedure for discography—lumbar or thoracic	5 base units
21914	Initiation of the management of anaesthesia for injection procedure for discography—cervical	6 base units
21915	Initiation of the management of anaesthesia for peripheral arteriogram	5 base units
21916	Initiation of the management of anaesthesia for arteriograms—cerebral, carotid or vertebral	5 base units
21918	Initiation of the management of anaesthesia for retrograde arteriogram—brachial or femoral	5 base units
21922	Initiation of the management of anaesthesia for computerised axial tomography scanning, magnetic resonance scanning or digital subtraction angiography scanning	6 base units
21925	Initiation of the management of anaesthesia for retrograde cystography, retrograde urethrography or retrograde cystourethrography	4 base units
21926	Initiation of the management of anaesthesia for fluoroscopy	4 base units
21930	Initiation of the management of anaesthesia for bronchography	6 base units
21935	Initiation of the management of anaesthesia for phlebography	5 base units
21936	Initiation of the management of anaesthesia for heart—2 dimensional real time transoesophageal examination	5 base units
21939	Initiation of the management of anaesthesia for peripheral venous cannulation	3 base units
21941	Initiation of the management of anaesthesia for cardiac catheterisation (including coronary arteriography, ventriculography, cardiac mapping or insertion of automatic defibrillator or transvenous pacemaker)	7 base units
21942	Initiation of the management of anaesthesia for cardiac electrophysiological procedures including radio frequency ablation	10 base units
21943	Initiation of the management of anaesthesia for central vein catheterisation or insertion of right heart balloon catheter (via jugular, subclavian or femoral vein) by percutaneous or open exposure	5 base units
21945	Initiation of the management of anaesthesia for lumbar puncture, cisternal puncture or epidural injection	5 base units
21949	Initiation of the management of anaesthesia for harvesting of bone marrow for the purpose of transplantation	5 base units
21952	Initiation of the management of anaesthesia for diagnostic muscle biopsy to assess for malignant hyperpyrexia	4 base units
21955	Initiation of the management of anaesthesia for electroencephalography	5 base units
21959	Initiation of the management of anaesthesia for brain stem evoked response audiometry	5 base units
21962	Initiation of the management of anaesthesia for electrocochleography by extratympanic method or transtympanic membrane insertion method	5 base units
21965	Initiation of the management of anaesthesia as a therapeutic procedure if there is a clinical need for anaesthesia, not for headache of any etiology	5 base units
21969	Initiation of the management of anaesthesia during hyperbaric therapy, if the medical practitioner is not confined in the chamber (including the administration of oxygen)	8 base units
21970	Initiation of the management of anaesthesia during hyperbaric therapy, if the medical practitioner is confined in the chamber (including the administration of oxygen)	15 base units
21973	Initiation of the management of anaesthesia for brachytherapy using radioactive sealed sources	5 base units
21976	Initiation of the management of anaesthesia for therapeutic nuclear medicine	5 base units
21980	Initiation of the management of anaesthesia for radiotherapy	5 base units
Subgroup 18—Miscellaneous
21990	Initiation of the management of anaesthesia, being a service to which another item in this Subgroup or in Subgroups 1 to 17 or 20 would have applied if the procedure in connection with which the service is provided had not been discontinued	3 base units
21992	Initiation of the management of anaesthesia performed on a patient under the age of 10 years in connection with a procedure covered by an item that does not include the word “(Anaes.)”	4 base units
21997	Initiation of the management of anaesthesia in connection with a procedure covered by an item that does not include the word “(Anaes.)”, other than a service to which item 21965 or 21992 applies, if there is a clinical need for anaesthesia	4 base units
Subgroup 19—Therapeutic and diagnostic services performed in connection with the management of anaesthesia
22002	Administration of homologous blood or bone marrow already collected, when performed in association with the management of anaesthesia	4 base units
22007	Endotracheal intubation with flexible fibreoptic scope associated with difficult airway, when performed in association with the management of anaesthesia	4 base units
22008	Double lumen endobronchial tube or bronchial blocker, insertion of, when performed in association with the management of anaesthesia	4 base units
22012	Monitoring that: (a) is of one of the following types of blood pressure: (i) central venous blood pressure; (ii) pulmonary arterial blood pressure; (iii) systemic arterial blood pressure; (iv) cardiac intracavity blood pressure; and (b) is conducted by indwelling catheter; and (c) is performed in association with the administration of anaesthesia for a procedure and not as a service to which item 13876 applies; and (d) is performed, on a day, on a patient who: (i) is categorised as having a high risk of complications; or (ii) during the procedure develops either complications or a high risk of complications; and (e) has not previously been performed in those circumstances on the day on the patient for that type of blood pressure	3 base units
22014	Monitoring that: (a) is of one of the following types of blood pressure: (i) central venous blood pressure; (ii) pulmonary arterial blood pressure; (iii) systemic arterial blood pressure; (iv) cardiac intracavity blood pressure; and (b) is conducted by indwelling catheter; and (c) is performed in association with the administration of anaesthesia for a procedure (the current procedure) and not as a service to which item 13876 applies; and (d) is performed, on a day, on a patient: (i) who is categorised as having a high risk of complications or develops during the current procedure either complications or a high risk of complications; and (ii) for whom monitoring of that type of blood pressure to which item 22012 applies has already been performed on the day in association with the administration of anaesthesia for another discrete procedure; and (e) has not previously been performed in association with the current procedure for that type of blood pressure	3 base units
22015	Right heart balloon catheter, insertion of, including pulmonary wedge pressure and cardiac output measurement, when performed in association with the management of anaesthesia	6 base units
22020	Central vein catheterisation by percutaneous or open exposure, other than a service to which item 13318 applies, when performed in association with the management of anaesthesia	4 base units
22025	Intra‑arterial cannulation when performed in association with the management of anaesthesia for a procedure for a patient who: (a) is categorised as having a high risk of complications; or (b) develops a high risk of complications during the procedure	4 base units
22031	Intrathecal or epidural injection (initial) of a therapeutic substance, with or without insertion of a catheter, in association with anaesthesia and surgery, for post‑operative pain management, other than a service associated with a service to which item 22036 applies	5 base units
22036	Intrathecal or epidural injection (subsequent) of a therapeutic substance, using an in‑situ catheter, in association with anaesthesia and surgery, for post‑operative pain, other than a service associated with a service to which item 22031 applies	3 base units
22041	Introduction of a plexus or nerve block proximal to the lower leg or forearm, perioperatively performed in the induction room, theatre or recovery room, for post‑operative pain management	2 base units
22042	Introduction of a regional or field nerve block performed via retrobulbar, peribulbar or sub‑Tenon’s block injection of an anaesthetic agent, or other complex eye block, when administered by an anaesthetist perioperatively	1 base unit
22051	Intra‑operative transoesophageal echocardiography—monitoring in real time the structure and function of the heart chambers, valves and surrounding structures, including assessment of blood flow, with appropriate permanent recording during procedures on the heart, pericardium or great vessels of the chest, other than a service associated with a service to which item 55130, 55135 or 21936 applies	9 base units
22052	Transfusion of blood by an anaesthetist, including collection from donor, when used for intra‑operative normovolaemic haemodilution, where the service is provided on the same occasion as the administration of anaesthesia by the same anaesthetist, other than a service associated with a service to which item 13703 applies	6 base units
22053	Insertion of lumbar cerebrospinal fluid drain, by an anaesthetist at the request of the treating specialist, where the service is provided on the same occasion as the administration of anaesthesia by the same anaesthetist, other than a service associated with a service to which item 40018 applies	6 base units
22054	Intraoperative two‑dimensional or three‑dimensional real time transoesophageal echocardiography by an anaesthetist, where the service: (a) is provided on the same day as a service to which item 38477, 38484, 38499, 38516 or 38517 applies; and (b) includes Doppler techniques with colour flow mapping and recordings on digital media; and (c) is performed during cardiac valve surgery (replacement or repair); and (d) incorporates sequential assessment of cardiac function and valve competence before and after the surgical procedure; and (e) is not associated with a service to which item 21936, 22051, 55118, 55130 or 55135 applies; and (f) is provided on the same occasion as the administration of anaesthesia by the same anaesthetist	18 base units
22055	Perfusion of limb or organ using heart‑lung machine or equivalent, other than a service associated with anaesthesia to which an item in Subgroup 21 applies	12 base units
22060	Whole body perfusion, cardiac bypass, if the heart‑lung machine or equivalent is continuously operated by a medical perfusionist, other than a service associated with anaesthesia to which an item in Subgroup 21 applies	30 base units
22065	Induced controlled hypothermia—total body, that is: (a) a service to which item 22060 applies; and (b) not a service associated with anaesthesia, to which an item in Subgroup 21 applies	5 base units
22075	Deep hypothermic circulatory arrest, with core temperature less than 22°c, including management of retrograde cerebral perfusion (if performed), other than a service associated with anaesthesia to which an item in Subgroup 21 applies	15 base units
Subgroup 20—Management of anaesthesia in connection with a dental service
22900	Initiation of the management by a medical practitioner of anaesthesia for extraction of tooth or teeth, with or without incision of soft tissue or removal of bone	6 base units
22905	Initiation of the management of anaesthesia for restorative dental work	6 base units
Subgroup 21—Anaesthesia, perfusion and assistance at anaesthesia (time component)
23010	Anaesthesia, perfusion or assistance, if the service time is not more than 15 minutes	1 base unit
23025	Anaesthesia, perfusion or assistance, if the service time is more than 15 minutes but not more than 30 minutes	2 base units
23035	Anaesthesia, perfusion or assistance, if the service time is more than 30 minutes but not more than 45 minutes	3 base units
23045	Anaesthesia, perfusion or assistance, if the service time is more than 45 minutes but not more than 1 hour	4 base units
23055	Anaesthesia, perfusion or assistance, if the service time is more than 1 hour but not more than 1:15 hours	5 base units
23065	Anaesthesia, perfusion or assistance, if the service time is more than 1:15 hours but not more than 1:30 hours	6 base units
23075	Anaesthesia, perfusion or assistance, if the service time is more than 1:30 hours but not more than 1:45 hours	7 base units
23085	Anaesthesia, perfusion or assistance, if the service time is more than 1:45 hours but not more than 2:00 hours	8 base units
23091	Anaesthesia, perfusion or assistance, if the service time is more than 2:00 hours but not more than 2:10 hours	9 base units
23101	Anaesthesia, perfusion or assistance, if the service time is more than 2:10 hours but not more than 2:20 hours	10 base units
23111	Anaesthesia, perfusion or assistance, if the service time is more than 2:20 hours but not more than 2:30 hours	11 base units
23112	Anaesthesia, perfusion or assistance, if the service time is more than 2:30 hours but not more than 2:40 hours	12 base units
23113	Anaesthesia, perfusion or assistance, if the service time is more than 2:40 hours but not more than 2:50 hours	13 base units
23114	Anaesthesia, perfusion or assistance, if the service time is more than 2:50 hours but not more than 3:00 hours	14 base units
23115	Anaesthesia, perfusion or assistance, if the service time is more than 3:00 hours but not more than 3:10 hours	15 base units
23116	Anaesthesia, perfusion or assistance, if the service time is more than 3:10 hours but not more than 3:20 hours	16 base units
23117	Anaesthesia, perfusion or assistance, if the service time is more than 3:20 hours but not more than 3:30 hours	17 base units
23118	Anaesthesia, perfusion or assistance, if the service time is more than 3:30 hours but not more than 3:40 hours	18 base units
23119	Anaesthesia, perfusion or assistance, if the service time is more than 3:40 hours but not more than 3:50 hours	19 base units
23121	Anaesthesia, perfusion or assistance, if the service time is more than 3:50 hours but not more than 4:00 hours	20 base units
23170	Anaesthesia, perfusion or assistance, if the service time is more than 4:00 hours but not more than 4:10 hours	21 base units
23180	Anaesthesia, perfusion or assistance, if the service time is more than 4:10 hours but not more than 4:20 hours	22 base units
23190	Anaesthesia, perfusion or assistance, if the service time is more than 4:20 hours but not more than 4:30 hours	23 base units
23200	Anaesthesia, perfusion or assistance, if the service time is more than 4:30 hours but not more than 4:40 hours	24 base units
23210	Anaesthesia, perfusion or assistance, if the service time is more than 4:40 hours but not more than 4:50 hours	25 base units
23220	Anaesthesia, perfusion or assistance, if the service time is more than 4:50 hours but not more than 5:00 hours	26 base units
23230	Anaesthesia, perfusion or assistance, if the service time is more than 5:00 hours but not more than 5:10 hours	27 base units
23240	Anaesthesia, perfusion or assistance, if the service time is more than 5:10 hours but not more than 5:20 hours	28 base units
23250	Anaesthesia, perfusion or assistance, if the service time is more than 5:20 hours but not more than 5:30 hours	29 base units
23260	Anaesthesia, perfusion or assistance, if the service time is more than 5:30 hours but not more than 5:40 hours	30 base units
23270	Anaesthesia, perfusion or assistance, if the service time is more than 5:40 hours but not more than 5:50 hours	31 base units
23280	Anaesthesia, perfusion or assistance, if the service time is more than 5:50 hours but not more than 6:00 hours	32 base units
23290	Anaesthesia, perfusion or assistance, if the service time is more than 6:00 hours but not more than 6:10 hours	33 base units
23300	Anaesthesia, perfusion or assistance, if the service time is more than 6:10 hours but not more than 6:20 hours	34 base units
23310	Anaesthesia, perfusion or assistance, if the service time is more than 6:20 hours but not more than 6:30 hours	35 base units
23320	Anaesthesia, perfusion or assistance, if the service time is more than 6:30 hours but not more than 6:40 hours	36 base units
23330	Anaesthesia, perfusion or assistance, if the service time is more than 6:40 hours but not more than 6:50 hours	37 base units
23340	Anaesthesia, perfusion or assistance, if the service time is more than 6:50 hours but not more than 7:00 hours	38 base units
23350	Anaesthesia, perfusion or assistance, if the service time is more than 7:00 hours but not more than 7:10 hours	39 base units
23360	Anaesthesia, perfusion or assistance, if the service time is more than 7:10 hours but not more than 7:20 hours	40 base units
23370	Anaesthesia, perfusion or assistance, if the service time is more than 7:20 hours but not more than 7:30 hours	41 base units
23380	Anaesthesia, perfusion or assistance, if the service time is more than 7:30 hours but not more than 7:40 hours	42 base units
23390	Anaesthesia, perfusion or assistance, if the service time is more than 7:40 hours but not more than 7:50 hours	43 base units
23400	Anaesthesia, perfusion or assistance, if the service time is more than 7:50 hours but not more than 8:00 hours	44 base units
23410	Anaesthesia, perfusion or assistance, if the service time is more than 8:00 hours but not more than 8:10 hours	45 base units
23420	Anaesthesia, perfusion or assistance, if the service time is more than 8:10 hours but not more than 8:20 hours	46 base units
23430	Anaesthesia, perfusion or assistance, if the service time is more than 8:20 hours but not more than 8:30 hours	47 base units
23440	Anaesthesia, perfusion or assistance, if the service time is more than 8:30 hours but not more than 8:40 hours	48 base units
23450	Anaesthesia, perfusion or assistance, if the service time is more than 8:40 hours but not more than 8:50 hours	49 base units
23460	Anaesthesia, perfusion or assistance, if the service time is more than 8:50 hours but not more than 9:00 hours	50 base units
23470	Anaesthesia, perfusion or assistance, if the service time is more than 9:00 hours but not more than 9:10 hours	51 base units
23480	Anaesthesia, perfusion or assistance, if the service time is more than 9:10 hours but not more than 9:20 hours	52 base units
23490	Anaesthesia, perfusion or assistance, if the service time is more than 9:20 hours but not more than 9:30 hours	53 base units
23500	Anaesthesia, perfusion or assistance, if the service time is more than 9:30 hours but not more than 9:40 hours	54 base units
23510	Anaesthesia, perfusion or assistance, if the service time is more than 9:40 hours but not more than 9:50 hours	55 base units
23520	Anaesthesia, perfusion or assistance, if the service time is more than 9:50 hours but not more than 10:00 hours	56 base units
23530	Anaesthesia, perfusion or assistance, if the service time is more than 10:00 hours but not more than 10:10 hours	57 base units
23540	Anaesthesia, perfusion or assistance, if the service time is more than 10:10 hours but not more than 10:20 hours	58 base units
23550	Anaesthesia, perfusion or assistance, if the service time is more than 10:20 hours but not more than 10:30 hours	59 base units
23560	Anaesthesia, perfusion or assistance, if the service time is more than 10:30 hours but not more than 10:40 hours	60 base units
23570	Anaesthesia, perfusion or assistance, if the service time is more than 10:40 hours but not more than 10:50 hours	61 base units
23580	Anaesthesia, perfusion or assistance, if the service time is more than 10:50 hours but not more than 11:00 hours	62 base units
23590	Anaesthesia, perfusion or assistance, if the service time is more than 11:00 hours but not more than 11:10 hours	63 base units
23600	Anaesthesia, perfusion or assistance, if the service time is more than 11:10 hours but not more than 11:20 hours	64 base units
23610	Anaesthesia, perfusion or assistance, if the service time is more than 11:20 hours but not more than 11:30 hours	65 base units
23620	Anaesthesia, perfusion or assistance, if the service time is more than 11:30 hours but not more than 11:40 hours	66 base units
23630	Anaesthesia, perfusion or assistance, if the service time is more than 11:40 hours but not more than 11:50 hours	67 base units
23640	Anaesthesia, perfusion or assistance, if the service time is more than 11:50 hours but not more than 12:00 hours	68 base units
23650	Anaesthesia, perfusion or assistance, if the service time is more than 12:00 hours but not more than 12:10 hours	69 base units
23660	Anaesthesia, perfusion or assistance, if the service time is more than 12:10 hours but not more than 12:20 hours	70 base units
23670	Anaesthesia, perfusion or assistance, if the service time is more than 12:20 hours but not more than 12:30 hours	71 base units
23680	Anaesthesia, perfusion or assistance, if the service time is more than 12:30 hours but not more than 12:40 hours	72 base units
23690	Anaesthesia, perfusion or assistance, if the service time is more than 12:40 hours but not more than 12:50 hours	73 base units
23700	Anaesthesia, perfusion or assistance, if the service time is more than 12:50 hours but not more than 13:00 hours	74 base units
23710	Anaesthesia, perfusion or assistance, if the service time is more than 13:00 hours but not more than 13:10 hours	75 base units
23720	Anaesthesia, perfusion or assistance, if the service time is more than 13:10 hours but not more than 13:20 hours	76 base units
23730	Anaesthesia, perfusion or assistance, if the service time is more than 13:20 hours but not more than 13:30 hours	77 base units
23740	Anaesthesia, perfusion or assistance, if the service time is more than 13:30 hours but not more than 13:40 hours	78 base units
23750	Anaesthesia, perfusion or assistance, if the service time is more than 13:40 hours but not more than 13:50 hours	79 base units
23760	Anaesthesia, perfusion or assistance, if the service time is more than 13:50 hours but not more than 14:00 hours	80 base units
23770	Anaesthesia, perfusion or assistance, if the service time is more than 14:00 hours but not more than 14:10 hours	81 base units
23780	Anaesthesia, perfusion or assistance, if the service time is more than 14:10 hours but not more than 14:20 hours	82 base units
23790	Anaesthesia, perfusion or assistance, if the service time is more than 14:20 hours but not more than 14:30 hours	83 base units
23800	Anaesthesia, perfusion or assistance, if the service time is more than 14:30 hours but not more than 14:40 hours	84 base units
23810	Anaesthesia, perfusion or assistance, if the service time is more than 14:40 hours but not more than 14:50 hours	85 base units
23820	Anaesthesia, perfusion or assistance, if the service time is more than 14:50 hours but not more than 15:00 hours	86 base units
23830	Anaesthesia, perfusion or assistance, if the service time is more than 15:00 hours but not more than 15:10 hours	87 base units
23840	Anaesthesia, perfusion or assistance, if the service time is more than 15:10 hours but not more than 15:20 hours	88 base units
23850	Anaesthesia, perfusion or assistance, if the service time is more than 15:20 hours but not more than 15:30 hours	89 base units
23860	Anaesthesia, perfusion or assistance, if the service time is more than 15:30 hours but not more than 15:40 hours	90 base units
23870	Anaesthesia, perfusion or assistance, if the service time is more than15:40 hours but not more than 15:50 hours	91 base units
23880	Anaesthesia, perfusion or assistance, if the service time is more than 15:50 hours but not more than 16:00 hours	92 base units
23890	Anaesthesia, perfusion or assistance, if the service time is more than 16:00 hours but not more than 16:10 hours	93 base units
23900	Anaesthesia, perfusion or assistance, if the service time is more than 16:10 hours but not more than 16:20 hours	94 base units
23910	Anaesthesia, perfusion or assistance, if the service time is more than 16:20 hours but not more than 16:30 hours	95 base units
23920	Anaesthesia, perfusion or assistance, if the service time is more than 16:30 hours but not more than 16:40 hours	96 base units
23930	Anaesthesia, perfusion or assistance, if the service time is more than 16:40 hours but not more than 16:50 hours	97 base units
23940	Anaesthesia, perfusion or assistance, if the service time is more than 16:50 hours but not more than 17:00 hours	98 base units
23950	Anaesthesia, perfusion or assistance, if the service time is more than 17:00 hours but not more than 17:10 hours	99 base units
23960	Anaesthesia, perfusion or assistance, if the service time is more than 17:10 hours but not more than 17:20 hours	100 base units
23970	Anaesthesia, perfusion or assistance, if the service time is more than 17:20 hours but not more than 17:30 hours	101 base units
23980	Anaesthesia, perfusion or assistance, if the service time is more than 17:30 hours but not more than 17:40 hours	102 base units
23990	Anaesthesia, perfusion or assistance, if the service time is more than 17:40 hours but not more than 17:50 hours	103 base units
24100	Anaesthesia, perfusion or assistance, if the service time is more than 17:50 hours but not more than 18:00 hours	104 base units
24101	Anaesthesia, perfusion or assistance, if the service time is more than 18:00 hours but not more than 18:10 hours	105 base units
24102	Anaesthesia, perfusion or assistance, if the service time is more than 18:10 hours but not more than 18:20 hours	106 base units
24103	Anaesthesia, perfusion or assistance, if the service time is more than 18:20 hours but not more than 18:30 hours	107 base units
24104	Anaesthesia, perfusion or assistance, if the service time is more than 18:30 hours but not more than 18:40 hours	108 base units
24105	Anaesthesia, perfusion or assistance, if the service time is more than 18:40 hours but not more than 18:50 hours	109 base units
24106	Anaesthesia, perfusion or assistance, if the service time is more than 18:50 hours but not more than 19:00 hours	110 base units
24107	Anaesthesia, perfusion or assistance, if the service time is more than 19:00 hours but not more than 19:10 hours	111 base units
24108	Anaesthesia, perfusion or assistance, if the service time is more than 19:10 hours but not more than 19:20 hours	112 base units
24109	Anaesthesia, perfusion or assistance, if the service time is more than 19:20 hours but not more than 19:30 hours	113 base units
24110	Anaesthesia, perfusion or assistance, if the service time is more than 19:30 hours but not more than 19:40 hours	114 base units
24111	Anaesthesia, perfusion or assistance, if the service time is more than 19:40 hours but not more than 19:50 hours	115 base units
24112	Anaesthesia, perfusion or assistance, if the service time is more than 19:50 hours but not more than 20:00 hours	116 base units
24113	Anaesthesia, perfusion or assistance, if the service time is more than 20:00 hours but not more than 20:10 hours	117 base units
24114	Anaesthesia, perfusion or assistance, if the service time is more than 20:10 hours but not more than 20:20 hours	118 base units
24115	Anaesthesia, perfusion or assistance, if the service time is more than 20:20 hours but not more than 20:30 hours	119 base units
24116	Anaesthesia, perfusion or assistance, if the service time is more than 20:30 hours but not more than 20:40 hours	120 base units
24117	Anaesthesia, perfusion or assistance, if the service time is more than 20:40 hours but not more than 20:50 hours	121 base units
24118	Anaesthesia, perfusion or assistance, if the service time is more than 20:50 hours but not more than 21:00 hours	122 base units
24119	Anaesthesia, perfusion or assistance, if the service time is more than 21:00 hours but not more than 21:10 hours	123 base units
24120	Anaesthesia, perfusion or assistance, if the service time is more than 21:10 hours but not more than 21:20 hours	124 base units
24121	Anaesthesia, perfusion or assistance, if the service time is more than 21:20 hours but not more than 21:30 hours	125 base units
24122	Anaesthesia, perfusion or assistance, if the service time is more than 21:30 hours but not more than 21:40 hours	126 base units
24123	Anaesthesia, perfusion or assistance, if the service time is more than 21:40 hours but not more than 21:50 hours	127 base units
24124	Anaesthesia, perfusion or assistance, if the service time is more than 21:50 hours but not more than 22:00 hours	128 base units
24125	Anaesthesia, perfusion or assistance, if the service time is more than 22:00 hours but not more than 22:10 hours	129 base units
24126	Anaesthesia, perfusion or assistance, if the service time is more than 22:10 hours but not more than 22:20 hours	130 base units
24127	Anaesthesia, perfusion or assistance, if the service time is more than 22:20 hours but not more than 22:30 hours	131 base units
24128	Anaesthesia, perfusion or assistance, if the service time is more than 22:30 hours but not more than 22:40 hours	132 base units
24129	Anaesthesia, perfusion or assistance, if the service time is more than 22:40 hours but not more than 22:50 hours	133 base units
24130	Anaesthesia, perfusion or assistance, if the service time is more than 22:50 hours but not more than 23:00 hours	134 base units
24131	Anaesthesia, perfusion or assistance, if the service time is more than 23:00 hours but not more than 23:10 hours	135 base units
24132	Anaesthesia, perfusion or assistance, if the service time is more than 23:10 hours but not more than 23:20 hours	136 base units
24133	Anaesthesia, perfusion or assistance, if the service time is more than 23:20 hours but not more than 23:30 hours	137 base units
24134	Anaesthesia, perfusion or assistance, if the service time is more than 23:30 hours but not more than 23:40 hours	138 base units
24135	Anaesthesia, perfusion or assistance, if the service time is more than 23:40 hours but not more than 23:50 hours	139 base units
24136	Anaesthesia, perfusion or assistance, if the service time is more than 23:50 hours but not more than 24:00 hours	140 base units
Subgroup 22—Anaesthesia, perfusion and assistance at anaesthesia (modifying components—physical status)
25000	Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient has severe systemic disease (equivalent to ASA physical status indicator 3)	1 base unit
25005	Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient has severe systemic disease which is a constant threat to life (equivalent to ASA physical status indicator 4)	2 base units
25010	Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient is not expected to survive for 24 hours, with or without the associated operation (equivalent to ASA physical status indicator 5)	3 base units
Subgroup 23—Anaesthesia, perfusion and assistance at anaesthesia (modifying components—other)
25013	Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient is aged under 4 years	1 base unit
25014	Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient is aged 75 years or more	1 base unit
25020	Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient requires immediate treatment without which there would be significant threat to life or body part—other than a service associated with a service to which item 25025, 25030 or 25050 applies	2 base units
Subgroup 24—Anaesthesia and assistance at anaesthesia (after hours emergency modifier)
25025	Anaesthesia, if the patient requires immediate treatment without which there would be significant threat to life or body part and if more than 50% of the service time occurs between 8 pm to 8 am on any weekday, or on a Saturday, Sunday or public holiday	Amount under clause 5.9.1
25030	Assistance in the management of anaesthesia, if the patient requires immediate treatment without which there would be significant threat to life or body part and if more than 50% of the service time occurs between 8 pm to 8 am on any weekday, or on a Saturday, Sunday or public holiday	Amount under clause 5.9.1
Subgroup 25—Perfusion (after hours emergency modifier)
25050	Perfusion, if the patient requires immediate treatment without which there would be significant threat to life or body part and if more than 50% of the service time occurs between 8 pm to 8 am on any weekday, or on a Saturday, Sunday or public holiday	Amount under clause 5.9.1
Subgroup 26—Assistance at anaesthesia
25200	Assistance in the management of anaesthesia requiring continuous anaesthesia on a patient in imminent danger of death requiring continuous life saving emergency treatment, to the exclusion of attendance on all other patients	Amount under clause 5.9.2
25205	Assistance in the management of elective anaesthesia, if: (a) the patient has complex airway problems; or (b) the patient is a neonate; or (c) the patient is a paediatric patient and is receiving one or more of the following services: (i) invasive monitoring, either intravascular or transoesophageal; (ii) organ transplantation; (iii) craniofacial surgery; (iv) major tumour resection; (v) separation of conjoint twins; or (d) there is anticipated to be massive blood loss (greater than 50% of blood volume) during the procedure; or (e) the patient is critically ill, with multiple organ failure; or (f) the service time of the management of anaesthesia exceeds 6 hours and the assistance is provided to the exclusion of attendance on all other patients	Amount under clause 5.9.2

Division 5.10—Group T8: Surgical operations

Subdivision A—Subgroup 1 of Group T8

5.10.1 Meaning of amount under clause 5.10.1

In item 30001:

amount under clause 5.10.1 means 50% of the fee that would normally apply for a surgical procedure if the surgical procedure had not been discontinued before completion.

5.10.2 Meaning of amount under clause 5.10.2

In item 31340:

amount under clause 5.10.2, for the excision of muscle, bone or cartilage in association with the excision of a malignant tumour of skin under another item, means 75% of the fee payable under that other item.

5.10.3 Histopathological proof of malignancy—items 30196 and 30202

For the purposes of items 30196 and 30202, the requirement for histopathological proof of malignancy is satisfied if:

(a) multiple lesions are removed from a single anatomical region; and

(b) a single lesion from that region is histologically tested and proven positive for malignancy.

5.10.5 Items 30440, 30451, 30492 and 30495 do not include imaging

A service described in item 30440, 30451, 30492 or 30495 does not include imaging.

Note: The imaging services associated with these services are described in the diagnostic imaging services table.

5.10.5A Meaning of treatment cycle

In item 30665:

treatment cycle, for a patient, means a series of treatments for the patient that:

(a) begins on the day of the initial failed attempt at biliary stone removal via ERCP extraction techniques; and

(b) ends at the conclusion of the aftercare period for the procedure (being either the lithotripsy procedure or a definitive surgical management procedure) that has resulted in removal of the biliary stones.

5.10.6 Restrictions on items 30688, 30690, 30692 and 30694—patient notes

Item 30688, 30690, 30692 or 30694 applies to a service only if the provider makes a record of the findings of the ultrasound imaging in the patient’s notes.

5.10.7 Application of item 35412

(1) Intra‑operative imaging is taken to be part of the service associated with the coiling of an aneurysm and cannot be charged in addition to item 35412.

(2) Pre‑operative diagnostic imaging, including aftercare, under item 60009, 60072, 60075 or 60078 of the diagnostic imaging services table may be separately claimed.

5.10.8 Restrictions on items 31569, 31572, 31575, 31578, 31581, 31587 and 31590—services provided on same occasion

(1) A service described in item 31569, 31572, 31575, 31578, 31581, 31587 or 31590 may only be claimed once for a patient for the same occasion.

(2) If 2 or more services described in item 31569, 31572, 31575, 31578, 31581, 31587 or 31590 are performed in conjunction on a patient on the same occasion, only one of the services may be claimed for the patient for the occasion.

5.10.9 Items in Subgroup 1 of Group T8

This clause sets out items in Subgroup 1 of Group T8.

Note: The fees in Group T8 are indexed in accordance with clause 1.3.1.

Group T8—Surgical operations
Column 1 Item	Column 2 Description	Column 3 Fee ($)
Subgroup 1—General
30001	Operative procedure, being a service to which an item in this Group would have applied had the procedure not been discontinued on medical grounds	Amount under clause 5.10.1
30003	Burns, involving 1% or more but less than 3% of total body surface, dressing of (including redressing of any related donor site, if required), without anaesthesia, if medical practitioner is present—each attendance at which the procedure is performed Not applicable for skin reactions secondary to radiotherapy	37.80
30006	Burns, involving 3% or more but less than 10% of total body surface, dressing of (including redressing of any related donor site, if required), without anaesthesia, if medical practitioner is present—each attendance at which the procedure is performed Not applicable for skin reactions secondary to radiotherapy	48.40
30007	Burns, involving 10% or more of total body surface, dressing of (including redressing of any related donor site, if required), without anaesthesia, if medical practitioner is present—each attendance at which the procedure is performed Not applicable for skin reactions secondary to radiotherapy	170.20
30010	Burns, involving not more than 3% of total body surface, dressing of (including redressing of any related donor site, if required), in an operating theatre under general anaesthesia or intravenous sedation, if medical practitioner is present (H) (Anaes.)	76.95
30014	Burns, involving 3% or more but less than 20% of total body surface, dressing of (including redressing of any related donor site, if required), in an operating theatre under general anaesthesia or intravenous sedation, if medical practitioner is present (H) (Anaes.)	161.70
30015	Burns, involving 20% or more but less than 50% of total body surface, or burns of less than 20% of total body surface involving 1% or more of total body surface within the hands or face, dressing of (including redressing of any related donor site, if required), in an operating theatre under general anaesthesia or intravenous sedation, if medical practitioner is present (H) (Anaes.) (Assist.)	255.30
30016	Burns, involving 50% or more of total body surface, dressing of (including redressing of any related donor site, if required), in an operating theatre under general anaesthesia or intravenous sedation, if medical practitioner is present (H) (Anaes.) (Assist.)	382.95
30023	Wound of soft tissue, traumatic, deep or extensively contaminated, debridement of, under general anaesthesia, or regional or field nerve block, including suturing of the wound if carried out (Anaes.) (Assist.)	339.25
30024	Wound of soft tissue, debridement of an extensively infected post‑surgical incision or Fournier’s gangrene, under general anaesthesia, or regional or field nerve block, including suturing of the wound if carried out (Anaes.) (Assist.)	339.25
30026	Skin and subcutaneous tissue or mucous membrane, repair of wound of, other than wound closure at time of surgery, not on face or neck, small (not more than 7 cm long), superficial, other than a service to which another item in Group T4 applies (Anaes.)	54.35
30029	Skin and subcutaneous tissue or mucous membrane, repair of wound of, other than wound closure at time of surgery, not on face or neck, small (not more than 7 cm in length), involving deeper tissue, other than a service to which another item in Group T4 applies (Anaes.)	93.65
30032	Skin and subcutaneous tissue or mucous membrane, repair of wound of, other than wound closure at time of surgery, on face or neck, small (not more than 7 cm long), superficial (Anaes.)	85.80
30035	Skin and subcutaneous tissue or mucous membrane, repair of wound of, other than wound closure at time of surgery, on face or neck, small (not more than 7 cm long), involving deeper tissue (Anaes.)	122.35
30038	Skin and subcutaneous tissue or mucous membrane, repair of wound of, other than wound closure at time of surgery, not on face or neck, large (more than 7 cm long), superficial, other than a service to which another item in Group T4 applies (Anaes.)	93.65
30042	Skin and subcutaneous tissue or mucous membrane, repair of wound of, other than wound closure at time of surgery, other than on face or neck, large (more than 7 cm long), involving deeper tissue, other than a service to which another item in Group T4 applies (Anaes.)	193.10
30045	Skin and subcutaneous tissue or mucous membrane, repair of wound of, other than wound closure at time of surgery, on face or neck, large (more than 7 cm long), superficial (Anaes.)	122.35
30049	Skin and subcutaneous tissue or mucous membrane, repair of wound of, other than wound closure at time of surgery, on face or neck, large (more than 7 cm long), involving deeper tissue (Anaes.)	193.10
30052	Full thickness laceration of ear, eyelid, nose or lip, repair of, with accurate apposition of each layer of tissue (Anaes.) (Assist.)	264.25
30055	Wounds, dressing of, under general, regional or intravenous sedation, with or without removal of sutures, other than a service associated with a service to which another item in this Group applies (Anaes.)	76.95
30058	Post‑operative haemorrhage, control of, under general anaesthesia, as an independent procedure (Anaes.)	150.20
30061	Superficial foreign body, removal of, (including from cornea or sclera) as an independent procedure (Anaes.)	24.45
30062	Etonogestrel subcutaneous implant, removal of, as an independent procedure (Anaes.)	63.20
30064	Subcutaneous foreign body, removal of, requiring incision and exploration, including closure of wound if performed, as an independent procedure (Anaes.)	114.30
30068	Foreign body in muscle, tendon or other deep tissue, removal of, as an independent procedure (Anaes.) (Assist.)	288.00
30071	Diagnostic biopsy of skin, as an independent procedure, if the biopsy specimen is sent for pathological examination (Anaes.)	54.35
30072	Diagnostic biopsy of mucous membrane, as an independent procedure, if the biopsy specimen is sent for pathological examination (Anaes.)	54.35
30075	Diagnostic biopsy of lymph node, muscle or other deep tissue or organ, as an independent procedure, if the biopsy specimen is sent for pathological examination (Anaes.)	155.85
30078	Diagnostic drill biopsy of lymph node, deep tissue or organ, as an independent procedure, if the biopsy specimen is sent for pathological examination (Anaes.)	50.45
30081	Diagnostic biopsy of bone marrow by trephine using an open approach, if the biopsy specimen is sent for pathological examination (Anaes.)	114.30
30084	Diagnostic biopsy of bone marrow by trephine using a percutaneous approach, if the biopsy specimen is sent for pathological examination (Anaes.)	61.20
30087	Diagnostic biopsy of bone marrow by aspiration or punch biopsy of synovial membrane, if the biopsy specimen is sent for pathological examination (Anaes.)	30.60
30090	Diagnostic biopsy of pleura, percutaneous, if the biopsy specimen is sent for pathological examination—one or more biopsies on any one occasion (Anaes.)	133.75
30093	Diagnostic needle biopsy of vertebra, if the biopsy specimen is sent for pathological examination (Anaes.)	178.50
30094	Diagnostic percutaneous aspiration biopsy of deep organ using interventional techniques (but not including imaging) if the biopsy specimen is sent for pathological examination (Anaes.)	197.10
30097	Personal performance of a Synacthen Stimulation Test, including associated consultation, by a medical practitioner with resuscitation training and access to facilities where life support procedures can be implemented, if: (a) serum cortisol at 8.30 am to 9.30 am on any day in the preceding month has been measured at greater than 100 nmol/L but less than 400 nmol/L; or (b) the patient is acutely unwell and adrenal insufficiency is suspected	101.10
30099	Sinus, excision of, involving superficial tissue only (Anaes.)	93.65
30103	Sinus, excision of, involving muscle and deep tissue (Anaes.)	191.35
30104	Pre‑auricular sinus, excision of, on a patient 10 years of age or over (Anaes.)	132.10
30105	Pre‑auricular sinus, excision of, on a patient under 10 years of age (Anaes.)	171.65
30107	Excision of ganglion, other than a service associated with a service to which another item in this Group applies (Anaes.)	228.85
30166	Removal of redundant abdominal skin and lipectomy, as a wedge excision, for functional problems following significant weight loss equivalent to at least 5 body mass index points and if there has been a stable weight for a period of at least 6 months prior to surgery, other than a service associated with a service to which item 30175, 30176, 30177, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 46088 or 46090 applies (H) (Anaes.) (Assist.)	821.45
30169	Removal of redundant non‑abdominal skin and lipectomy for functional problems following significant weight loss equivalent to at least 5 body mass index points and if there has been a stable weight for a period of at least 6 months prior to surgery, one or 2 non‑abdominal areas, other than a service associated with a service to which item 30175, 30176, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 46088 or 46090 applies (H) (Anaes.) (Assist.)	657.15
30175	Radical abdominoplasty, with repair of rectus diastasis, excision of skin and subcutaneous tissue, and transposition of umbilicus, not being a laparoscopic procedure, if: (a) the patient has an abdominal wall defect as a consequence of pregnancy; and (b) the patient: (i) has a diastasis of at least 3cm measured by diagnostic imaging prior to this service; and (ii) has either or both of the following: (A) at least moderately severe pain or discomfort at the site of the diastasis in the abdominal wall during functional use and the pain or discomfort has been documented in the patient’s records by the practitioner providing the service; (B) low back pain or urinary symptoms likely due to rectus diastasis and the pain or symptoms have been documented in the patient’s records by the practitioner providing the service; and (iii) has failed to respond to non‑surgical conservative treatment, that must have included physiotherapy; and (iv) has not been pregnant in the last 12 months; and (c) the service is not a service associated with a service to which item 30166, 30169, 30176, 30177, 30179, 30651, 30655, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 46088 or 46090 applies Applicable once per lifetime (H) (Anaes.) (Assist.)	1,062.50
30176	Radical abdominoplasty, with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus, not being a service associated with a service to which item 30166, 30169, 30175, 30177, 30179, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070 or 46072 applies, if the patient has previously had a massive intra‑abdominal or pelvic tumour surgically removed (H) (Anaes.) (Assist.)	1,025.60
30177	Lipectomy, excision of skin and subcutaneous tissue associated with redundant abdominal skin and fat that is a direct consequence of significant weight loss, in conjunction with a radical abdominoplasty, with or without repair of musculoaponeurotic layer and transposition of umbilicus, not being a service associated with a service to which item 30166, 30175, 30176, 30179, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 46088 or 46090 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non‑surgical) treatment; and (b) the redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy (H) (Anaes.) (Assist.)	1,025.60
30179	Circumferential lipectomy, as an independent procedure, to correct circumferential excess of redundant skin and fat that is a direct consequence of significant weight loss, with or without a radical abdominoplasty, not being a service associated with a service to which item 30175, 30176, 30177, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 46088 or 46090 applies, if: (a) the circumferential excess of redundant skin and fat is complicated by intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non‑surgical) treatment; and (b) the circumferential excess of redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy (H) (Anaes.) (Assist.)	1,262.30
30180	Axillary hyperhidrosis, partial excision for (Anaes.)	142.05
30183	Axillary hyperhidrosis, total excision of sweat gland bearing area (Anaes.)	256.50
30187	Palmar or plantar warts, removal of, by carbon dioxide laser or erbium laser, requiring admission to a hospital, or when performed by a specialist in the practice of the specialist’s specialty (5 or more warts) (Anaes.)	267.35
30189	Warts or molluscum contagiosum (one or more), removal of, by any method (other than by chemical means), if undertaken in the operating theatre of a hospital, other than a service associated with a service to which another item in this Group applies (Anaes.)	153.25
30190	Angiofibromas, trichoepitheliomas or other severely disfiguring tumours of the face or neck (excluding melanocytic naevi, sebaceous hyperplasia, dermatosis papulosa nigra, Campbell De Morgan angiomas and seborrheic or viral warts), suitable for laser ablation as confirmed by the opinion of a specialist in the specialty of dermatology—removal of, by carbon dioxide laser or erbium laser ablation, including associated resurfacing (10 or more tumours) (Anaes.)	413.85
30191	Angiofibromas, trichoepithelioma, epidermal naevi, xanthelasma, pyogenic granuloma, genital angiokeratomas, hereditary haemorrhagic telangiectasia and other severely disfiguring or recurrently bleeding tumours (excluding melanocytic naevi, sebaceous hyperplasia, dermatosis papulosa nigra, Campbell De Morgan angiomas and seborrheic or viral warts), treatment of, with carbon dioxide/erbium or other appropriate laser (or curettage and fine point diathermy for pyogenic granuloma only), if confirmed by the opinion of a specialist in the specialty of dermatology, one or more lesions	66.05
30192	Premalignant skin lesions (including solar keratoses), treatment of, by ablative technique (10 or more lesions) (Anaes.)	41.15
30196	Malignant neoplasm of skin or mucous membrane that has been: (a) proven by histopathology; or (b) confirmed by the opinion of a specialist in the specialty of dermatology or plastic surgery where a specimen has been submitted for histologic confirmation; removal of, by serial curettage, or carbon dioxide laser or erbium laser excision‑ablation, including any associated cryotherapy or diathermy (Anaes.)	131.35
30202	Malignant neoplasm of skin or mucous membrane proven by histopathology or confirmed by the opinion of a specialist in the specialty of dermatology or plastic surgery—removal of, by liquid nitrogen cryotherapy using repeat freeze‑thaw cycles	50.30
30207	Skin lesions, multiple injections with glucocorticoid preparations (Anaes.)	46.40
30210	Keloid and other skin lesions, extensive, multiple injections of glucocorticoid preparations, if undertaken in the operating theatre of a hospital (H) (Anaes.)	169.55
30216	Haematoma, aspiration of (Anaes.)	28.45
30219	Haematoma, furuncle, small abscess or similar lesion not requiring admission to a hospital, incision with drainage of, excluding after‑care	28.45
30223	Large haematoma, large abscess, carbuncle, cellulitis or similar lesion, incision with drainage of, excluding after‑care (H) (Anaes.)	169.55
30224	Percutaneous drainage of deep abscess using interventional techniques—but not including imaging (Anaes.)	247.20
30225	Abscess drainage tube, exchange of using interventional techniques—but not including imaging (Anaes.)	278.55
30226	Muscle, excision of (limited) or fasciotomy (Anaes.)	155.85
30229	Muscle, excision of (extensive) (Anaes.) (Assist.)	284.00
30232	Muscle, ruptured, repair of (limited), not associated with external wound (Anaes.)	232.70
30235	Muscle, ruptured, repair of (extensive), not associated with external wound (Anaes.) (Assist.)	307.70
30238	Fascia, deep, repair of, for herniated muscle (Anaes.)	155.85
30241	Bone tumour, innocent, excision of, other than a service to which another item in this Group applies (Anaes.) (Assist.)	370.80
30244	Styloid process of temporal bone, removal of (H) (Anaes.) (Assist.)	370.80
30246	Parotid duct, repair of, using micro‑surgical techniques (H) (Anaes.) (Assist.)	717.75
30247	Parotid gland, total extirpation of, including removal of tumour, other than a service associated with a service to which item 39321, 39324, 39327 or 39330 applies (H) (Anaes.) (Assist.)	769.30
30250	Parotid gland, total extirpation of, with preservation of facial nerve, including: (a) removal of tumour; and (b) exposure or mobilisation of facial nerve; other than a service associated with a service to which item 39321, 39324, 39327 or 39330 applies (H) (Anaes.) (Assist.)	1,301.75
30251	Recurrent parotid tumour, excision of, with preservation of facial nerve, including: (a) removal of tumour; and (b) exposure or mobilisation of facial nerve; other than a service associated with a service to which item 39321, 39324, 39327 or 39330 applies (H) (Anaes.) (Assist.)	1,999.65
30253	Parotid gland, superficial lobectomy of, with exposure of facial nerve, including: (a) removal of tumour; and (b) exposure or mobilisation of facial nerve; other than a service associated with a service to which item 39321, 39324, 39327 or 39330 applies (H) (Anaes.) (Assist.)	867.85
30255	Submandibular ducts, relocation of, for surgical control of drooling (H) (Anaes.) (Assist.)	1,155.65
30256	Submandibular gland, extirpation of, other than a service associated with a service to which item 31423, 31426, 31429, 31432, 31435 or 31438 applies on the same side (H) (Anaes.) (Assist.)	463.50
30257	Sialendoscopy, of submandibular or parotid duct, with or without removal of calculus or treatment of stricture (Anaes.)	528.55
30259	Sublingual gland, extirpation of (Anaes.)	206.60
30262	Salivary gland, dilatation or diathermy of duct (Anaes.)	61.20
30266	Salivary gland, removal of calculus from duct or meatotomy or marsupialisation, one or more such procedures (Anaes.)	155.85
30269	Salivary gland, repair of cutaneous fistula of (Anaes.)	155.85
30272	Tongue, partial excision of (Anaes.) (Assist.)	307.70
30275	Radical excision of intra‑oral tumour, with or without resection of mandible, including dissection of lymph glands of neck, unilateral, other than a service associated with a service to which item 31423, 31426, 31429, 31432, 31435 or 31438 applies on the same side (H) (Anaes.) (Assist.)	1,834.15
30278	Tongue tie, repair of, other than: (a) a service to which another item in this Subgroup applies; or (b) a service associated with a service to which item 45009 applies (Anaes.)	48.40
30281	Tongue tie, mandibular frenulum or maxillary frenulum, repair of, in a person aged 2 years and over, under general anaesthesia, other than a service associated with a service to which item 45009 applies (Anaes.)	124.30
30283	Ranula or mucous cyst of mouth, removal of (Anaes.)	213.00
30286	Branchial cyst, removal of, on a patient 10 years of age or over (Anaes.) (Assist.)	413.95
30287	Branchial cyst, removal of, on a patient under 10 years of age (Anaes.) (Assist.)	538.20
30289	Branchial fistula, removal of, on a patient 10 years of age or over (H) (Anaes.) (Assist.)	522.60
30293	Cervical oesophagostomy, or closure of cervical oesophagostomy with or without plastic repair (Anaes.) (Assist.)	463.50
30294	Cervical oesophagectomy with tracheostomy and oesophagostomy, with or without plastic reconstruction, or laryngopharyngectomy with tracheostomy and plastic reconstruction (H) (Anaes.) (Assist.)	1,834.15
30296	Thyroidectomy, total (H) (Anaes.) (Assist.)	1,065.20
30297	Thyroidectomy following previous thyroid surgery (H) (Anaes.) (Assist.)	1,065.20
30299	Sentinel lymph node biopsy or biopsies for breast cancer, involving dissection in an axilla, using preoperative lymphoscintigraphy and/or lymphotropic dye injection (H) (Anaes.) (Assist.)	777.85
30305	Sentinel lymph node biopsy or biopsies for breast cancer, involving dissection along internal mammary chain (H) (Anaes.) (Assist.)	777.90
30306	Total hemithyroidectomy (H) (Anaes.) (Assist.)	831.00
30310	Partial or subtotal thyroidectomy (H) (Anaes.) (Assist.)	831.00
30311	Sentinel lymph node biopsy or biopsies for cutaneous melanoma, using preoperative lymphoscintigraphy and/or lymphotropic dye injection, if: (a) the primary lesion is greater than 1.0 mm in depth (or at least 0.8 mm in depth in the presence of ulceration); and (b) appropriate excision of the primary melanoma has occurred; and (c) the service is not associated with a service to which item 30075, 30078, 30299, 30305, 30329, 30332, 30618, 30820, 31423, 52025 or 52027 applies Applicable to only one lesion per occasion on which the service is provided (H) (Anaes.) (Assist.)	647.65
30314	Thyroglossal cyst or fistula or both, radical removal of, including thyroglossal duct and portion of hyoid bone, on a patient 10 years of age or over (H) (Anaes.) (Assist.)	475.90
30315	Minimally invasive parathyroidectomy. Removal of one or more parathyroid adenomas through a small cervical incision for an image localised adenoma, including thymectomy Applicable only once per occasion on which the service is provided Not applicable to a service performed in association with a service to which item 30317, 30318 or 30320 applies (H) (Anaes.) (Assist.)	1,186.10
30317	Redo parathyroidectomy. Cervical re‑exploration for persistent or recurrent hyperparathyroidism, including thymectomy and cervical exploration of the mediastinum Applicable only once per occasion on which the service is provided Not applicable to a service performed in association with a service to which item 30315, 30318 or 30320 applies (H) (Anaes.) (Assist.)	1,420.20
30318	Open parathyroidectomy, exploration and removal of one or more adenomas or hyperplastic glands via a cervical incision including thymectomy and cervical exploration of the mediastinum (when performed) Applicable only once per occasion on which the service is provided Not applicable to a service performed in association with a service to which item 30315, 30317 or 30320 applies (H) (Anaes.) (Assist.)	1,186.10
30320	Removal of a mediastinal parathyroid adenoma via sternotomy or mediastinal thorascopic approach Applicable only once per occasion on which the service is provided Not applicable to a service performed in association with a service to which item 30315, 30317 or 30318 applies (H) (Anaes.) (Assist.)	1,420.20
30323	Excision of phaeochromocytoma or extra‑adrenal paraganglioma via endoscopic or open approach (H) (Anaes.) (Assist.)	1,420.20
30324	Excision of an adrenocortical tumour or hyperplasia via endoscopic or open approach (H) (Anaes.) (Assist.)	1,420.20
30326	Thyroglossal cyst or fistula or both, radical removal of, including thyroglossal duct and portion of hyoid bone, on a patient under 10 years of age (H) (Anaes.) (Assist.)	618.65
30329	Lymph nodes of groin, limited excision of (Anaes.)	256.95
30330	Lymph nodes of groin, radical excision of (H) (Anaes.) (Assist.)	747.85
30332	Lymph nodes of axilla, limited excision of (H) (Anaes.) (Assist.)	360.80
30336	Lymph nodes of axilla, complete excision of (H) (Anaes.) (Assist.)	1,082.40
30382	Enterocutaneous fistula, repair of, if dissection and resection of bowel is performed, with or without anastomosis or formation of a stoma (H) (Anaes.) (Assist.)	1,359.85
30384	Open or minimally invasive excision of a retroperitoneal mass, 4 cm or greater in largest dimension, lasting more than 3 hours, other than a service to which another item in this Group applies (H) (Anaes.) (Assist.)	1,420.20
30385	Unplanned return to theatre for laparotomy or laparoscopy for control or drainage of intra‑abdominal haemorrhage following abdominal surgery (H) (Anaes.) (Assist.)	586.15
30387	Laparoscopy or laparotomy when an operation is performed on abdominal, retroperitoneal or pelvic viscera, excluding lymph node biopsy, other than a service to which another item in this Group applies (H) (Anaes.) (Assist.)	660.75
30388	Laparotomy for abdominal trauma, including control of haemorrhage (with or without packing) and containment of contamination (H) (Anaes.) (Assist.)	1,108.20
30390	Laparoscopy, diagnostic, with or without aspiration of fluid, on a patient 10 years of age or over, if no other intra‑abdominal procedure is performed (H) (Anaes.) (Assist)	228.85
30392	Radical or debulking operation for advanced intra‑abdominal malignancy, with or without omentectomy, as an independent procedure (H) (Anaes.) (Assist.)	701.85
30396	Laparotomy or laparoscopy for generalised intra‑peritoneal sepsis (also known as peritonitis), with or without removal of foreign material or enteric contents, with lavage of the entire peritoneal cavity, with or without closure of the abdomen when performed by laparotomy (H) (Anaes.) (Assist.)	1,057.75
30397	Laparostomy, via wound previously made and left open or closed, including change of dressings or packs, with or without drainage of loculated collections (H) (Anaes.)	241.75
30399	Laparostomy, final closure of wound made at previous operation, after removal of dressings or packs (H) (Anaes.) (Assist.)	332.50
30400	Laparotomy with insertion of portacath for administration of cytotoxic therapy including placement of reservoir (H) (Anaes.) (Assist.)	658.10
30406	Paracentesis abdominis (Anaes.)	54.35
30408	Peritoneo venous shunt, insertion of (H) (Anaes.) (Assist.)	408.00
30409	Liver biopsy, percutaneous (Anaes.)	181.50
30411	Liver biopsy by wedge excision when performed in association with another intra‑abdominal procedure (H) (Anaes.)	92.35
30412	Liver biopsy by core needle, when performed in conjunction with another intra‑abdominal procedure (Anaes.)	54.50
30414	Liver, subsegmental resection of, (local excision), other than for trauma (H) (Anaes.) (Assist.)	717.75
30415	Liver, segmental resection of, other than for trauma (H) (Anaes.) (Assist.)	1,435.35
30416	Liver cysts, greater than 5 cm in diameter, marsupialisation of 4 or less (H) (Anaes.) (Assist.)	779.30
30417	Liver cysts, greater than 5 cm in diameter, marsupialisation of 5 or more (H) (Anaes.) (Assist.)	1,168.90
30418	Liver, lobectomy of, other than for trauma (H) (Anaes.) (Assist.)	1,662.30
30419	Liver tumour, other than a hepatocellular carcinoma, destruction of one or more, by local ablation, other than a service associated with a service to which item 50950 or 50952 applies (Anaes.) (Assist.)	850.20
30421	Liver, extended lobectomy of, or central resections of segments 4, 5 and 8, other than for trauma (H) (Anaes.) (Assist.)	2,077.50
30422	Liver, repair of superficial laceration of, for trauma (H) (Anaes.) (Assist.)	702.70
30425	Liver, repair of deep multiple lacerations of, or debridement of, for trauma (H) (Anaes.) (Assist.)	1,359.85
30427	Liver, segmental resection of, for trauma (H) (Anaes.) (Assist.)	1,624.25
30428	Liver, lobectomy of, for trauma (Anaes.) (Assist.)	1,737.65
30430	Liver, extended lobectomy of, or central resections of segments 4, 5 and 8, for trauma (Anaes.) (Assist.)	2,417.40
30431	Liver abscess, single, open or minimally invasive abdominal drainage of, excluding aftercare (Anaes.) (Assist.)	542.40
30433	Liver abscess, multiple, open or minimally invasive abdominal drainage of, excluding aftercare (H) (Anaes.) (Assist.)	755.45
30439	Intraoperative ultrasound of biliary tract, or operative cholangiography, if the service: (a) is performed in association with an intra‑abdominal procedure; and (b) is not associated with a service to which item 30443 or 30445 applies (H) (Anaes.) (Assist.)	193.10
30440	Cholangiogram, percutaneous transhepatic, and insertion of biliary drainage tube, using interventional imaging techniques, other than a service associated with a service to which item 30451 applies (Anaes.) (Assist.)	547.70
30441	Intraoperative ultrasound for staging of intra‑abdominal tumours (H) (Anaes.)	141.80
30442	Choledochoscopy in conjunction with another procedure (H) (Anaes.)	193.10
30443	Cholecystectomy, by any approach, without cholangiogram (H) (Anaes.) (Assist.)	668.45
30445	Cholecystectomy, by any approach, with attempted or completed cholangiogram or intraoperative ultrasound of the biliary system, when performed via laparoscopic or open approach or when conversion from laparoscopic to open approach is required (H) (Anaes.) (Assist.)	865.85
30448	Cholecystectomy, by any approach, involving removal of common duct calculi via the cystic duct, with or without stent insertion (H) (Anaes.) (Assist.)	1,012.35
30449	Cholecystectomy with removal of common duct calculi via choledochotomy, by any approach, with or without insertion of a stent (H) (Anaes.) (Assist.)	1,125.70
30450	Calculus of biliary tract, extraction of, using interventional imaging techniques (Anaes.) (Assist.)	545.65
30451	Biliary drainage tube, exchange of, using interventional imaging techniques, other than a service associated with a service to which item 30440 applies (Anaes.) (Assist.)	278.55
30452	Choledochoscopy with balloon dilatation of a stricture or passage of stent or extraction of calculi (H) (Anaes.) (Assist.)	392.80
30454	Choledochotomy without cholecystectomy, with or without removal of calculi (H) (Anaes.) (Assist.)	1,371.65
30455	Choledochotomy with cholecystectomy, with removal of calculi, including biliary intestinal anastomosis (H) (Anaes.) (Assist.)	1,371.65
30457	Choledochotomy, intrahepatic, involving removal of intrahepatic bile duct calculi (Anaes.) (Assist.)	1,435.35
30458	Transduodenal operation on sphincter of Oddi, involving one or more of, removal of calculi, sphincterotomy, sphincteroplasty, biopsy, local excision of peri‑ampullary or duodenal tumour, sphincteroplasty of the pancreatic duct, pancreatic duct septoplasty, with or without choledochotomy (H) (Anaes.) (Assist.)	1,055.10
30460	Cholecystoduodenostomy, cholecystoenterostomy, choledochojejunostomy or Roux‑en‑Y loop as a bypass procedure when no prior biliary surgery performed (H) (Anaes.) (Assist.)	897.45
30461	Radical resection of porta hepatis (including associated neuro‑lymphatic tissue), for cancer, suspected cancer or choledochal cyst, including bile duct excision and biliary‑enteric anastomoses, other than a service associated with a service to which item 30440, 30451 or 31454 applies (H) (Anaes.) (Assist.)	1,538.30
30463	Radical resection of common hepatic duct and right and left hepatic ducts, with 2 duct anastomoses, for cancer, suspected cancer or choledochal cyst (H) (Anaes.) (Assist.)	1,888.75
30464	Radical resection of common hepatic duct and right and left hepatic ducts, for cancer, suspected cancer or choledochal cyst, involving either or both of the following: (a) more than 2 anastomoses; (b) resection of segment (or major portion of segment) of liver (H) (Anaes.) (Assist.)	2,266.50
30469	Biliary stricture, repair of, after one or more operations on the biliary tree (Anaes.) (Assist.)	1,790.65
30472	Repair of bile duct injury, including immediate reconstruction, other than a service associated with a service to which item 30584 applies (H) (Anaes.) (Assist.)	1,386.90
30473	Oesophagoscopy (other than a service associated with a service to which item 41822 applies), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures), with or without biopsy, other than a service associated with a service to which item 30478 or 30479 applies (Anaes.)	184.30
30475	Endoscopic dilatation of stricture of upper gastrointestinal tract (including the use of imaging intensification if clinically indicated) (Anaes.)	363.10
30478	Oesophagoscopy (other than a service associated with a service to which item 41822 or 41825 applies), gastroscopy, duodenoscopy, panendoscopy or push enteroscopy, one or more such procedures, if: (a) the procedures are performed using one or more of the following endoscopic procedures: (i) polypectomy; (ii) sclerosing or adrenalin injections; (iii) banding; (iv) endoscopic clips; (v) haemostatic powders; (vi) diathermy; (vii) argon plasma coagulation; and (b) the procedures are for the treatment of one or more of the following: (i) upper gastrointestinal tract bleeding; (ii) polyps; (iii) removal of foreign body; (iv) oesophageal or gastric varices; (v) peptic ulcers; (vi) neoplasia; (vii) benign vascular lesions; (viii) strictures of the gastrointestinal tract; (ix) tumorous overgrowth through or over oesophageal stents; other than a service associated with a service to which item 30473 or 30479 applies (Anaes.)	255.55
30479	Endoscopy with laser therapy, for the treatment of one or more of the following: (a) neoplasia; (b) benign vascular lesions; (c) strictures of the gastrointestinal tract; (d) tumorous overgrowth through or over oesophageal stents; (e) peptic ulcers; (f) angiodysplasia; (g) gastric antral vascular ectasia; (h) post‑polypectomy bleeding; other than a service associated with a service to which item 30473 or 30478 applies (Anaes.)	495.35
30481	Percutaneous gastrostomy (initial procedure): (a) including any associated imaging services; and (b) excluding the insertion of a device for the purpose of facilitating weight loss (Anaes.)	371.45
30482	Percutaneous gastrostomy (repeat procedure): (a) including any associated imaging services; and (b) excluding the insertion of a device for the purpose of facilitating weight loss (Anaes.)	264.10
30483	Gastrostomy button, caecostomy antegrade enema device (chait etc.) or stomal indwelling device: (a) non‑endoscopic insertion of; or (b) non‑endoscopic replacement of; on a patient 10 years of age or over, excluding the insertion of a device for the purpose of facilitating weight loss (Anaes.)	184.25
30484	Endoscopic retrograde cholangiopancreatography, other than a service to which item 30664 or 30665 applies (Anaes.)	379.70
30485	Endoscopic sphincterotomy with or without extraction of stones from common bile duct (Anaes.)	586.15
30488	Small bowel intubation—as an independent procedure (Anaes.)	93.65
30490	Oesophageal prosthesis, insertion of, including endoscopy and dilatation (Anaes.)	547.70
30491	Bile duct, endoscopic stenting of (including endoscopy and dilatation) (Anaes.)	577.85
30492	Bile duct, percutaneous stenting of (including dilatation when performed), using interventional imaging techniques (H) (Anaes.)	819.20
30494	Endoscopic biliary dilatation (H) (Anaes.)	437.55
30495	Percutaneous biliary dilatation for biliary stricture using interventional imaging techniques (H) (Anaes.)	819.20
30515	Gastroenterostomy (including gastroduodenostomy), enterocolostomy or enteroenterostomy, as an independent procedure or in combination with another procedure, only if required for irresectable obstruction, other than a service to which any of items 31569 to 31581 apply (H) (Anaes.) (Assist.)	732.90
30517	Revision of gastroenterostomy, pyloroplasty or gastroduodenostomy (H) (Anaes.) (Assist.)	959.55
30518	Partial gastrectomy, not being a service associated with a service to which any of items 31569 to 31581 apply (H) (Anaes.) (Assist.)	1,027.50
30520	Gastric tumour, 2 cm or greater in diameter, removal of, by local excision, by laparoscopic or open approach, including any associated anastomosis, excluding polypectomy, other than a service to which item 30518 applies (H) (Anaes.) (Assist.)	884.00
30521	Gastrectomy, total, for benign disease (H) (Anaes.) (Assist.)	1,503.40
30526	Gastrectomy, total, and removal of lower oesophagus, performed by open or minimally invasive approach, with anastomosis in the mediastinum, including any of the following (if performed): (a) distal pancreatectomy; (b) nodal dissection; (c) splenectomy (H) (Anaes.) (Assist.)	2,243.70
30529	Antireflux operation by fundoplasty, with oesophagoplasty for stricture or short oesophagus (H) (Anaes.) (Assist.)	1,359.85
30530	Antireflux operation by cardiopexy, with or without fundoplasty (H) (Anaes.) (Assist.)	816.00
30532	Oesophagogastric myotomy (Heller’s operation) by endoscopic, abdominal or thoracic approach, whether performed by open or minimally invasive approach, including fundoplication when performed laparoscopically (H) (Anaes.) (Assist.)	936.90
30533	Oesophagogastric myotomy (Heller’s operation) via abdominal or thoracic approach, with fundoplasty, with or without closure of the diaphragmatic hiatus, by laparoscopy or open operation (H) (Anaes.) (Assist.)	1,114.40
30559	Oesophagus, local excision for tumour of (Anaes.) (Assist.)	884.00
30560	Oesophageal perforation, repair of, by abdominal or thoracic approach, including thoracic drainage (H) (Anaes.) (Assist.)	982.05
30562	Enterostomy or colostomy, closure of (not involving resection of bowel), on a patient 10 years of age or over (H) (Anaes.) (Assist.)	619.05
30563	Colostomy or ileostomy, refashioning of, on a patient 10 years of age or over (Anaes.) (Assist.)	619.05
30565	Small intestine, resection of, without anastomosis (including formation of stoma) (H) (Anaes.) (Assist.)	906.65
30574	Appendicectomy, when performed in conjunction with another intra‑abdominal procedure and during which a specimen is collected and sent for pathological testing (H) (Anaes.)	64.10
30577	Initial pancreatic necrosectomy by open, laparoscopic or endoscopic approach, excluding aftercare (H) (Anaes.) (Assist.)	1,133.30
30583	Distal pancreatectomy with splenic preservation, by open or minimally invasive approach (H) (Anaes.) (Assist.)	1,617.35
30584	Pancreatico‑duodenectomy (Whipple’s procedure), with or without preservation of pylorus, including any of the following (if performed): (a) cholecystectomy; (b) pancreatico‑biliary anastomosis; (c) gastro‑jejunal anastomosis (H) (Anaes.) (Assist.)	3,121.55
30589	Pancreatico‑jejunostomy for pancreatitis or trauma (H) (Anaes.) (Assist.)	1,301.75
30590	Pancreatico‑jejunostomy following previous pancreatic surgery (H) (Anaes.) (Assist.)	1,435.35
30593	Pancreatectomy, near total or total (including duodenum), with or without splenectomy (Anaes.) (Assist.)	1,964.20
30594	Pancreatectomy for pancreatitis following previously attempted drainage procedure or partial resection (H) (Anaes.) (Assist.)	2,266.50
30596	Splenorrhaphy or partial splenectomy (H) (Anaes.) (Assist.)	933.65
30599	Splenectomy, for massive spleen (weighing more than 1,500 g) or involving thoraco‑abdominal incision (H) (Anaes.) (Assist.)	1,359.85
30600	Emergency repair of diaphragmatic laceration or hernia, following recent trauma, by any approach, including when performed in conjunction with another procedure indicated as a result of abdominal or chest trauma (H) (Anaes.) (Assist.)	808.60
30601	Diaphragmatic hernia, congenital, or delayed presentation of traumatic rupture, repair of, by thoracic or abdominal approach, on a patient 10 years of age or over, other than a service to which any of items 31569 to 31581 apply (H) (Anaes.) (Assist.)	996.10
30606	Portal hypertension, oesophageal transection via stapler or oversew of gastric varices with or without devascularisation (H) (Anaes.) (Assist.)	1,155.80
30608	Small intestine, resection of, with anastomosis, on a patient under 10 years of age (H) (Anaes.) (Assist.)	1,309.25
30611	Benign tumour of soft tissue (other than tumours of skin, cartilage and bone, simple lipomas covered by item 31345 and lipomata), removal of, by surgical excision, on a patient under 10 years of age, if the specimen excised is sent for histological confirmation of diagnosis, other than a service to which another item in this Group applies (Anaes.) (Assist.)	586.20
30615	Strangulated, incarcerated or obstructed hernia, repair of, without bowel resection, on a patient 10 years of age or over (H) (Anaes.) (Assist.)	542.40
30618	Lymph nodes of neck, selective dissection of one or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck, on a patient under 10 years of age (Anaes.) (Assist.)	543.40
30619	Laparoscopic splenectomy, on a patient under 10 years of age (H) (Anaes.) (Assist.)	974.20
30621	Repair of symptomatic umbilical, epigastric or linea alba hernia requiring mesh or other repair, by open or minimally invasive approach, in a patient 10 years of age or over, other than a service to which item 30651 or 30655 applies (H) (Anaes.) (Assist.)	424.00
30622	Caecostomy, enterostomy, colostomy, enterotomy, colotomy, cholecystostomy, gastrostomy, gastrotomy, reduction of intussusception, removal of Meckel’s diverticulum, suture of perforated peptic ulcer, simple repair of ruptured viscus, reduction of volvulus, pyloroplasty or drainage of pancreas, on a patient under 10 years of age (H) (Anaes.) (Assist.)	705.15
30623	Laparotomy involving division of peritoneal adhesions (if no other intra‑abdominal procedure is performed), on a patient under 10 years of age (H) (Anaes.) (Assist.)	705.15
30626	Laparotomy involving division of adhesions in association with another intra‑abdominal procedure if the time taken to divide the adhesions is between 45 minutes and 2 hours, on a patient under 10 years of age (H) (Anaes.) (Assist.)	708.40
30627	Laparoscopy, diagnostic, if no other intra‑abdominal procedure is performed, on a patient under 10 years of age (H) (Anaes.)	297.55
30628	Hydrocele, tapping of	37.05
30629	Orchidectomy, radical, including spermatic cord, unilateral, for tumour, inguinal approach, without insertion of testicular prosthesis, other than a service associated with a service to which item 30631, 30635, 30641, 30643 or 30644 applies (H) (Anaes.) (Assist.)	542.40
30630	Insertion of testicular prosthesis, at least 6 months after orchidectomy (H) (Anaes.) (Assist.)	518.90
30631	Hydrocele, removal of, other than a service associated with a service to which item 30641, 30642 or 30644 applies (Anaes.)	246.25
30635	Varicocele, surgical correction of, including microsurgical techniques, other than a service associated with a service to which item 30390, 30627, 30641, 30642 or 30644 applies—one procedure (H) (Anaes.) (Assist.)	303.60
30636	Gastrostomy button, caecostomy antegrade enema device (chait etc.) or stomal indwelling device, non‑endoscopic insertion of, or non‑endoscopic replacement of, on a patient under 10 years of age (Anaes.)	242.60
30637	Enterostomy or colostomy, closure of (not involving resection of bowel), on a patient under 10 years of age (H) (Anaes.) (Assist.)	804.90
30639	Colostomy or ileostomy, refashioning of, on a patient under 10 years of age (Anaes.) (Assist.)	804.90
30640	Repair of large and irreducible scrotal hernia, if surgery exceeds 2 hours, in a patient 10 years of age or over, other than a service to which item 30615, 30621, 30648, 30651 or 30655 applies (H) (Anaes.) (Assist.)	952.05
30641	Orchidectomy, simple or subcapsular, unilateral with or without insertion of testicular prosthesis (H) (Anaes.) (Assist.)	424.00
30642	Orchidectomy, radical, including spermatic cord, unilateral, for tumour, inguinal approach, with insertion of testicular prosthesis, other than a service associated with a service to which item 30631, 30635, 30641, 30643, 30644 or 45051 applies (H) (Anaes.) (Assist.)	788.90
30643	Exploration of spermatic cord, inguinal approach, with or without testicular biopsy, with or without excision of spermatic cord lesion, for a patient under 10 years of age, other than a service associated with a service to which item 30629, 30630 or 30642 applies (H) (Anaes.) (Assist.)	705.15
30644	Exploration of spermatic cord, inguinal approach, with or without testicular biopsy, with or without excision of spermatic cord lesion, for a patient at least 10 years of age, other than a service associated with a service to which item 30629, 30630 or 30642 applies (H) (Anaes.) (Assist.)	542.40
30645	Appendicectomy, on a patient under 10 years of age, other than a service to which item 30574 applies (H) (Anaes.) (Assist.)	602.40
30646	Laparoscopic appendicectomy, on a patient under 10 years of age (H) (Anaes.) (Assist.)	602.40
30648	Femoral or inguinal hernia or infantile hydrocele, repair of, by open or minimally invasive approach, on a patient 10 years of age or over, other than a service to which item 30615 or 30651 applies (H) (Anaes.) (Assist.)	483.35
30649	Haemorrhage, arrest of, following circumcision requiring general anaesthesia, on a patient under 10 years of age (Anaes.)	195.25
30651	Ventral hernia repair involving primary fascial closure by suture, with or without onlay mesh or insertion of intraperitoneal onlay mesh repair, without closure of the defect or advancement of the rectus muscle toward the midline, by open or minimally invasive approach, in a patient 10 years of age or over, other than a service associated with a service to which item 30175, 30621, 30655 or 30657 applies (H) (Anaes.) (Assist.)	542.40
30652	Recurrent groin hernia regardless of size of defect, repair of, with or without mesh, by open or minimally invasive approach, in a patient 10 years of age or over (H) (Anaes.) (Assist.)	542.40
30654	Circumcision of the penis, with topical or local analgesia, other than a service to which item 30658 applies	48.40
30655	Ventral hernia, repair of, with advancement of the rectus muscles to the midline using a retro‑rectus, pre‑peritoneal or sublay technique, by open or minimally invasive approach, in a patient 10 years of age or over, other than a service associated with a service to which item 30175, 30621 or 30651 applies (H) (Anaes.) (Assist.)	952.05
30657	Unilateral abdominal wall reconstruction with component separation, including transversus abdominus release and external oblique release for abdominal wall closure by mobilising the rectus abdominis muscles to the midline, by open or minimally invasive approach (H) (Anaes.) (Assist.)	1,355.65
30658	Circumcision of the penis, when performed under general or regional anaesthesia and in conjunction with a service to which an item in Group T7 or Group T10 applies (Anaes.)	147.70
30661	Minor surgical repair following a complication from the circumcision of a penis, when performed in conjunction with a service to which an item in Group T7 or Group T10 applies, other than a service associated with a service to which item 45206 applies (H) (Anaes.)	405.50
30662	Complex surgical repair following a complication from the circumcision of a penis, including single stage local flap, if indicated, to repair one defect, on genitals (other than a service associated with a service to which item 37819, 37822, 45200, 45201, 45202, 45203 or 45206 applies) (H) (Anaes.) (Assist.)	810.90
30663	Haemorrhage, arrest of, following circumcision requiring general anaesthesia, on a patient 10 years of age or over (Anaes.)	150.20
30664	Endoscopic retrograde cholangiopancreatography (ERCP), with single operator, single use peroral cholangiopancreatoscopy (POCPS) and biopsy, for the diagnosis of biliary strictures for a patient for whom: (a) a previous ERCP service has been provided; and (b) results from guided brush cytology or intraductal biopsy (or both) are indeterminate Applicable not more than 2 times in a 12 month period, or not more than 3 times in a 12 month period if the patient has been diagnosed with primary sclerosing cholangitis (PSC) (H) (Anaes.) (Assist.)	644.40
30665	Endoscopic retrograde cholangiopancreatography (ERCP), with single operator, single use peroral cholangiopancreatoscopy (POCPS) and electrohydraulic or laser lithotripsy for the removal of biliary stones that are: (a) greater than 10mm in diameter; or (b) proximal to a stricture; for a patient for whom there has been at least one failed attempt at removal via ERCP extraction techniques Applicable not more than 2 times per treatment cycle (H) (Anaes.) (Assist.)	901.35
30666	Paraphimosis or phimosis, reduction of, under general anaesthesia, with or without dorsal incision, other than a service associated with a service to which another item in this Group applies (Anaes.)	49.35
30672	Coccyx, excision of (H) (Anaes.) (Assist.)	463.50
30676	Pilonidal sinus or cyst, or sacral sinus or cyst, definitive excision of (Anaes.)	394.40
30679	Pilonidal sinus, injection of sclerosant fluid under anaesthesia (Anaes.)	100.20
30680	Balloon enteroscopy, examination of the small bowel (oral approach), with or without biopsy, without intraprocedural therapy, for diagnosis of patients with obscure gastrointestinal bleeding if the patient: (a) has recurrent or persistent bleeding; and (b) is anaemic or has active bleeding; and (c) has had an upper gastrointestinal endoscopy and a colonoscopy performed that did not identify the cause of the bleeding; not in association with another item in this Subgroup (other than item 30682 or 30686) (Anaes.)	1,217.40
30682	Balloon enteroscopy, examination of the small bowel (anal approach), with or without biopsy, without intraprocedural therapy, for diagnosis of patients with obscure gastrointestinal bleeding if the patient: (a) has recurrent or persistent bleeding; and (b) is anaemic or has active bleeding; and (c) has had an upper gastrointestinal endoscopy and a colonoscopy performed that did not identify the cause of the bleeding; not in association with another item in this Subgroup (other than item 30680 or 30684) (Anaes.)	1,217.40
30684	Balloon enteroscopy, examination of the small bowel (oral approach), with or without biopsy, with one or more of the following procedures—snare polypectomy, removal of foreign body, diathermy, heater probe, laser coagulation or argon plasma coagulation, for diagnosis and management of patients with obscure gastrointestinal bleeding if the patient: (a) has recurrent or persistent bleeding; and (b) is anaemic or has active bleeding; and (c) has had an upper gastrointestinal endoscopy and a colonoscopy performed that did not identify the cause of the bleeding; not in association with another item in this Subgroup (other than item 30682 or 30686) (Anaes.)	1,498.20
30686	Balloon enteroscopy, examination of the small bowel (anal approach), with or without biopsy, with one or more of the following procedures—snare polypectomy, removal of foreign body, diathermy, heater probe, laser coagulation or argon plasma coagulation, for diagnosis and management of patients with obscure gastrointestinal bleeding if the patient: (a) has recurrent or persistent bleeding; and (b) is anaemic or has active bleeding; and (c) has had an upper gastrointestinal endoscopy and a colonoscopy performed that did not identify the cause of the bleeding; not in association with another item in this Subgroup (other than item 30680 or 30684) (Anaes.)	1,498.20
30687	Endoscopy with radiofrequency ablation of mucosal metaplasia for the treatment of Barrett’s Oesophagus in a single course of treatment, following diagnosis of high grade dysplasia confirmed by histological examination (Anaes.)	495.35
30688	Endoscopic ultrasound (endoscopy with ultrasound imaging), with or without biopsy, for the staging of one or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup (other than item 30484, 30485, 30491 or 30494) and other than a service associated with the routine monitoring of chronic pancreatitis (Anaes.)	379.70
30690	Endoscopic ultrasound (endoscopy with ultrasound imaging), with or without biopsy, with fine needle aspiration (including aspiration of the locoregional lymph nodes if performed, for the staging of one or more of oesophageal, gastric or pancreatic cancer), not in association with another item in this Subgroup (other than item 30484, 30485, 30491 or 30494) and other than a service associated with the routine monitoring of chronic pancreatitis (Anaes.)	586.15
30692	Endoscopic ultrasound (endoscopy with ultrasound imaging), with or without biopsy, for the diagnosis of one or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup (other than item 30484, 30485, 30491 or 30494) and other than a service associated with the routine monitoring of chronic pancreatitis (Anaes.)	379.70
30694	Endoscopic ultrasound (endoscopy with ultrasound imaging), with or without biopsy, with fine needle aspiration for the diagnosis of one or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup (other than item 30484, 30485, 30491 or 30494) and other than a service associated with the routine monitoring of chronic pancreatitis (Anaes.)	586.15
30720	Appendicectomy, on a patient 10 years of age or over, whether performed by: (a) laparoscopy or right iliac fossa open incision; or (b) conversion of a laparoscopy to an open right iliac fossa incision; other than a service to which item 30574 applies (H) (Anaes.) (Assist.)	463.50
30721	Laparotomy or laparoscopy, or laparoscopy converted to laparotomy, with or without associated biopsies, including the division of adhesions (if performed, but only if the time taken to divide adhesions is 45 minutes or less), if no other intra‑abdominal procedure is performed (H) (Anaes.) (Assist.)	502.85
30722	Laparotomy or laparoscopy, on a patient 10 years of age or over, including any of the following procedures (if performed, and including division of one or more adhesions, but only if the time taken to divide the adhesions is 45 minutes or less): (a) colostomy; (b) colotomy; (c) cholecystostomy; (d) enterostomy; (e) enterotomy; (f) gastrostomy; (g) gastrotomy; (h) caecostomy; (i) gastric fixation by cardiopexy; (j) reduction of intussusception; (k) simple repair of ruptured viscus (including perforated peptic ulcer); (l) reduction of volvulus; (m) drainage of pancreas (H) (Anaes.) (Assist.)	542.40
30723	Laparotomy, laparoscopy or extra‑peritoneal approach, for drainage of an intra‑abdominal, pancreatic or retroperitoneal collection or abscess (H) (Anaes.) (Assist.)	542.40
30724	Laparotomy or laparoscopy with division of adhesions, lasting more than 45 minutes but less than 2 hours, performed either: (a) as a primary procedure; or (b) when the division of adhesions is performed in conjunction with another primary procedure—to provide access to a surgical field (but excluding mobilisation or normal anatomical dissection of the organ or structure for which the primary procedure is being carried out) (H) (Anaes.) (Assist.)	544.95
30725	Laparotomy or laparoscopy for intestinal obstruction or division of extensive, complex adhesions, lasting 2 hours or more, performed either: (a) as a primary procedure; or (b) when the division of adhesions is performed in conjunction with another procedure—to provide access to a surgical field, but excluding mobilisation or normal anatomical dissection of the organ or structure for which the other procedure is being carried out (H) (Anaes.) (Assist.)	965.75
30730	Small intestine, resection of, including either of the following: (a) a small bowel diverticulum (such as Meckel’s procedure) with anastomosis; (b) stricturoplasty (H) (Anaes.) (Assist.)	1,007.10
30731	Intraoperative enterotomy for visualisation of the small intestine by endoscopy, including endoscopic examination using a flexible endoscope, with or without biopsies (H) (Anaes.) (Assist.)	755.45
30732	Peritonectomy, lasting more than 5 hours, including hyperthermic intra‑peritoneal chemotherapy (H) (Anaes.) (Assist.)	4,136.10
30750	Oesophagectomy with colon or jejunal interposition graft, by any approach, including: (a) any gastrointestinal anastomoses (except vascular anastomoses); and (b) anastomoses in the chest or neck (if appropriate) One surgeon (H) (Anaes.) (Assist.)	2,145.80
30751	Oesophagectomy with colon or jejunal interposition graft, by any approach, including: (a) any gastrointestinal anastomoses (except vascular anastomoses); and (b) anastomoses in the chest or neck (if appropriate) Conjoint surgery, principal surgeon (H) (Anaes.) (Assist.)	2,145.80
30752	Oesophagectomy with colon or jejunal interposition graft, by any approach, including: (a) any gastrointestinal anastomoses (except vascular anastomoses); and (b) anastomoses in the chest or neck (if appropriate) Conjoint surgery, co‑surgeon (H) (Anaes.) (Assist.)	1,609.35
30753	Oesophagectomy, by any approach, including: (a) gastric reconstruction by abdominal mobilisation, thoracotomy or thoracoscopy; and (b) anastomosis in the neck or chest One surgeon (H) (Anaes.) (Assist.)	1,790.65
30754	Oesophagectomy, by any approach, including: (a) gastric reconstruction by abdominal mobilisation, thoracotomy or thoracoscopy; and (b) anastomosis in the neck or chest Conjoint surgery, principal surgeon (H) (Anaes.) (Assist.)	1,790.65
30755	Oesophagectomy by any approach, including: (a) gastric reconstruction by abdominal mobilisation, thoracotomy or thoracoscopy; and (b) anastomosis in the neck or chest Conjoint surgery, co‑surgeon (H) (Anaes.) (Assist.)	1,343.00
30756	Antireflux operation by fundoplasty, with or without cardiopexy, by any approach, with or without closure of the diaphragmatic hiatus, other than a service to which item 30601 applies (H) (Anaes.) (Assist.)	906.65
30760	Vagotomy, with or without gastroenterostomy, pyloroplasty or other drainage procedure (H) (Anaes.) (Assist.)	611.95
30761	Bleeding peptic ulcer, control of, by laparoscopy or laparotomy, involving suture of bleeding point or wedge excision (with or without gastric resection), including either of the following (if performed): (a) vagotomy and pyloroplasty; (b) gastroenterostomy (H) (Anaes.) (Assist.)	789.45
30762	Gastrectomy, subtotal or total radical, for carcinoma, by open or minimally invasive approach, including all necessary anastomoses, including either or both of the following (if performed): (a) extended lymph node dissection; (b) splenectomy (H) (Anaes.) (Assist.)	1,730.05
30763	Gastric tumour, 2cm or greater in diameter, removal of, by local excision, by endoscopic approach, including any required anastomosis, excluding polypectomy, other than a service to which item 30518 applies (H) (Anaes.) (Assist.)	702.70
30770	Hydatid cyst of liver, peritoneum or viscus, complete removal of contents of, with or without suture of biliary radicles, with omentoplasty or myeloplasty (H) (Anaes.) (Assist.)	870.25
30771	Portal hypertension, porto‑caval, meso‑caval or selective spleno‑renal shunt for (H) (Anaes.) (Assist.)	1,755.20
30780	Intrahepatic biliary bypass of left or right hepatic ductal system by Roux‑en‑Y loop to peripheral ductal system (H) (Anaes.) (Assist.)	1,461.85
30790	Pancreatic cyst anastomosis to stomach, duodenum or small intestine, by endoscopic, open or minimally invasive approach, with or without the use of endoscopic or intraoperative ultrasound (H) (Anaes.) (Assist.)	729.70
30791	Pancreatic necrosectomy, by open, laparoscopic or endoscopic approach, excluding aftercare, subsequent procedure (H) (Anaes.) (Assist.)	453.35
30792	Distal pancreatectomy with splenectomy, by open or minimally invasive approach (H) (Anaes.) (Assist.)	1,242.65
30800	Splenectomy, by open or minimally invasive approach, other than a service to which item 30792 applies (H) (Anaes.) (Assist.)	749.40
30810	Exploration of pancreas or duodenum for endocrine tumour, including associated imaging, either: (a) followed by local excision of tumour; or (b) when, after extensive exploration, no tumour is found (H) (Anaes.) (Assist.)	1,193.70
30820	Lymph node of neck, biopsy of, by open procedure, if the specimen excised is sent for pathological examination (Anaes.)	191.35
31000	Mohs surgery of skin tumour located on the head, neck, genitalia, hand, digits, leg (below knee) or foot, utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon—6 or fewer sections (Anaes.)	604.45
31001	Mohs surgery of skin tumour located on the head, neck, genitalia, hand, digits, leg (below